data_2lrc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.359 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 114.751 0.661 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 120.156 -0.246 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 114.119 0.408 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.418 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 N-CA-C 113.827 0.291 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 55' ' ' LYS . 45.5 m-85 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 N-CA-C 113.511 0.165 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.483 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 N-CA-C 113.871 0.308 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 113.395 0.118 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 tpp . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.39 -23.41 46.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 p -115.31 154.35 29.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.403 1.481 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -93.79 -175.3 3.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.845 2.058 . . . . 0.0 111.509 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.98 156.71 30.38 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -80.53 92.83 5.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.7 -9.23 58.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.956 1.302 . . . . 0.0 114.428 -165.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.19 -72.8 1.16 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.718 1.151 . . . . 0.0 111.389 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.22 -22.09 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.247 3.298 . . . . 0.0 113.918 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.01 -167.23 34.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.045 1.307 . . . . 0.0 114.757 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -60.05 135.57 57.75 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.562 0.745 . . . . 0.0 111.231 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -78.59 51.23 1.04 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.744 1.618 . . . . 0.0 112.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.35 -36.27 75.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 113.108 -168.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.23 -21.63 62.12 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.523 1.058 . . . . 0.0 114.674 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.87 -19.31 65.71 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.053 1.741 . . . . 0.0 114.628 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 p -64.89 159.03 23.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.493 1.917 . . . . 0.0 113.245 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.1 169.15 17.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.262 1.425 . . . . 0.0 110.817 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.0 152.89 26.64 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -77.89 116.22 18.23 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.1 132.62 55.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.768 1.227 . . . . 0.0 111.281 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.42 -168.08 12.66 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.908 1.242 . . . . 0.0 113.372 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 135.78 71.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.43 2.753 . . . . 0.0 112.497 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.58 -15.2 10.0 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 124.866 1.222 . . . . 0.0 114.365 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 72.65 152.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.581 3.152 . . . . 0.0 113.992 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -98.94 -112.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 109.279 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.4 -32.44 70.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.988 1.315 . . . . 0.0 113.078 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.02 67.85 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 121.099 -1.001 . . . . 0.0 114.504 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.56 -1.99 18.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.271 1.828 . . . . 0.0 115.201 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -58.54 149.87 24.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.241 2.216 . . . . 0.0 112.013 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -69.34 170.8 9.64 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.995 1.318 . . . . 0.0 113.076 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -58.42 154.51 13.63 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -68.29 118.87 11.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.49 147.47 47.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.362 -0.836 . . . . 0.0 112.723 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.25 164.2 30.05 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.493 1.044 . . . . 0.0 113.446 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.05 -30.26 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.548 2.832 . . . . 0.0 113.436 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.93 113.68 4.53 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 125.158 1.361 . . . . 0.0 111.667 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 52.18 -132.47 1.94 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 112.14 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 75.71 155.89 0.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.597 2.759 . . . . 0.0 111.184 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.5 tp -57.32 -31.26 65.51 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.814 1.646 . . . . 0.0 113.898 -163.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.69 65.8 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 119.3 0.954 . . . . 0.0 114.751 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.93 -133.47 1.61 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.222 1.809 . . . . 0.0 113.06 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 p -78.73 148.53 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.75 1.62 . . . . 0.0 112.248 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.81 168.1 17.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.143 1.377 . . . . 0.0 112.498 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -68.35 158.05 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.24 109.51 5.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -91.99 -150.41 0.26 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.492 2.317 . . . . 0.0 110.007 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 -133.58 11.69 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.895 1.712 . . . . 0.0 110.038 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.12 -33.0 95.0 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.134 2.556 . . . . 0.0 113.669 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.52 118.01 5.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.52 1.057 . . . . 0.0 110.837 167.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.17 29.88 0.91 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.597 1.559 . . . . 0.0 112.25 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -61.52 134.47 56.9 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.325 1.45 . . . . 0.0 112.158 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tp 71.97 -44.15 0.58 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.708 2.803 . . . . 0.0 112.574 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.88 72.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.211 1.369 . . . . 0.0 113.177 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.611 0.243 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.24 -24.75 37.15 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -169.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -73.01 129.72 38.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.743 1.217 . . . . 0.0 110.895 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 163.09 28.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 0.0 113.269 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.22 153.77 4.97 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -73.21 106.28 4.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.86 154.59 25.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.573 1.149 . . . . 0.0 112.688 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.29 179.33 24.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.343 1.449 . . . . 0.0 113.952 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -52.03 138.68 52.77 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.542 3.495 . . . . 0.0 112.968 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.48 49.55 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.955 1.265 . . . . 0.0 114.113 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 77.18 122.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.44 2.696 . . . . 0.0 111.216 173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -93.36 -131.7 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.517 1.527 . . . . 0.0 110.376 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.3 tp -52.35 -36.69 54.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.031 1.287 . . . . 0.0 113.333 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.71 -20.22 59.24 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 124.653 1.121 . . . . 0.0 114.667 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 121.122 0.487 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.23 -40.3 62.5 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.487 -0.758 . . . . 0.0 112.185 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.0 p -90.63 161.27 15.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.018 1.727 . . . . 0.0 110.699 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -150.58 164.58 35.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.501 1.12 . . . . 0.0 113.188 -166.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.13 167.33 12.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.066 1.346 . . . . 0.0 113.401 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -74.95 96.51 3.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.37 -40.06 77.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.835 0.854 . . . . 0.0 112.53 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.51 11.2 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -86.21 -5.04 8.59 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.441 2.094 . . . . 0.0 114.403 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.1 44.43 0.17 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 119.674 1.124 . . . . 0.0 113.88 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -75.1 -170.77 1.21 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.425 1.49 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -60.53 150.37 31.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.103 1.361 . . . . 0.0 112.846 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.1 tp 102.68 -55.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 130.836 3.654 . . . . 0.0 112.571 163.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.97 -26.48 70.23 Favored Glycine 0 N--CA 1.482 1.743 0 CA-C-N 120.563 1.528 . . . . 0.0 114.119 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 120.6 0.238 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -70.89 0.73 6.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 0.0 114.132 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.1 p -71.8 -17.57 62.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.45 2.3 . . . . 0.0 113.185 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.11 146.52 32.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.052 1.341 . . . . 0.0 112.507 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -93.75 165.95 12.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -79.39 132.69 36.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.17 149.11 50.93 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.271 1.428 . . . . 0.0 112.303 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 62' ' ' ARG . . . 97.01 -117.45 5.77 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -165.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.39 106.8 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.441 2.094 . . . . 0.0 109.273 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.9 -10.4 6.67 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.899 1.237 . . . . 0.0 115.351 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 59' ' ' GLY . 90.4 mtt180 -55.1 -30.37 59.58 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.71 -35.02 70.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.786 0.834 . . . . 0.0 112.669 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -66.27 -54.11 28.74 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.734 -0.603 . . . . 0.0 110.076 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.18 -29.73 71.96 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 118.947 0.794 . . . . 0.0 114.218 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.42 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.42 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -79.53 166.74 21.62 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.892 1.677 . . . . 0.0 112.774 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -69.32 162.85 26.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.874 1.27 . . . . 0.0 110.967 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -172.86 4.23 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.69 1.596 . . . . 0.0 111.118 -174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -64.15 149.01 48.65 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.22 100.71 1.73 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -100.87 -172.96 2.27 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.771 2.028 . . . . 0.0 111.137 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.1 171.37 27.03 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.897 -1.127 . . . . 0.0 114.72 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 -30.36 29.93 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.062 3.175 . . . . 0.0 113.751 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.27 88.98 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.265 0.936 . . . . 0.0 114.048 171.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 72.76 125.13 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.347 3.059 . . . . 0.0 112.474 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -94.14 -111.07 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.816 1.646 . . . . 0.0 108.978 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.37 -30.95 71.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.481 1.491 . . . . 0.0 111.63 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -24.43 58.64 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 119.344 0.975 . . . . 0.0 114.374 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -61.74 -26.57 68.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.047 1.339 . . . . 0.0 114.054 -172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -26.96 57.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.08 1.752 . . . . 0.0 113.639 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -70.67 148.82 47.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 113.566 -166.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -77.5 172.3 13.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.672 1.989 . . . . 0.0 115.954 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.26 71.43 2.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.43 10.81 1.47 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.044 2.137 . . . . 0.0 113.695 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.73 -86.03 1.47 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.014 1.293 . . . . 0.0 110.527 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.85 -13.28 9.4 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.268 3.312 . . . . 0.0 114.587 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.2 -167.78 34.23 Favored Glycine 0 N--CA 1.472 1.076 0 CA-C-N 119.512 1.051 . . . . 0.0 113.85 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -62.49 -23.76 67.1 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 69.47 159.28 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.222 2.609 . . . . 0.0 112.046 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.0 tp -151.15 -28.11 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.216 . . . . 0.0 112.287 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.16 -23.78 66.51 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 120.222 1.374 . . . . 0.0 113.544 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.285 0.564 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.3 138.72 39.54 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.456 168.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.9 p -86.2 151.73 23.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.228 1.011 . . . . 0.0 112.574 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -84.48 -25.24 29.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.436 1.494 . . . . 0.0 112.924 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.13 161.25 31.43 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.107 1.763 . . . . 0.0 113.208 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.95 75.9 3.53 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.93 29.59 0.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.823 2.449 . . . . 0.0 112.775 -162.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.89 -74.26 0.71 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.915 1.721 . . . . 0.0 111.472 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -60.08 -38.05 80.13 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.555 2.837 . . . . 0.0 115.846 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.51 169.84 39.08 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-N 118.503 0.592 . . . . 0.0 114.403 -175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 51.68 46.79 25.97 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.443 1.497 . . . . 0.0 111.668 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -71.78 78.24 0.86 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.913 2.085 . . . . 0.0 112.125 -170.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.0 -29.01 64.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.4 1.88 . . . . 0.0 113.388 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.2 -23.04 67.73 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.476 1.034 . . . . 0.0 114.439 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.418 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 110.845 -0.058 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -76.4 -0.15 21.74 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.0 p -64.29 163.83 12.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.581 1.552 . . . . 0.0 112.828 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.16 149.11 50.48 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -172.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -65.52 161.75 19.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.994 1.718 . . . . 0.0 114.659 171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.29 112.22 8.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.48 -125.0 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.235 1.814 . . . . 0.0 109.754 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.51 17.88 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.103 1.335 . . . . 0.0 111.767 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -30.24 22.81 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.709 2.272 . . . . 0.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.59 97.81 2.35 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.66 142.48 58.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.777 0.831 . . . . 0.0 112.209 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -153.67 119.35 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.802 1.241 . . . . 0.0 112.014 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 tp 67.12 -45.21 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.565 3.146 . . . . 0.0 114.752 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.09 -21.31 65.78 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 120.253 1.388 . . . . 0.0 113.827 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -69.84 145.16 52.28 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.517 0.727 . . . . 0.0 112.068 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -82.94 156.89 23.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.614 1.566 . . . . 0.0 111.568 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -80.41 -29.41 37.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.464 1.506 . . . . 0.0 113.668 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 55' ' ' LYS . 45.5 m-85 -86.44 161.4 18.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.608 1.963 . . . . 0.0 114.271 178.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.68 75.17 3.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.78 28.49 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.34 2.256 . . . . 0.0 112.593 -168.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -61.1 2.43 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.34 -1.811 . . . . 0.0 113.543 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.79 71.06 7.24 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.769 2.98 . . . . 0.0 110.681 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.16 168.6 32.98 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.603 1.097 . . . . 0.0 112.657 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -71.14 118.3 13.75 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.682 0.393 . . . . 0.0 110.319 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -90.83 -120.1 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.018 1.727 . . . . 0.0 108.554 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.13 -30.37 64.35 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.854 1.206 . . . . 0.0 112.166 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.47 -19.22 59.83 Favored Glycine 0 N--CA 1.477 1.372 0 CA-C-N 119.315 0.961 . . . . 0.0 114.803 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.91 -39.93 63.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.666 1.186 . . . . 0.0 112.369 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.26 173.0 10.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.558 1.943 . . . . 0.0 110.774 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.09 153.02 33.1 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.088 1.755 . . . . 0.0 111.6 174.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -109.32 166.84 10.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.0 1.32 . . . . 0.0 113.871 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.18 111.56 10.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -89.12 -18.31 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.06 1.344 . . . . 0.0 113.445 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -38.53 95.29 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.069 1.795 . . . . 0.0 114.051 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -62.2 -8.94 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.986 3.124 . . . . 0.0 115.794 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.35 32.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.693 1.139 . . . . 0.0 114.246 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -56.29 140.39 45.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.708 1.203 . . . . 0.0 113.21 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.6 1.69 57.12 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.102 1.361 . . . . 0.0 114.494 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.52 -49.87 75.8 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.971 1.259 . . . . 0.0 110.701 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.53 84.46 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 119.555 1.071 . . . . 0.0 113.511 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 137.53 57.16 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.738 1.615 . . . . 0.0 113.804 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.6 m -79.83 136.87 36.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.811 1.645 . . . . 0.0 111.375 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.8 143.08 30.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.258 1.023 . . . . 0.0 112.874 -171.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -82.24 169.32 16.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.314 2.246 . . . . 0.0 115.395 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -70.96 94.91 1.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -105.29 10.31 33.62 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 113.022 -163.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.6 -42.86 7.59 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.89 1.709 . . . . 0.0 114.018 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.0 178.21 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.424 3.416 . . . . 0.0 113.84 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.69 -28.84 73.97 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.14 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -75.93 122.13 23.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.342 1.057 . . . . 0.0 109.591 167.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.09 155.33 44.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.647 1.579 . . . . 0.0 111.865 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.0 tp -114.48 -33.52 5.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.119 1.367 . . . . 0.0 111.309 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.27 -20.25 60.58 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 119.72 1.145 . . . . 0.0 114.441 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -68.94 -23.19 64.13 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -167.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.3 p -77.33 -49.28 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 111.839 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -91.49 -159.62 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.882 2.073 . . . . 0.0 111.087 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.05 147.13 50.41 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.8 -1.188 . . . . 0.0 112.532 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -76.78 110.64 11.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -89.35 132.62 34.87 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.284 1.034 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.95 -142.56 3.44 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.288 -1.284 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.27 -31.82 34.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.842 2.361 . . . . 0.0 112.016 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.09 107.16 3.4 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.717 1.151 . . . . 0.0 110.454 167.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -86.44 59.94 5.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.634 1.174 . . . . 0.0 110.56 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -61.8 -23.46 66.24 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -160.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.42 -38.53 0.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.697 0.799 . . . . 0.0 112.982 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.06 -25.14 69.26 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 120.113 1.324 . . . . 0.0 114.171 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -93.74 -11.45 31.39 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.003 1.321 . . . . 0.0 113.384 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -89.9 -27.32 19.95 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -124.61 152.18 43.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.061 1.345 . . . . 0.0 112.968 -166.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 -102.08 162.97 12.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -163.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -73.63 71.04 1.38 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.94 -15.95 61.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.51 1.524 . . . . 0.0 113.986 -155.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.5 -73.74 0.95 Allowed Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.656 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -87.13 -17.34 3.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.709 2.939 . . . . 0.0 114.622 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.24 -159.58 29.8 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.508 1.051 . . . . 0.0 114.165 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -57.53 -35.9 70.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.695 0.798 . . . . 0.0 112.806 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 77.71 133.06 0.05 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.335 2.654 . . . . 0.0 110.436 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -135.13 -30.02 1.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.095 1.358 . . . . 0.0 111.969 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.27 63.22 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 119.63 1.105 . . . . 0.0 113.871 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -76.84 -39.88 49.73 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.398 1.079 . . . . 0.0 112.974 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.7 m -81.64 146.65 29.96 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.22 1.408 . . . . 0.0 111.721 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 152.95 31.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.768 1.627 . . . . 0.0 111.561 168.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.52 158.46 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.547 1.539 . . . . 0.0 113.428 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.76 128.93 37.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -119.97 144.72 47.34 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.273 1.429 . . . . 0.0 111.483 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.38 -166.26 11.4 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.156 1.36 . . . . 0.0 113.834 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.9 -25.9 22.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.276 2.651 . . . . 0.0 112.237 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.53 143.25 19.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.438 1.018 . . . . 0.0 111.447 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.53 148.61 41.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -161.65 -176.34 5.24 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.821 2.048 . . . . 0.0 108.35 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.5 tp -38.26 -40.21 0.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.884 2.873 . . . . 0.0 116.112 -173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.91 -27.09 66.35 Favored Glycine 0 N--CA 1.483 1.814 0 CA-C-N 120.451 1.478 . . . . 0.0 114.793 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -72.83 -24.27 60.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 166.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -71.73 141.6 49.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.658 1.983 . . . . 0.0 110.064 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.83 168.05 12.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.126 1.371 . . . . 0.0 113.431 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -59.28 163.0 4.14 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.007 1.323 . . . . 0.0 113.017 164.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -64.78 105.95 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -105.23 -163.1 0.92 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.409 1.884 . . . . 0.0 109.481 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 -166.15 38.52 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.754 -1.841 . . . . 0.0 115.047 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.52 -41.74 74.85 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 124.23 3.287 . . . . 0.0 112.172 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.74 109.26 3.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -67.59 146.48 53.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.731 0.812 . . . . 0.0 112.346 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 -119.56 -122.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.709 1.604 . . . . 0.0 109.604 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -53.56 -37.45 62.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.392 1.477 . . . . 0.0 113.352 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.24 -22.85 63.57 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.487 1.04 . . . . 0.0 114.553 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.22 -9.58 48.17 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.4 p -69.32 162.74 26.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.027 1.731 . . . . 0.0 112.574 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.62 161.83 16.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -67.0 164.68 17.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.79 1.636 . . . . 0.0 114.843 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -72.38 111.21 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -94.0 141.78 28.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.334 1.053 . . . . 0.0 112.197 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -172.19 43.17 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.107 1.336 . . . . 0.0 113.472 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.99 138.28 61.73 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.277 2.651 . . . . 0.0 110.125 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.69 1.4 90.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.625 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.46 129.38 56.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.633 1.573 . . . . 0.0 110.14 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.12 -16.69 12.98 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -166.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.36 -48.4 80.71 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.678 1.126 . . . . 0.0 112.297 -168.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.45 -26.74 72.8 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-N 119.123 0.874 . . . . 0.0 114.089 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.428 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.75 -12.9 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.018 1.327 . . . . 0.0 114.569 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -71.64 -68.1 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.36 1.864 . . . . 0.0 111.973 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -176.41 2.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.235 1.814 . . . . 0.0 113.118 177.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -62.85 159.08 17.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -76.21 118.59 19.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -100.12 171.16 7.99 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.021 1.329 . . . . 0.0 112.022 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.23 -169.96 28.5 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 120.908 -1.12 . . . . 0.0 113.682 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.26 -40.86 80.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.282 3.321 . . . . 0.0 113.165 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.85 4.62 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 161.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -77.3 134.76 38.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 117.335 0.567 . . . . 0.0 112.257 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -79.8 -85.46 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.466 1.506 . . . . 0.0 112.196 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.0 tp -106.42 -33.95 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.099 0.96 . . . . 0.0 113.523 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.52 -22.0 63.2 Favored Glycine 0 N--CA 1.481 1.652 0 CA-C-N 119.591 1.087 . . . . 0.0 113.395 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.446 ' CE2' ' HB ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 76' ' ' PHE . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.359 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD21 ' HE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 HG11 HD22 ' A' ' 97' ' ' LEU . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.59 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' HD13 ' A' ' 23' ' ' LEU . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.525 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 76' ' ' PHE . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 114.751 0.661 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.538 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.538 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 120.156 -0.246 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 23' ' ' LEU . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.549 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.459 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.47 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 114.119 0.408 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 97' ' ' LEU . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.507 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 44' ' ' VAL . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 25.7 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.531 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 97' ' ' LEU . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 23' ' ' LEU . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 97' ' ' LEU . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 23' ' ' LEU . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 97' ' ' LEU . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 N-CA-C 113.827 0.291 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.544 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.558 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 76' ' ' PHE . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 N-CA-C 113.511 0.165 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 23' ' ' LEU . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 55' ' ' LYS . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.445 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.483 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 N-CA-C 113.871 0.308 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 23' ' ' LEU . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 97' ' ' LEU . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 23' ' ' LEU . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 40.9 m-85 . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 29.8 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 76' ' ' PHE . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 113.395 0.118 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 tpp . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.39 -23.41 46.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 p -115.31 154.35 29.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.403 1.481 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -93.79 -175.3 3.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.845 2.058 . . . . 0.0 111.509 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.98 156.71 30.38 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 76' ' ' PHE . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -80.53 92.83 5.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.7 -9.23 58.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.956 1.302 . . . . 0.0 114.428 -165.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.19 -72.8 1.16 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.718 1.151 . . . . 0.0 111.389 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.22 -22.09 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.247 3.298 . . . . 0.0 113.918 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.01 -167.23 34.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.045 1.307 . . . . 0.0 114.757 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -60.05 135.57 57.75 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.562 0.745 . . . . 0.0 111.231 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -78.59 51.23 1.04 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.744 1.618 . . . . 0.0 112.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.35 -36.27 75.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 113.108 -168.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.23 -21.63 62.12 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.523 1.058 . . . . 0.0 114.674 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD21 ' HE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.87 -19.31 65.71 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.053 1.741 . . . . 0.0 114.628 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 p -64.89 159.03 23.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.493 1.917 . . . . 0.0 113.245 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.1 169.15 17.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.262 1.425 . . . . 0.0 110.817 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.0 152.89 26.64 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 HG11 HD22 ' A' ' 97' ' ' LEU . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -77.89 116.22 18.23 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.1 132.62 55.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.768 1.227 . . . . 0.0 111.281 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.42 -168.08 12.66 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.908 1.242 . . . . 0.0 113.372 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 135.78 71.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.43 2.753 . . . . 0.0 112.497 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.58 -15.2 10.0 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 124.866 1.222 . . . . 0.0 114.365 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 72.65 152.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.581 3.152 . . . . 0.0 113.992 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -98.94 -112.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 109.279 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.4 -32.44 70.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.988 1.315 . . . . 0.0 113.078 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.02 67.85 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 121.099 -1.001 . . . . 0.0 114.504 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.59 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' HD13 ' A' ' 23' ' ' LEU . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.525 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.56 -1.99 18.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.271 1.828 . . . . 0.0 115.201 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -58.54 149.87 24.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.241 2.216 . . . . 0.0 112.013 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -69.34 170.8 9.64 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.995 1.318 . . . . 0.0 113.076 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -58.42 154.51 13.63 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 76' ' ' PHE . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -68.29 118.87 11.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.49 147.47 47.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.362 -0.836 . . . . 0.0 112.723 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.25 164.2 30.05 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.493 1.044 . . . . 0.0 113.446 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.05 -30.26 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.548 2.832 . . . . 0.0 113.436 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.93 113.68 4.53 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 125.158 1.361 . . . . 0.0 111.667 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 52.18 -132.47 1.94 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 112.14 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 75.71 155.89 0.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.597 2.759 . . . . 0.0 111.184 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.5 tp -57.32 -31.26 65.51 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.814 1.646 . . . . 0.0 113.898 -163.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.69 65.8 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 119.3 0.954 . . . . 0.0 114.751 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.538 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.538 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.93 -133.47 1.61 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.222 1.809 . . . . 0.0 113.06 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 p -78.73 148.53 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.75 1.62 . . . . 0.0 112.248 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.81 168.1 17.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.143 1.377 . . . . 0.0 112.498 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -68.35 158.05 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.24 109.51 5.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -91.99 -150.41 0.26 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.492 2.317 . . . . 0.0 110.007 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 -133.58 11.69 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.895 1.712 . . . . 0.0 110.038 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.12 -33.0 95.0 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.134 2.556 . . . . 0.0 113.669 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.52 118.01 5.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.52 1.057 . . . . 0.0 110.837 167.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.17 29.88 0.91 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.597 1.559 . . . . 0.0 112.25 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -61.52 134.47 56.9 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.325 1.45 . . . . 0.0 112.158 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tp 71.97 -44.15 0.58 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.708 2.803 . . . . 0.0 112.574 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.88 72.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.211 1.369 . . . . 0.0 113.177 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 23' ' ' LEU . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.549 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.611 0.243 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.24 -24.75 37.15 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -169.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -73.01 129.72 38.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.743 1.217 . . . . 0.0 110.895 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 163.09 28.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 0.0 113.269 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.22 153.77 4.97 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -73.21 106.28 4.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.86 154.59 25.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.573 1.149 . . . . 0.0 112.688 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.29 179.33 24.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.343 1.449 . . . . 0.0 113.952 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -52.03 138.68 52.77 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.542 3.495 . . . . 0.0 112.968 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.48 49.55 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.955 1.265 . . . . 0.0 114.113 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 77.18 122.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.44 2.696 . . . . 0.0 111.216 173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -93.36 -131.7 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.517 1.527 . . . . 0.0 110.376 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.3 tp -52.35 -36.69 54.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.031 1.287 . . . . 0.0 113.333 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.71 -20.22 59.24 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 124.653 1.121 . . . . 0.0 114.667 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.459 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 121.122 0.487 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.23 -40.3 62.5 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.487 -0.758 . . . . 0.0 112.185 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.0 p -90.63 161.27 15.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.018 1.727 . . . . 0.0 110.699 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -150.58 164.58 35.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.501 1.12 . . . . 0.0 113.188 -166.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.13 167.33 12.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.066 1.346 . . . . 0.0 113.401 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.47 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -74.95 96.51 3.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.37 -40.06 77.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.835 0.854 . . . . 0.0 112.53 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.51 11.2 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -86.21 -5.04 8.59 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.441 2.094 . . . . 0.0 114.403 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.1 44.43 0.17 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 119.674 1.124 . . . . 0.0 113.88 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -75.1 -170.77 1.21 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.425 1.49 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -60.53 150.37 31.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.103 1.361 . . . . 0.0 112.846 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.1 tp 102.68 -55.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 130.836 3.654 . . . . 0.0 112.571 163.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.97 -26.48 70.23 Favored Glycine 0 N--CA 1.482 1.743 0 CA-C-N 120.563 1.528 . . . . 0.0 114.119 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 120.6 0.238 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -70.89 0.73 6.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 0.0 114.132 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.1 p -71.8 -17.57 62.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.45 2.3 . . . . 0.0 113.185 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.11 146.52 32.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.052 1.341 . . . . 0.0 112.507 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -93.75 165.95 12.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 97' ' ' LEU . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -79.39 132.69 36.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.17 149.11 50.93 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.271 1.428 . . . . 0.0 112.303 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.01 -117.45 5.77 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.39 106.8 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.441 2.094 . . . . 0.0 109.273 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.9 -10.4 6.67 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.899 1.237 . . . . 0.0 115.351 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -55.1 -30.37 59.58 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.71 -35.02 70.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.786 0.834 . . . . 0.0 112.669 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -66.27 -54.11 28.74 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.734 -0.603 . . . . 0.0 110.076 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.18 -29.73 71.96 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 118.947 0.794 . . . . 0.0 114.218 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.507 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 44' ' ' VAL . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -79.53 166.74 21.62 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.892 1.677 . . . . 0.0 112.774 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -69.32 162.85 26.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.874 1.27 . . . . 0.0 110.967 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -172.86 4.23 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.69 1.596 . . . . 0.0 111.118 -174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 25.7 m-85 -64.15 149.01 48.65 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.22 100.71 1.73 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -100.87 -172.96 2.27 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.771 2.028 . . . . 0.0 111.137 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.1 171.37 27.03 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.897 -1.127 . . . . 0.0 114.72 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 -30.36 29.93 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.062 3.175 . . . . 0.0 113.751 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.27 88.98 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.265 0.936 . . . . 0.0 114.048 171.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 72.76 125.13 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.347 3.059 . . . . 0.0 112.474 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -94.14 -111.07 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.816 1.646 . . . . 0.0 108.978 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.37 -30.95 71.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.481 1.491 . . . . 0.0 111.63 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -24.43 58.64 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 119.344 0.975 . . . . 0.0 114.374 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.531 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -61.74 -26.57 68.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.047 1.339 . . . . 0.0 114.054 -172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -26.96 57.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.08 1.752 . . . . 0.0 113.639 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -70.67 148.82 47.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 113.566 -166.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -77.5 172.3 13.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.672 1.989 . . . . 0.0 115.954 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 97' ' ' LEU . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.26 71.43 2.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.43 10.81 1.47 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.044 2.137 . . . . 0.0 113.695 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.73 -86.03 1.47 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.014 1.293 . . . . 0.0 110.527 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.85 -13.28 9.4 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.268 3.312 . . . . 0.0 114.587 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.2 -167.78 34.23 Favored Glycine 0 N--CA 1.472 1.076 0 CA-C-N 119.512 1.051 . . . . 0.0 113.85 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -62.49 -23.76 67.1 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 69.47 159.28 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.222 2.609 . . . . 0.0 112.046 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.0 tp -151.15 -28.11 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.216 . . . . 0.0 112.287 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.16 -23.78 66.51 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 120.222 1.374 . . . . 0.0 113.544 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 23' ' ' LEU . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.285 0.564 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.3 138.72 39.54 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.456 168.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.9 p -86.2 151.73 23.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.228 1.011 . . . . 0.0 112.574 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -84.48 -25.24 29.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.436 1.494 . . . . 0.0 112.924 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.13 161.25 31.43 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.107 1.763 . . . . 0.0 113.208 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 97' ' ' LEU . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.95 75.9 3.53 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.93 29.59 0.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.823 2.449 . . . . 0.0 112.775 -162.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.89 -74.26 0.71 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.915 1.721 . . . . 0.0 111.472 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -60.08 -38.05 80.13 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.555 2.837 . . . . 0.0 115.846 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.51 169.84 39.08 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-N 118.503 0.592 . . . . 0.0 114.403 -175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 51.68 46.79 25.97 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.443 1.497 . . . . 0.0 111.668 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -71.78 78.24 0.86 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.913 2.085 . . . . 0.0 112.125 -170.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.0 -29.01 64.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.4 1.88 . . . . 0.0 113.388 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.2 -23.04 67.73 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.476 1.034 . . . . 0.0 114.439 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 23' ' ' LEU . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 110.845 -0.058 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -76.4 -0.15 21.74 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.0 p -64.29 163.83 12.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.581 1.552 . . . . 0.0 112.828 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.16 149.11 50.48 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -172.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -65.52 161.75 19.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.994 1.718 . . . . 0.0 114.659 171.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 97' ' ' LEU . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.29 112.22 8.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.48 -125.0 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.235 1.814 . . . . 0.0 109.754 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.51 17.88 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.103 1.335 . . . . 0.0 111.767 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -30.24 22.81 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.709 2.272 . . . . 0.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.59 97.81 2.35 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.66 142.48 58.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.777 0.831 . . . . 0.0 112.209 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -153.67 119.35 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.802 1.241 . . . . 0.0 112.014 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 tp 67.12 -45.21 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.565 3.146 . . . . 0.0 114.752 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.09 -21.31 65.78 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 120.253 1.388 . . . . 0.0 113.827 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.544 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -69.84 145.16 52.28 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.517 0.727 . . . . 0.0 112.068 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -82.94 156.89 23.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.614 1.566 . . . . 0.0 111.568 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -80.41 -29.41 37.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.464 1.506 . . . . 0.0 113.668 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -86.44 161.4 18.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.608 1.963 . . . . 0.0 114.271 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.68 75.17 3.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.78 28.49 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.34 2.256 . . . . 0.0 112.593 -168.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -61.1 2.43 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.34 -1.811 . . . . 0.0 113.543 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.79 71.06 7.24 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.769 2.98 . . . . 0.0 110.681 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.16 168.6 32.98 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.603 1.097 . . . . 0.0 112.657 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -71.14 118.3 13.75 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.682 0.393 . . . . 0.0 110.319 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -90.83 -120.1 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.018 1.727 . . . . 0.0 108.554 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.13 -30.37 64.35 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.854 1.206 . . . . 0.0 112.166 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.47 -19.22 59.83 Favored Glycine 0 N--CA 1.477 1.372 0 CA-C-N 119.315 0.961 . . . . 0.0 114.803 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.91 -39.93 63.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.666 1.186 . . . . 0.0 112.369 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.26 173.0 10.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.558 1.943 . . . . 0.0 110.774 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.09 153.02 33.1 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.088 1.755 . . . . 0.0 111.6 174.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -109.32 166.84 10.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.0 1.32 . . . . 0.0 113.871 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 76' ' ' PHE . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.18 111.56 10.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -89.12 -18.31 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.06 1.344 . . . . 0.0 113.445 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -38.53 95.29 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.069 1.795 . . . . 0.0 114.051 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -62.2 -8.94 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.986 3.124 . . . . 0.0 115.794 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.35 32.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.693 1.139 . . . . 0.0 114.246 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -56.29 140.39 45.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.708 1.203 . . . . 0.0 113.21 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.6 1.69 57.12 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.102 1.361 . . . . 0.0 114.494 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.52 -49.87 75.8 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.971 1.259 . . . . 0.0 110.701 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.53 84.46 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 119.555 1.071 . . . . 0.0 113.511 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 23' ' ' LEU . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 137.53 57.16 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.738 1.615 . . . . 0.0 113.804 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.6 m -79.83 136.87 36.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.811 1.645 . . . . 0.0 111.375 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.8 143.08 30.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.258 1.023 . . . . 0.0 112.874 -171.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -82.24 169.32 16.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.314 2.246 . . . . 0.0 115.395 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 55' ' ' LYS . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -70.96 94.91 1.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -105.29 10.31 33.62 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 113.022 -163.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.6 -42.86 7.59 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.89 1.709 . . . . 0.0 114.018 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.0 178.21 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.424 3.416 . . . . 0.0 113.84 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.69 -28.84 73.97 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.14 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -75.93 122.13 23.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.342 1.057 . . . . 0.0 109.591 167.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.09 155.33 44.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.647 1.579 . . . . 0.0 111.865 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.0 tp -114.48 -33.52 5.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.119 1.367 . . . . 0.0 111.309 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.27 -20.25 60.58 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 119.72 1.145 . . . . 0.0 114.441 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -68.94 -23.19 64.13 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -167.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.3 p -77.33 -49.28 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 111.839 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -91.49 -159.62 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.882 2.073 . . . . 0.0 111.087 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.05 147.13 50.41 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.8 -1.188 . . . . 0.0 112.532 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.445 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -76.78 110.64 11.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -89.35 132.62 34.87 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.284 1.034 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.95 -142.56 3.44 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.288 -1.284 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.27 -31.82 34.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.842 2.361 . . . . 0.0 112.016 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.09 107.16 3.4 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.717 1.151 . . . . 0.0 110.454 167.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -86.44 59.94 5.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.634 1.174 . . . . 0.0 110.56 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -61.8 -23.46 66.24 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -160.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.42 -38.53 0.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.697 0.799 . . . . 0.0 112.982 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.06 -25.14 69.26 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 120.113 1.324 . . . . 0.0 114.171 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -93.74 -11.45 31.39 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.003 1.321 . . . . 0.0 113.384 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -89.9 -27.32 19.95 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -124.61 152.18 43.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.061 1.345 . . . . 0.0 112.968 -166.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 -102.08 162.97 12.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -163.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -73.63 71.04 1.38 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.94 -15.95 61.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.51 1.524 . . . . 0.0 113.986 -155.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.5 -73.74 0.95 Allowed Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.656 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -87.13 -17.34 3.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.709 2.939 . . . . 0.0 114.622 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.24 -159.58 29.8 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.508 1.051 . . . . 0.0 114.165 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -57.53 -35.9 70.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.695 0.798 . . . . 0.0 112.806 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 77.71 133.06 0.05 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.335 2.654 . . . . 0.0 110.436 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -135.13 -30.02 1.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.095 1.358 . . . . 0.0 111.969 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.27 63.22 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 119.63 1.105 . . . . 0.0 113.871 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 23' ' ' LEU . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -76.84 -39.88 49.73 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.398 1.079 . . . . 0.0 112.974 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.7 m -81.64 146.65 29.96 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.22 1.408 . . . . 0.0 111.721 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 152.95 31.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.768 1.627 . . . . 0.0 111.561 168.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.52 158.46 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.547 1.539 . . . . 0.0 113.428 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.76 128.93 37.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -119.97 144.72 47.34 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.273 1.429 . . . . 0.0 111.483 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.38 -166.26 11.4 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.156 1.36 . . . . 0.0 113.834 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.9 -25.9 22.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.276 2.651 . . . . 0.0 112.237 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.53 143.25 19.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.438 1.018 . . . . 0.0 111.447 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.53 148.61 41.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -161.65 -176.34 5.24 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.821 2.048 . . . . 0.0 108.35 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.5 tp -38.26 -40.21 0.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.884 2.873 . . . . 0.0 116.112 -173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.91 -27.09 66.35 Favored Glycine 0 N--CA 1.483 1.814 0 CA-C-N 120.451 1.478 . . . . 0.0 114.793 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -72.83 -24.27 60.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 166.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -71.73 141.6 49.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.658 1.983 . . . . 0.0 110.064 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.83 168.05 12.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.126 1.371 . . . . 0.0 113.431 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -59.28 163.0 4.14 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.007 1.323 . . . . 0.0 113.017 164.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 97' ' ' LEU . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -64.78 105.95 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -105.23 -163.1 0.92 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.409 1.884 . . . . 0.0 109.481 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 -166.15 38.52 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.754 -1.841 . . . . 0.0 115.047 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.52 -41.74 74.85 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 124.23 3.287 . . . . 0.0 112.172 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.74 109.26 3.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -67.59 146.48 53.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.731 0.812 . . . . 0.0 112.346 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 -119.56 -122.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.709 1.604 . . . . 0.0 109.604 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -53.56 -37.45 62.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.392 1.477 . . . . 0.0 113.352 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.24 -22.85 63.57 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.487 1.04 . . . . 0.0 114.553 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 23' ' ' LEU . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.22 -9.58 48.17 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.4 p -69.32 162.74 26.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.027 1.731 . . . . 0.0 112.574 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.62 161.83 16.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 40.9 m-85 -67.0 164.68 17.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.79 1.636 . . . . 0.0 114.843 175.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -72.38 111.21 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -94.0 141.78 28.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.334 1.053 . . . . 0.0 112.197 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -172.19 43.17 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.107 1.336 . . . . 0.0 113.472 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.99 138.28 61.73 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.277 2.651 . . . . 0.0 110.125 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.69 1.4 90.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.625 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.46 129.38 56.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.633 1.573 . . . . 0.0 110.14 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.12 -16.69 12.98 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -166.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.36 -48.4 80.71 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.678 1.126 . . . . 0.0 112.297 -168.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.45 -26.74 72.8 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-N 119.123 0.874 . . . . 0.0 114.089 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.75 -12.9 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.018 1.327 . . . . 0.0 114.569 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -71.64 -68.1 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.36 1.864 . . . . 0.0 111.973 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -176.41 2.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.235 1.814 . . . . 0.0 113.118 177.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 29.8 m-85 -62.85 159.08 17.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 76' ' ' PHE . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -76.21 118.59 19.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -100.12 171.16 7.99 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.021 1.329 . . . . 0.0 112.022 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.23 -169.96 28.5 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 120.908 -1.12 . . . . 0.0 113.682 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.26 -40.86 80.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.282 3.321 . . . . 0.0 113.165 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.85 4.62 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 161.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -77.3 134.76 38.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 117.335 0.567 . . . . 0.0 112.257 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -79.8 -85.46 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.466 1.506 . . . . 0.0 112.196 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.0 tp -106.42 -33.95 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.099 0.96 . . . . 0.0 113.523 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.52 -22.0 63.2 Favored Glycine 0 N--CA 1.481 1.652 0 CA-C-N 119.591 1.087 . . . . 0.0 113.395 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 76' ' ' PHE . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.359 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD21 ' HE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 HG11 HD22 ' A' ' 97' ' ' LEU . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.411 0 N-CA-C 114.504 0.562 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.59 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' HD13 ' A' ' 23' ' ' LEU . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.525 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 76' ' ' PHE . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.552 0 N-CA-C 114.751 0.661 . . . . 0.0 114.751 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.538 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.538 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 120.156 -0.246 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 23' ' ' LEU . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.549 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.362 0 N-CA-C 114.667 0.627 . . . . 0.0 114.667 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.459 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.47 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 . . . . . 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 114.119 0.408 . . . . 0.0 114.119 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 97' ' ' LEU . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.218 0.447 . . . . 0.0 114.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.507 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 44' ' ' VAL . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 25.7 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.531 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 97' ' ' LEU . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 23' ' ' LEU . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 97' ' ' LEU . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 N-CA-C 114.439 0.536 . . . . 0.0 114.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 23' ' ' LEU . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 97' ' ' LEU . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.424 0 N-CA-C 113.827 0.291 . . . . 0.0 113.827 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.544 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.558 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.372 0 N-CA-C 114.803 0.681 . . . . 0.0 114.803 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 76' ' ' PHE . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.154 0 N-CA-C 113.511 0.165 . . . . 0.0 113.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 23' ' ' LEU . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 55' ' ' LYS . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 . . . . . 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 114.441 0.536 . . . . 0.0 114.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.445 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.483 0 N-CA-C 114.171 0.428 . . . . 0.0 114.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.411 0 N-CA-C 113.871 0.308 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 23' ' ' LEU . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 97' ' ' LEU . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.46 0 N-CA-C 114.553 0.581 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 23' ' ' LEU . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 40.9 m-85 . . . . . 0 CA--C 1.544 0.746 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 29.8 m-85 . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 76' ' ' PHE . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 113.395 0.118 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 tpp . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -78.39 -23.41 46.81 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.7 p -115.31 154.35 29.3 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.403 1.481 . . . . 0.0 112.751 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -93.79 -175.3 3.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.845 2.058 . . . . 0.0 111.509 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.98 156.71 30.38 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -124.99 128.21 48.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.947 1.299 . . . . 0.0 112.601 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.05 -23.14 41.59 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.535 1.134 . . . . 0.0 112.376 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -78.44 23.03 0.31 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.86 2.464 . . . . 0.0 113.355 -170.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 156.53 71.38 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.412 1.485 . . . . 0.0 113.323 -175.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.5 161.86 43.26 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.154 3.236 . . . . 0.0 112.304 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.19 157.93 32.18 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.608 164.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 48.3 tpt85 -60.42 -29.6 69.09 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.65 -29.41 36.7 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.722 0.809 . . . . 0.0 112.84 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -74.94 -38.8 61.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.944 -1.097 . . . . 0.0 110.688 175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -57.65 -36.03 71.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.776 1.631 . . . . 0.0 112.149 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -66.92 -14.99 63.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.451 1.101 . . . . 0.0 112.651 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -85.8 -14.2 45.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.181 1.393 . . . . 0.0 113.616 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.428 1.013 . . . . 0.0 111.643 173.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.11 120.02 8.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.511 0.725 . . . . 0.0 111.83 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.68 165.77 11.24 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.202 1.858 . . . . 0.0 112.512 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.49 108.32 1.8 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.984 2.456 . . . . 0.0 109.35 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.5 m -136.68 115.63 12.31 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.286 1.034 . . . . 0.0 109.679 -169.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 76' ' ' PHE . 31.0 tp -85.52 125.51 33.13 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.38 -0.825 . . . . 0.0 109.654 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.6 t -109.05 115.52 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.67 126.99 52.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.696 1.998 . . . . 0.0 111.98 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -103.43 137.08 42.01 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.809 1.244 . . . . 0.0 110.322 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.7 -149.71 19.09 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.934 0.778 . . . . 0.0 111.701 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.0 p -146.5 176.72 9.6 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.356 1.862 . . . . 0.0 109.772 168.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -82.64 -3.16 55.83 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.41 -0.806 . . . . 0.0 112.646 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -128.9 -13.1 4.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -164.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.1 t -70.98 144.67 50.42 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.082 1.31 . . . . 0.0 111.243 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.05 -24.14 68.38 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.468 1.509 . . . . 0.0 113.478 176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -62.59 -49.13 76.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.926 1.363 . . . . 0.0 110.608 167.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -65.92 -33.8 76.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -64.17 -21.27 66.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.311 0.959 . . . . 0.0 112.556 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.48 -39.77 11.77 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.088 1.755 . . . . 0.0 112.976 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.93 -30.82 28.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -59.88 -53.07 68.95 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-O 117.408 -1.282 . . . . 0.0 113.38 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.91 -18.43 46.73 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.187 1.925 . . . . 0.0 112.444 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -56.21 11.32 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.93 -49.08 74.46 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 124.319 1.047 . . . . 0.0 108.798 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.23 -37.39 62.0 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -70.69 -48.05 56.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.48 0.712 . . . . 0.0 112.309 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.52 -48.91 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 118.667 0.667 . . . . 0.0 111.908 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.56 -24.24 65.26 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.892 1.677 . . . . 0.0 113.774 -173.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -60.47 -18.24 50.2 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -101.81 -7.14 22.8 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.327 1.451 . . . . 0.0 113.822 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -131.92 44.81 1.46 Allowed Pre-proline 0 CA--C 1.559 1.307 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.66 -13.93 36.91 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 123.712 2.941 . . . . 0.0 114.802 -173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -73.87 -15.23 61.16 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.6 t -75.65 143.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 119.149 0.886 . . . . 0.0 109.157 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.72 24.58 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.213 -0.929 . . . . 0.0 111.291 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -132.78 128.94 37.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.229 1.514 . . . . 0.0 111.855 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.8 tp -120.39 107.28 12.73 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.272 1.429 . . . . 0.0 109.753 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -86.25 95.51 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.45 1.1 . . . . 0.0 111.526 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.09 115.61 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.004 0.922 . . . . 0.0 111.183 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -80.53 92.83 5.96 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.144 1.378 . . . . 0.0 110.815 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.7 -9.23 58.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.956 1.302 . . . . 0.0 114.428 -165.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.19 -72.8 1.16 Allowed Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.718 1.151 . . . . 0.0 111.389 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.22 -22.09 4.2 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.247 3.298 . . . . 0.0 113.918 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.01 -167.23 34.53 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.045 1.307 . . . . 0.0 114.757 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -60.05 135.57 57.75 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.562 0.745 . . . . 0.0 111.231 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -78.59 51.23 1.04 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.744 1.618 . . . . 0.0 112.977 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.4 tp -59.35 -36.27 75.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 113.108 -168.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.23 -21.63 62.12 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.523 1.058 . . . . 0.0 114.674 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -60.97 -48.5 81.53 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.33 1.065 . . . . 0.0 110.671 168.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.9 m -81.67 -9.67 59.59 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.902 1.281 . . . . 0.0 112.794 -175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -89.09 -9.27 51.73 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.22 1.008 . . . . 0.0 113.337 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.58 49.09 10.92 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.753 1.621 . . . . 0.0 110.685 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.92 136.88 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 126.09 1.756 . . . . 0.0 112.067 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -63.12 1.39 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.059 . . . . 0.0 113.209 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.9 tp -107.98 141.4 39.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.358 1.063 . . . . 0.0 109.344 169.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 47.3 t90 -54.18 -45.2 99.22 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -169.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.51 89.92 1.24 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.351 2.034 . . . . 0.0 109.98 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.3 m -137.31 147.84 45.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.569 1.548 . . . . 0.0 108.8 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -137.66 126.5 24.0 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.565 174.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.7 t -101.75 119.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.573 1.549 . . . . 0.0 108.926 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.9 m-85 -80.64 115.53 20.19 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -100.13 162.42 12.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 122.287 1.041 . . . . 0.0 110.376 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -156.94 137.13 12.78 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.632 2.373 . . . . 0.0 106.894 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.1 t70 61.97 14.31 6.31 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.428 1.091 . . . . 0.0 113.361 -168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.38 16.68 77.67 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.489 1.043 . . . . 0.0 114.502 -173.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -133.49 150.06 51.72 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.545 1.538 . . . . 0.0 110.789 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -61.23 126.92 29.09 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.662 0.785 . . . . 0.0 113.062 -175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.32 -22.14 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.73 1.612 . . . . 0.0 112.509 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.37 177.89 2.51 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.935 2.094 . . . . 0.0 110.439 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -153.96 157.81 39.71 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.561 1.144 . . . . 0.0 111.152 163.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 49.5 t -116.42 125.63 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 170.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.66 125.15 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.749 1.62 . . . . 0.0 107.593 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.1 ttt-85 54.62 81.77 0.26 Allowed Pre-proline 0 CA--C 1.56 1.346 0 C-N-CA 125.413 1.485 . . . . 0.0 112.243 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.98 -50.65 2.81 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.084 2.523 . . . . 0.0 113.389 -170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.57 -54.0 3.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.381 0.991 . . . . 0.0 113.837 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 62.0 m -144.75 143.98 30.95 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.766 1.627 . . . . 0.0 111.523 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -27.2 55.74 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.489 1.116 . . . . 0.0 113.028 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.7 p -57.43 -29.41 64.14 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.8 t -84.1 -42.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.028 0.931 . . . . 0.0 110.628 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD21 ' HE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.28 -49.19 36.62 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.815 -176.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -56.95 -43.9 82.0 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.034 0.933 . . . . 0.0 112.1 175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -56.41 -37.57 70.35 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.559 1.144 . . . . 0.0 112.611 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.86 -41.52 59.67 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.857 -0.527 . . . . 0.0 111.543 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -60.51 -50.15 74.71 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.794 -1.191 . . . . 0.0 110.99 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.83 -35.68 75.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.9 t -68.36 -32.86 73.26 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.367 -0.833 . . . . 0.0 112.829 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.76 -22.89 15.64 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.26 -24.24 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.843 0.857 . . . . 0.0 111.549 170.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.24 13.59 35.69 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.365 1.459 . . . . 0.0 114.827 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -98.88 13.05 33.9 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.52 1.928 . . . . 0.0 112.117 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.893 0 C-N-CA 125.154 1.359 . . . . 0.0 113.784 -166.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.87 -19.31 65.71 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 126.053 1.741 . . . . 0.0 114.628 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.3 p -64.89 159.03 23.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.493 1.917 . . . . 0.0 113.245 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.1 169.15 17.8 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.262 1.425 . . . . 0.0 110.817 177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -61.0 152.89 26.64 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 174.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.2 m -113.19 114.92 27.44 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.417 1.087 . . . . 0.0 112.49 -177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.54 -22.85 53.82 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.226 -0.922 . . . . 0.0 112.703 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.62 23.41 1.15 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.308 1.843 . . . . 0.0 113.882 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.97 154.09 70.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.235 1.014 . . . . 0.0 112.704 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -65.8 160.0 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.215 3.277 . . . . 0.0 113.238 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 159.58 31.95 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.615 0.766 . . . . 0.0 111.05 161.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 -63.6 -27.25 69.11 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.16 -0.963 . . . . 0.0 113.418 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -72.33 -26.17 61.83 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.374 1.069 . . . . 0.0 113.547 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -86.17 -33.49 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.961 1.304 . . . . 0.0 110.918 174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.61 -37.44 83.94 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 127.037 2.135 . . . . 0.0 111.056 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.19 -15.22 22.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.983 1.713 . . . . 0.0 113.569 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -74.52 -16.69 60.82 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.331 1.053 . . . . 0.0 112.737 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -70.15 159.58 33.67 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.543 1.065 . . . . 0.0 111.749 175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.16 -24.56 1.25 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.05 172.2 54.06 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 119.42 1.009 . . . . 0.0 113.13 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.3 110.56 1.82 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.205 2.603 . . . . 0.0 108.756 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -137.72 121.14 17.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.168 0.987 . . . . 0.0 109.486 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -83.56 134.49 34.82 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.025 0.53 . . . . 0.0 109.809 167.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.1 t -115.07 114.83 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.787 1.235 . . . . 0.0 109.233 175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -109.52 131.36 55.14 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.222 1.809 . . . . 0.0 111.758 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -103.38 128.63 50.44 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.648 1.179 . . . . 0.0 109.652 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.58 29.27 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.678 0.656 . . . . 0.0 114.489 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.7 p -146.95 171.76 14.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.92 1.688 . . . . 0.0 110.112 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.62 -8.87 57.87 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.314 0.646 . . . . 0.0 112.222 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -130.14 -15.66 3.71 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -161.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.9 t -65.18 141.16 58.77 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 120.544 1.52 . . . . 0.0 111.31 173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.04 75.51 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.468 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -68.16 -46.69 70.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.663 1.732 . . . . 0.0 109.777 166.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 m -61.61 -34.92 76.48 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.989 0.915 . . . . 0.0 113.313 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -64.77 -24.41 67.55 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.349 0.977 . . . . 0.0 112.236 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.64 -38.29 11.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.883 1.273 . . . . 0.0 112.232 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.69 -29.67 32.92 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -59.64 -53.88 61.35 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-O 117.776 -1.106 . . . . 0.0 113.536 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.09 -18.09 45.71 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.691 1.594 . . . . 0.0 112.003 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -57.33 6.89 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -58.85 -42.82 90.26 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 124.352 1.061 . . . . 0.0 109.415 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.75 75.84 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.68 -46.85 57.56 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.516 0.727 . . . . 0.0 111.52 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 HG11 HD22 ' A' ' 97' ' ' LEU . 3.0 p -64.9 -49.79 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 118.937 0.79 . . . . 0.0 112.243 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -56.82 -25.97 57.1 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.617 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.7 m -63.6 -18.99 64.48 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -99.18 -7.86 25.95 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.471 1.108 . . . . 0.0 113.268 172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -130.79 48.31 3.62 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 125.724 1.61 . . . . 0.0 114.02 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.18 -15.39 43.91 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.655 2.903 . . . . 0.0 114.597 -174.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -74.66 -12.57 60.47 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.7 t -84.33 139.87 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.26 1.024 . . . . 0.0 108.901 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.12 157.0 24.69 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.262 0.934 . . . . 0.0 112.165 174.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -127.66 130.55 49.11 Favored 'General case' 0 CA--C 1.543 0.712 0 CA-C-N 118.293 1.046 . . . . 0.0 111.64 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.71 102.33 10.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.76 1.224 . . . . 0.0 109.345 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -79.8 94.06 5.72 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.38 1.072 . . . . 0.0 111.021 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.8 t -81.75 120.25 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.615 1.166 . . . . 0.0 110.068 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -77.89 116.22 18.23 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.67 0.606 . . . . 0.0 109.666 169.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.1 132.62 55.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.768 1.227 . . . . 0.0 111.281 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.42 -168.08 12.66 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.908 1.242 . . . . 0.0 113.372 -174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.91 135.78 71.06 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.43 2.753 . . . . 0.0 112.497 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.58 -15.2 10.0 Favored Glycine 0 N--CA 1.478 1.46 0 C-N-CA 124.866 1.222 . . . . 0.0 114.365 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 72.65 152.6 0.13 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.581 3.152 . . . . 0.0 113.992 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.0 ttt85 -98.94 -112.19 0.17 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.9 1.68 . . . . 0.0 109.279 171.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.6 tp -70.4 -32.44 70.08 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.988 1.315 . . . . 0.0 113.078 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.02 67.85 Favored Glycine 0 N--CA 1.477 1.411 0 O-C-N 121.099 -1.001 . . . . 0.0 114.504 -176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -71.91 -37.24 70.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.22 1.01 . . . . 0.0 111.981 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -71.44 -26.25 62.65 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.115 0.966 . . . . 0.0 111.225 174.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -82.02 -7.64 59.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 113.692 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.79 36.09 10.74 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.74 1.616 . . . . 0.0 112.063 178.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.46 131.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.191 1.396 . . . . 0.0 112.251 -171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.35 28.0 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -172.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.3 tp -96.78 -130.72 0.18 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.27 1.428 . . . . 0.0 108.463 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.59 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 64.9 t90 -138.57 -48.02 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 116.856 -1.545 . . . . 0.0 114.062 166.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.59 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 95.2 Cg_endo -73.38 99.84 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.631 1.618 . . . . 0.0 108.617 174.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 m -154.83 145.64 22.48 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.798 1.239 . . . . 0.0 108.745 -167.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -140.95 129.47 22.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.932 0.893 . . . . 0.0 110.124 177.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.0 t -106.28 121.55 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.212 1.805 . . . . 0.0 109.405 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' HD13 ' A' ' 23' ' ' LEU . 47.2 m-85 -83.55 117.36 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 109.015 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -107.55 155.94 19.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.376 1.47 . . . . 0.0 110.566 177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 31.7 ttm-85 -165.36 132.6 2.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 108.358 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 62.63 21.03 12.44 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.111 1.364 . . . . 0.0 112.643 -173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.91 -10.51 60.05 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.225 1.869 . . . . 0.0 114.575 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -96.46 152.21 18.83 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.848 1.659 . . . . 0.0 110.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -64.52 129.27 39.21 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 110.204 164.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 m -102.59 -24.69 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.646 1.178 . . . . 0.0 112.538 169.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.22 -179.06 2.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.597 1.559 . . . . 0.0 110.848 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.53 157.69 37.28 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.052 0.941 . . . . 0.0 111.173 165.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.422 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.4 t -120.04 127.34 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.179 0.991 . . . . 0.0 108.376 172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.86 131.89 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.276 1.83 . . . . 0.0 107.659 176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 56.53 77.02 0.44 Allowed Pre-proline 0 CA--C 1.557 1.241 0 C-N-CA 125.036 1.335 . . . . 0.0 112.752 173.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.08 124.15 13.45 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.99 2.46 . . . . 0.0 111.009 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.14 -32.39 14.35 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 123.074 0.369 . . . . 0.0 113.692 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -175.12 164.88 3.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.226 2.21 . . . . 0.0 109.445 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.01 62.69 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.773 0.829 . . . . 0.0 111.997 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.9 p -60.1 -27.14 66.78 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.764 -1.21 . . . . 0.0 114.078 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.9 t -86.73 -42.59 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.203 1.401 . . . . 0.0 110.625 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.525 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.6 -49.53 46.72 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.975 0.51 . . . . 0.0 111.952 -178.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.06 -43.07 73.49 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.433 1.093 . . . . 0.0 112.643 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.11 -38.93 74.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.322 1.049 . . . . 0.0 112.69 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.07 -37.93 61.47 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.673 -0.642 . . . . 0.0 111.978 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -62.33 -50.19 72.59 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 120.845 -1.16 . . . . 0.0 111.002 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.89 -35.53 76.88 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.163 0.506 . . . . 0.0 112.096 176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.7 m -67.92 -26.15 65.83 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.12 -20.6 13.47 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.201 1.001 . . . . 0.0 113.101 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -25.48 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.792 0.837 . . . . 0.0 111.393 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.67 12.64 37.2 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.364 1.459 . . . . 0.0 114.592 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -95.29 -14.09 24.27 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.2 1.4 . . . . 0.0 113.032 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.241 0 C-N-CA 124.305 0.955 . . . . 0.0 113.12 -176.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.2 mtp . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -72.56 -1.99 18.11 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.271 1.828 . . . . 0.0 115.201 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -58.54 149.87 24.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.241 2.216 . . . . 0.0 112.013 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -69.34 170.8 9.64 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.995 1.318 . . . . 0.0 113.076 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -58.42 154.51 13.63 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.0 m -123.28 130.52 52.85 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.338 1.055 . . . . 0.0 113.047 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.09 -27.0 30.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -79.98 41.98 0.53 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.811 1.644 . . . . 0.0 112.37 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.42 156.53 88.26 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 120.915 -1.116 . . . . 0.0 112.671 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -69.3 162.72 40.72 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 123.552 2.835 . . . . 0.0 112.006 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.38 154.73 28.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.376 0.671 . . . . 0.0 110.733 162.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -29.76 69.76 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.302 -0.874 . . . . 0.0 112.27 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.06 -42.15 94.49 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.971 0.805 . . . . 0.0 112.398 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -73.04 -32.94 65.4 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.594 0.758 . . . . 0.0 111.78 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -63.05 -35.57 80.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.933 1.293 . . . . 0.0 111.565 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.02 -9.87 34.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.725 1.21 . . . . 0.0 113.559 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -75.76 -18.62 59.48 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.464 -0.772 . . . . 0.0 112.944 168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.6 156.98 37.48 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 119.662 1.119 . . . . 0.0 112.347 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.41 -20.14 2.68 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 172.65 53.74 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 119.232 0.924 . . . . 0.0 113.959 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.03 109.15 2.48 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 123.593 2.862 . . . . 0.0 109.427 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.9 m -132.96 118.5 18.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.536 1.134 . . . . 0.0 109.517 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 76' ' ' PHE . 24.0 tp -82.84 129.56 35.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 167.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.2 117.61 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.701 0.8 . . . . 0.0 109.109 172.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -111.69 138.06 48.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.705 1.602 . . . . 0.0 111.514 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -114.64 134.3 55.17 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 110.669 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.03 -157.41 29.67 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.355 0.979 . . . . 0.0 114.053 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 66.1 p -145.21 171.23 14.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.429 1.491 . . . . 0.0 110.452 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.67 -8.66 57.37 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.338 -0.851 . . . . 0.0 112.979 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -129.75 -13.16 4.22 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -161.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.0 t -72.48 142.92 48.58 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 120.482 1.492 . . . . 0.0 111.764 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.49 -23.75 68.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.147 1.356 . . . . 0.0 113.656 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 24.1 m170 -63.55 -48.69 76.42 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.018 1.409 . . . . 0.0 110.65 167.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.84 -34.93 79.55 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.879 0.872 . . . . 0.0 113.255 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -64.27 -23.7 67.4 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.138 0.881 . . . . 0.0 112.079 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.04 -37.42 16.31 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.317 1.447 . . . . 0.0 112.714 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.83 -28.8 22.68 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -61.67 -51.85 73.44 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 117.521 -1.228 . . . . 0.0 113.336 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.98 -16.5 45.35 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.919 1.746 . . . . 0.0 112.419 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -58.36 3.97 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.864 0.866 . . . . 0.0 109.609 173.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.92 -42.76 90.45 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 124.045 0.938 . . . . 0.0 109.366 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.18 70.88 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.678 0.791 . . . . 0.0 113.082 176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -73.22 -46.56 49.63 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.126 0.571 . . . . 0.0 112.058 178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -65.57 -50.28 72.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 118.576 0.625 . . . . 0.0 112.084 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.76 -27.03 58.77 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.9 m -62.27 -18.24 60.71 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.07 -8.57 23.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.694 1.198 . . . . 0.0 113.213 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.82 47.89 3.18 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 125.166 1.386 . . . . 0.0 113.785 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.44 -14.84 41.6 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.462 2.775 . . . . 0.0 114.691 -173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.28 -16.27 60.95 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.6 137.81 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.322 1.049 . . . . 0.0 108.61 171.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.13 153.0 23.21 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.626 1.108 . . . . 0.0 111.789 173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -124.55 128.54 49.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.26 1.03 . . . . 0.0 111.722 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 45.4 tp -111.61 103.84 12.18 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 109.441 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -86.82 96.38 10.18 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.408 1.083 . . . . 0.0 111.648 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.2 t -84.33 115.79 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.392 1.477 . . . . 0.0 109.791 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -68.29 118.87 11.95 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.64 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.49 147.47 47.74 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.362 -0.836 . . . . 0.0 112.723 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -151.25 164.2 30.05 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.493 1.044 . . . . 0.0 113.446 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.05 -30.26 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.548 2.832 . . . . 0.0 113.436 -174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.93 113.68 4.53 Favored Glycine 0 C--N 1.344 0.99 0 C-N-CA 125.158 1.361 . . . . 0.0 111.667 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 52.18 -132.47 1.94 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.792 1.637 . . . . 0.0 112.14 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 75.71 155.89 0.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.597 2.759 . . . . 0.0 111.184 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.5 tp -57.32 -31.26 65.51 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.814 1.646 . . . . 0.0 113.898 -163.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.69 65.8 Favored Glycine 0 N--CA 1.479 1.552 0 CA-C-N 119.3 0.954 . . . . 0.0 114.751 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -64.17 -45.22 89.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -72.89 -23.62 60.74 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.393 1.077 . . . . 0.0 112.382 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -84.07 -11.87 56.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.501 1.521 . . . . 0.0 114.129 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.22 47.14 11.98 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.252 1.421 . . . . 0.0 109.978 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 t -52.47 126.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.061 1.344 . . . . 0.0 111.375 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -85.52 -49.2 8.25 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -154.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.9 tp -101.6 -109.94 0.22 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.468 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 61.2 t90 -147.23 -49.93 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.503 1.521 . . . . 0.0 111.62 169.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 65.8 Cg_endo -70.85 100.4 0.95 Allowed 'Trans proline' 0 C--N 1.361 1.207 0 CA-C-N 121.519 1.578 . . . . 0.0 108.316 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.3 m -156.47 139.91 15.8 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -167.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.538 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -145.63 130.77 18.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.353 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.65 120.43 62.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 126.236 1.815 . . . . 0.0 109.711 -169.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CG ' HD13 ' A' ' 23' ' ' LEU . 40.3 m-85 -84.87 116.16 23.16 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.697 1.199 . . . . 0.0 109.084 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.0 mp -106.47 152.37 23.74 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.017 1.327 . . . . 0.0 111.008 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -166.48 135.31 2.95 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.62 1.968 . . . . 0.0 108.175 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.17 19.74 11.85 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.794 1.238 . . . . 0.0 112.249 -165.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.16 -10.62 26.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.313 1.435 . . . . 0.0 114.495 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -94.84 147.93 22.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 127.123 2.169 . . . . 0.0 109.66 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -67.41 123.17 19.65 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 m -97.22 -24.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.615 1.166 . . . . 0.0 112.247 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.42 178.99 2.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.413 1.885 . . . . 0.0 111.085 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -155.26 156.41 35.53 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.062 0.945 . . . . 0.0 111.566 162.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.0 t -119.43 132.23 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.3 t -122.13 125.83 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.719 1.608 . . . . 0.0 108.338 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 56.05 79.42 0.33 Allowed Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 125.705 1.602 . . . . 0.0 112.535 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.93 125.95 17.01 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.27 2.646 . . . . 0.0 111.082 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.82 -33.2 16.21 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.54 0.591 . . . . 0.0 113.723 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.4 t -174.18 163.56 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.205 2.202 . . . . 0.0 109.842 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.94 -33.27 62.1 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.951 0.9 . . . . 0.0 112.263 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.4 p -56.6 -32.54 65.35 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.83 -40.0 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.481 1.513 . . . . 0.0 110.837 178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.538 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.11 -49.54 35.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.144 0.578 . . . . 0.0 111.305 -179.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -56.62 -40.49 75.44 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.933 1.293 . . . . 0.0 112.645 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.687 1.195 . . . . 0.0 112.686 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.84 -45.22 36.96 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.237 -0.914 . . . . 0.0 111.389 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -56.58 -49.94 73.4 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.126 -0.984 . . . . 0.0 111.959 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -33.14 72.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.2 t -69.68 -33.08 72.05 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.12 -25.23 15.95 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.32 -27.17 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.069 0.948 . . . . 0.0 111.678 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 97.96 10.48 52.13 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.538 1.542 . . . . 0.0 114.64 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -84.69 -18.73 34.37 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.334 1.067 . . . . 0.0 112.831 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.143 0 C-N-CA 126.134 1.826 . . . . 0.0 114.285 178.788 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.8 mttm 49.93 -133.47 1.61 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.222 1.809 . . . . 0.0 113.06 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 p -78.73 148.53 33.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.75 1.62 . . . . 0.0 112.248 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.81 168.1 17.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.143 1.377 . . . . 0.0 112.498 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -68.35 158.05 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -137.59 134.45 35.58 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.916 0.865 . . . . 0.0 113.171 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 -14.36 58.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.047 0.939 . . . . 0.0 112.357 166.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.37 23.13 1.14 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.538 1.535 . . . . 0.0 112.842 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.44 153.47 69.18 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.367 1.067 . . . . 0.0 112.903 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.46 161.13 44.72 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.231 3.287 . . . . 0.0 112.607 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.6 154.73 39.65 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.357 0.663 . . . . 0.0 110.904 165.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.2 tpt85 -63.67 -25.44 68.21 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.899 -1.125 . . . . 0.0 113.546 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -73.21 -29.27 62.68 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.497 1.119 . . . . 0.0 112.945 172.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.64 -36.9 43.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.836 1.255 . . . . 0.0 110.443 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 tp -60.17 -38.0 81.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.453 1.501 . . . . 0.0 111.775 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.61 -20.93 66.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.299 1.44 . . . . 0.0 113.35 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.71 -6.81 48.36 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.884 1.674 . . . . 0.0 112.559 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.0 164.2 6.92 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 119.161 0.891 . . . . 0.0 112.09 170.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.61 -39.42 0.8 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 168.86 54.89 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 118.911 0.778 . . . . 0.0 113.044 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.13 109.71 1.38 Allowed 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.736 2.29 . . . . 0.0 109.179 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.3 m -129.2 116.98 20.01 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.279 1.032 . . . . 0.0 109.214 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.5 tp -84.05 131.54 34.8 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 170.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.24 112.7 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.563 1.145 . . . . 0.0 109.317 177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -108.52 134.41 51.33 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.799 2.04 . . . . 0.0 111.423 -173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -110.64 140.02 45.36 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.562 1.545 . . . . 0.0 110.37 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 151.02 -156.34 26.62 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.668 1.127 . . . . 0.0 112.12 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.5 p -138.46 175.74 9.3 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.193 1.397 . . . . 0.0 110.264 173.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.61 -4.07 57.13 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.592 -0.693 . . . . 0.0 112.235 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -128.34 -14.17 4.83 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -75.14 145.96 41.74 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.483 1.492 . . . . 0.0 111.372 176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.02 -27.16 69.96 Favored Glycine 0 N--CA 1.472 1.053 0 C-N-CA 125.378 1.466 . . . . 0.0 114.019 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -58.71 -48.51 80.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.416 1.108 . . . . 0.0 111.021 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.6 m -69.87 -33.15 71.87 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.91 -21.75 66.87 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.313 0.96 . . . . 0.0 112.064 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.92 -40.17 14.16 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.925 1.69 . . . . 0.0 112.485 175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.22 -29.55 23.07 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -60.47 -53.21 66.87 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.384 -1.293 . . . . 0.0 112.818 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.34 -16.7 44.03 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.143 1.895 . . . . 0.0 112.125 175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 -57.24 6.06 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.759 0.824 . . . . 0.0 109.488 172.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -57.84 -41.81 83.09 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.045 0.938 . . . . 0.0 109.753 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.57 72.52 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.946 0.898 . . . . 0.0 113.122 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -70.78 -45.26 65.05 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.39 0.541 . . . . 0.0 111.996 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -68.3 -52.09 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.705 0.684 . . . . 0.0 112.177 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -56.77 -26.13 56.84 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.919 1.288 . . . . 0.0 114.096 -176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.9 m -62.37 -18.6 61.95 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -99.48 -8.46 24.62 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.66 1.184 . . . . 0.0 113.137 173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -130.14 48.8 4.0 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.376 1.47 . . . . 0.0 113.671 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -62.28 -17.03 54.99 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 123.608 2.872 . . . . 0.0 113.894 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.82 -15.35 63.09 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.8 t -85.12 141.37 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.648 1.179 . . . . 0.0 108.77 172.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.75 154.32 22.01 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 124.618 1.104 . . . . 0.0 111.998 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -130.72 114.55 15.51 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.84 1.32 . . . . 0.0 111.917 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.86 113.07 24.79 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.877 0.871 . . . . 0.0 108.949 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.78 100.36 12.57 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.395 0.678 . . . . 0.0 110.398 176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -89.0 117.79 33.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.005 1.322 . . . . 0.0 110.349 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -71.24 109.51 5.31 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 124.259 0.974 . . . . 0.0 111.906 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -91.99 -150.41 0.26 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 127.492 2.317 . . . . 0.0 110.007 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 110.12 -133.58 11.69 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.895 1.712 . . . . 0.0 110.038 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.12 -33.0 95.0 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.134 2.556 . . . . 0.0 113.669 176.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -96.52 118.01 5.89 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.52 1.057 . . . . 0.0 110.837 167.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.17 29.88 0.91 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.597 1.559 . . . . 0.0 112.25 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -61.52 134.47 56.9 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.325 1.45 . . . . 0.0 112.158 -168.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 tp 71.97 -44.15 0.58 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 128.708 2.803 . . . . 0.0 112.574 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.05 -28.88 72.83 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 120.211 1.369 . . . . 0.0 113.177 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.4 -43.37 97.75 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.286 1.034 . . . . 0.0 111.502 168.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -68.39 -33.29 73.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.206 1.402 . . . . 0.0 111.604 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.2 -7.2 58.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.099 1.36 . . . . 0.0 113.92 172.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.66 40.69 16.17 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.087 1.755 . . . . 0.0 111.055 -178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.44 123.99 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.682 1.193 . . . . 0.0 112.099 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -69.21 -43.82 73.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.023 1.329 . . . . 0.0 114.123 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 20.0 tp -112.6 -118.63 0.3 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.462 1.505 . . . . 0.0 108.708 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -151.58 -50.1 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.735 0 CA-C-O 116.48 -1.724 . . . . 0.0 113.016 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.41 94.03 0.84 Allowed 'Trans proline' 0 C--N 1.361 1.22 0 CA-C-N 121.789 1.675 . . . . 0.0 108.106 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 m -149.72 143.45 25.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.024 1.33 . . . . 0.0 107.732 -169.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.549 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -144.02 125.78 15.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.177 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.11 120.66 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.077 1.751 . . . . 0.0 109.011 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 23' ' ' LEU . 44.9 m-85 -83.55 117.25 23.0 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.444 1.098 . . . . 0.0 108.955 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.29 152.82 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -165.66 136.8 3.82 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.0 108.513 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 t70 62.5 22.94 13.6 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.277 1.431 . . . . 0.0 112.764 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.51 -7.96 70.62 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.462 1.506 . . . . 0.0 114.926 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -109.44 150.23 28.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.169 1.788 . . . . 0.0 109.993 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.41 123.86 19.4 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.784 -0.572 . . . . 0.0 109.523 167.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.9 m -97.9 -25.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.0 1.32 . . . . 0.0 112.465 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.63 -179.4 2.51 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.357 1.863 . . . . 0.0 110.828 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -155.6 155.8 33.95 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.23 1.012 . . . . 0.0 111.525 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 77.4 t -125.21 142.0 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.056 1.342 . . . . 0.0 108.135 173.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.7 p -138.93 135.89 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.408 1.483 . . . . 0.0 109.088 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 55.63 67.69 2.85 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.788 1.635 . . . . 0.0 111.686 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.4 124.0 13.88 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.771 2.98 . . . . 0.0 111.147 -172.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.18 -30.54 34.02 Favored Glycine 0 N--CA 1.472 1.051 0 C-N-CA 123.143 0.402 . . . . 0.0 113.725 -174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -174.12 163.18 3.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.548 2.339 . . . . 0.0 109.898 177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.51 -33.73 64.01 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.188 0.995 . . . . 0.0 112.259 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.6 p -54.72 -39.12 67.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.504 1.047 . . . . 0.0 113.299 173.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.05 -40.55 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.324 1.45 . . . . 0.0 110.629 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.549 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.53 -50.01 42.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.195 0.598 . . . . 0.0 111.565 178.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -55.67 -42.99 75.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.593 1.157 . . . . 0.0 112.061 173.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -56.01 -37.99 69.9 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.2 1.0 . . . . 0.0 112.752 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.56 -38.1 59.47 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.404 -0.81 . . . . 0.0 111.94 173.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -62.19 -50.8 70.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.648 -1.282 . . . . 0.0 111.349 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.37 -32.6 71.44 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.147 0.579 . . . . 0.0 112.251 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.4 m -71.51 -27.15 63.01 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 104' ' ' LEU . 2.4 mm? -105.35 -25.29 12.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.148 0.979 . . . . 0.0 113.522 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -26.02 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.147 0.979 . . . . 0.0 111.049 170.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.43 19.71 26.99 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.429 1.49 . . . . 0.0 114.47 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -87.6 -20.95 25.69 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.738 1.215 . . . . 0.0 113.189 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.054 0 C-N-CA 124.384 0.992 . . . . 0.0 113.717 174.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.611 0.243 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -81.24 -24.75 37.15 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -169.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.2 m -73.01 129.72 38.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.743 1.217 . . . . 0.0 110.895 -176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 163.09 28.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 0.0 113.269 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.22 153.77 4.97 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.0 m -122.67 129.07 51.42 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.81 -33.51 22.92 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.938 -1.101 . . . . 0.0 113.677 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -76.77 36.44 0.17 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.34 1.856 . . . . 0.0 114.068 -174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.14 154.62 93.68 Favored Pre-proline 0 CA--C 1.554 1.123 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.33 164.29 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 125.04 3.827 . . . . 0.0 113.023 175.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.75 162.7 16.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.671 1.588 . . . . 0.0 113.507 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.4 mmm-85 -54.51 -36.21 63.98 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.651 -1.281 . . . . 0.0 113.182 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -67.39 -21.75 65.59 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.345 1.058 . . . . 0.0 113.445 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -90.61 -34.8 15.33 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.905 1.682 . . . . 0.0 111.329 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.87 -33.91 75.05 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.138 -0.976 . . . . 0.0 111.871 169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -56.74 -24.15 47.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.937 1.295 . . . . 0.0 113.134 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -81.88 -12.95 58.2 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.573 1.549 . . . . 0.0 113.057 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.73 160.98 29.32 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.087 0.858 . . . . 0.0 111.917 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.53 -41.44 0.62 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.04 170.42 55.13 Favored Glycine 0 CA--C 1.538 1.531 0 O-C-N 121.09 -1.006 . . . . 0.0 112.944 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -64.96 113.32 2.32 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.122 2.548 . . . . 0.0 108.536 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.2 m -130.56 119.36 22.42 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.182 0.993 . . . . 0.0 109.433 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -87.71 128.28 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.376 1.07 . . . . 0.0 110.579 173.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.3 116.41 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.075 0.95 . . . . 0.0 109.441 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -114.08 126.71 55.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.455 2.302 . . . . 0.0 110.801 -168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -109.05 131.49 55.02 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.306 1.442 . . . . 0.0 111.254 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.04 -154.3 25.23 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.075 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -143.62 175.49 9.92 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.59 1.556 . . . . 0.0 109.823 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.54 -3.41 55.94 Favored 'General case' 0 CA--C 1.552 1.04 0 O-C-N 121.093 -1.004 . . . . 0.0 112.24 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -129.98 -17.72 3.48 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 116.021 1.86 . . . . 0.0 116.021 -164.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.94 143.61 52.64 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.403 1.456 . . . . 0.0 111.941 177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.24 -25.18 66.25 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.978 1.275 . . . . 0.0 114.119 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -62.19 -48.4 80.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.427 1.114 . . . . 0.0 110.904 167.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 m -67.7 -33.65 75.33 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.889 0.876 . . . . 0.0 113.351 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -65.81 -20.87 66.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.661 1.118 . . . . 0.0 112.09 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.57 -39.37 15.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.751 1.62 . . . . 0.0 112.383 175.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.82 -29.3 23.87 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -60.29 -53.17 67.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 117.446 -1.264 . . . . 0.0 112.927 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.0 -15.5 39.97 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.046 1.831 . . . . 0.0 112.347 175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.52 -56.07 7.43 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 123.589 0.756 . . . . 0.0 109.837 173.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -54.77 -45.8 74.28 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.064 0.946 . . . . 0.0 109.122 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.56 -39.66 58.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -73.41 -45.29 55.48 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.237 0.615 . . . . 0.0 112.299 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -70.28 -51.13 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 118.659 0.663 . . . . 0.0 112.497 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -23.17 67.0 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.903 1.681 . . . . 0.0 113.122 -171.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -58.99 -21.32 58.7 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.042 0.937 . . . . 0.0 113.231 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.2 -8.96 26.43 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.864 1.266 . . . . 0.0 113.639 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -129.95 43.99 1.26 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.53 1.532 . . . . 0.0 114.455 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -61.55 -16.8 50.28 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.355 2.703 . . . . 0.0 113.754 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.72 -15.97 63.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.43 142.93 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.135 0.88 . . . . 0.0 109.434 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.64 149.44 23.48 Favored Glycine 0 N--CA 1.47 0.923 0 O-C-N 120.929 -1.107 . . . . 0.0 110.939 172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -133.09 125.09 28.82 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.97 1.385 . . . . 0.0 111.401 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.8 tp -114.88 94.53 4.8 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.008 1.323 . . . . 0.0 109.251 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -80.69 99.53 8.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.582 1.153 . . . . 0.0 111.087 174.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.14 119.1 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.373 1.069 . . . . 0.0 110.558 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -73.21 106.28 4.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.862 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -81.86 154.59 25.79 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.573 1.149 . . . . 0.0 112.688 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.29 179.33 24.29 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.343 1.449 . . . . 0.0 113.952 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -52.03 138.68 52.77 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.542 3.495 . . . . 0.0 112.968 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.28 -15.48 49.55 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.955 1.265 . . . . 0.0 114.113 -174.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 77.18 122.43 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 128.44 2.696 . . . . 0.0 111.216 173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -93.36 -131.7 0.14 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.517 1.527 . . . . 0.0 110.376 -170.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.3 tp -52.35 -36.69 54.17 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 120.031 1.287 . . . . 0.0 113.333 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.71 -20.22 59.24 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 124.653 1.121 . . . . 0.0 114.667 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -67.45 -43.62 80.66 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.449 1.1 . . . . 0.0 111.041 169.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -81.08 -7.97 59.67 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.886 1.274 . . . . 0.0 113.182 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.14 -8.79 47.71 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.81 1.244 . . . . 0.0 113.014 160.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.33 51.61 12.75 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.032 1.333 . . . . 0.0 110.164 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 t -59.94 140.83 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.282 1.433 . . . . 0.0 111.882 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.98 -46.63 56.62 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.732 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.3 tp -118.2 -116.76 0.32 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.275 1.43 . . . . 0.0 108.966 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.459 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 56.7 t90 -147.89 -49.92 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 116.387 -1.768 . . . . 0.0 112.03 172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 77.5 Cg_endo -72.33 96.91 0.82 Allowed 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.81 1.674 . . . . 0.0 107.959 165.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.6 m -156.58 139.07 14.91 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.178 1.391 . . . . 0.0 107.788 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -139.75 128.65 23.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.054 0.942 . . . . 0.0 110.232 -178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -106.58 121.73 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.256 1.822 . . . . 0.0 109.573 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 38.4 m-85 -85.77 114.92 23.1 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.013 0.925 . . . . 0.0 108.616 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.46 153.43 21.13 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.702 1.601 . . . . 0.0 110.493 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -165.48 139.07 4.55 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.722 2.009 . . . . 0.0 108.793 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 61.11 23.87 14.03 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.88 1.272 . . . . 0.0 113.047 -175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.09 -0.81 89.55 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.3 1.429 . . . . 0.0 115.11 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -119.9 148.01 44.02 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.112 1.765 . . . . 0.0 111.034 -174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -64.47 123.16 18.49 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.082 -1.011 . . . . 0.0 110.363 170.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -98.27 -23.28 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.955 1.302 . . . . 0.0 112.124 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.18 177.49 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.678 1.991 . . . . 0.0 110.618 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -154.17 156.2 36.71 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.74 0.816 . . . . 0.0 111.183 161.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.1 t -118.77 126.52 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.31 128.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.024 1.73 . . . . 0.0 107.554 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 52.73 77.58 0.44 Allowed Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 125.727 1.611 . . . . 0.0 112.667 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.9 119.82 6.99 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.041 2.494 . . . . 0.0 110.817 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.46 -29.15 37.2 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 123.61 0.624 . . . . 0.0 113.454 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 t -173.57 162.95 4.27 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.453 2.301 . . . . 0.0 109.209 176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -32.51 57.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.256 1.023 . . . . 0.0 112.239 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.5 p -58.15 -28.45 64.73 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.9 t -86.94 -39.81 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.89 1.276 . . . . 0.0 110.667 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.57 -49.26 49.8 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.184 0.593 . . . . 0.0 111.602 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.79 -40.66 80.37 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.76 1.224 . . . . 0.0 112.948 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -58.09 -34.24 69.95 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.111 1.364 . . . . 0.0 112.48 176.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.35 -47.65 17.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.801 -0.562 . . . . 0.0 111.492 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -54.9 -49.26 71.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.705 1.139 . . . . 0.0 112.006 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -32.82 69.32 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.7 t -79.45 -23.42 43.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.504 0.722 . . . . 0.0 112.373 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.66 -25.13 12.83 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.868 0.867 . . . . 0.0 113.24 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.52 -29.59 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.097 0.959 . . . . 0.0 111.08 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.06 5.34 35.29 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.16 1.362 . . . . 0.0 115.666 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -88.77 -29.09 20.04 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.656 1.228 . . . . 0.0 113.426 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 C-N-CA 125.247 1.403 . . . . 0.0 113.059 -175.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 121.122 0.487 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -74.23 -40.3 62.5 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.487 -0.758 . . . . 0.0 112.185 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.0 p -90.63 161.27 15.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.018 1.727 . . . . 0.0 110.699 170.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -150.58 164.58 35.68 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.501 1.12 . . . . 0.0 113.188 -166.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -90.13 167.33 12.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.066 1.346 . . . . 0.0 113.401 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.4 t -140.81 138.18 33.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.13 -13.59 58.53 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.553 0.741 . . . . 0.0 112.906 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -85.19 37.16 0.66 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.36 1.464 . . . . 0.0 112.35 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.46 154.94 94.12 Favored Pre-proline 0 CA--C 1.551 0.997 0 O-C-N 120.966 -1.084 . . . . 0.0 113.134 -178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.01 167.3 23.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.406 3.404 . . . . 0.0 112.043 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.61 151.44 27.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.866 0.866 . . . . 0.0 111.678 171.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -32.23 66.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.683 1.193 . . . . 0.0 112.68 -177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -62.41 -42.35 99.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.22 1.408 . . . . 0.0 113.002 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -74.84 -32.88 62.05 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.401 0.68 . . . . 0.0 111.813 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -15.26 62.52 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.555 1.542 . . . . 0.0 112.692 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.06 -17.41 52.78 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.288 -0.883 . . . . 0.0 112.726 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.3 mtm-85 -101.98 -4.63 25.77 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.636 1.574 . . . . 0.0 114.027 -172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.62 169.25 1.86 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 113.279 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.6 141.93 26.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.68 159.03 25.71 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 126.243 1.878 . . . . 0.0 111.936 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.8 121.88 8.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.722 2.282 . . . . 0.0 109.585 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.6 m -139.83 124.06 17.88 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.838 1.255 . . . . 0.0 109.742 -174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.0 tp -95.46 128.06 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.35 1.06 . . . . 0.0 110.253 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.66 116.83 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.094 0.957 . . . . 0.0 109.267 173.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -109.32 126.71 53.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.744 2.418 . . . . 0.0 110.937 -171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -110.11 124.56 51.73 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.621 1.569 . . . . 0.0 111.056 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.31 -148.85 12.53 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 123.835 0.731 . . . . 0.0 112.639 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 80.5 p -147.96 176.39 10.21 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.978 1.711 . . . . 0.0 109.45 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -86.08 7.11 26.0 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.243 -0.911 . . . . 0.0 112.409 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -139.06 -15.56 1.12 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -167.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.5 t -64.62 141.37 58.8 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.162 1.801 . . . . 0.0 111.378 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.34 -18.85 63.61 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.356 0.979 . . . . 0.0 113.752 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -68.8 -51.5 40.19 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.182 1.491 . . . . 0.0 110.849 164.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.2 m -61.13 -36.77 80.63 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.767 0.827 . . . . 0.0 112.773 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -62.36 -22.97 66.53 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.082 0.856 . . . . 0.0 112.295 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.12 -35.76 13.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.453 1.501 . . . . 0.0 112.885 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.94 -29.32 39.66 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 119.445 1.021 . . . . 0.0 113.162 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -60.0 -53.87 61.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.953 -1.022 . . . . 0.0 112.565 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.88 -17.91 36.74 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.215 1.943 . . . . 0.0 112.183 175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -56.84 9.4 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 172.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -56.42 -48.53 76.78 Favored 'General case' 0 C--O 1.218 -0.579 0 C-N-CA 124.445 1.098 . . . . 0.0 108.85 177.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.69 63.25 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -72.18 -45.33 60.83 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.47 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -67.27 -48.85 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 CA-C-N 118.863 0.756 . . . . 0.0 112.327 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -23.77 66.14 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.67 1.588 . . . . 0.0 113.722 -173.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.3 m -60.64 -16.91 43.58 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -103.49 -7.57 20.8 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.942 1.297 . . . . 0.0 113.784 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -129.26 45.71 1.88 Allowed Pre-proline 0 CA--C 1.559 1.288 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -62.89 -14.86 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.568 2.846 . . . . 0.0 114.916 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -73.73 -15.64 61.21 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.9 t -75.84 143.56 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 118.97 0.804 . . . . 0.0 109.363 175.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.68 154.34 29.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.205 -0.934 . . . . 0.0 111.845 172.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -141.98 113.06 7.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.74 1.27 . . . . 0.0 112.513 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 tp -103.2 111.99 24.63 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.028 1.331 . . . . 0.0 109.754 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -92.23 100.72 13.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.198 0.599 . . . . 0.0 110.41 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.2 t -88.94 111.96 23.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 126.01 1.724 . . . . 0.0 109.554 -176.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -74.95 96.51 3.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.602 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.37 -40.06 77.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.835 0.854 . . . . 0.0 112.53 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.73 -119.51 11.2 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 108.687 -1.765 . . . . 0.0 108.687 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -86.21 -5.04 8.59 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.441 2.094 . . . . 0.0 114.403 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.1 44.43 0.17 Allowed Glycine 0 N--CA 1.473 1.147 0 CA-C-N 119.674 1.124 . . . . 0.0 113.88 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -75.1 -170.77 1.21 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.425 1.49 . . . . 0.0 112.952 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -60.53 150.37 31.65 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.103 1.361 . . . . 0.0 112.846 -175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.1 tp 102.68 -55.69 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 130.836 3.654 . . . . 0.0 112.571 163.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.97 -26.48 70.23 Favored Glycine 0 N--CA 1.482 1.743 0 CA-C-N 120.563 1.528 . . . . 0.0 114.119 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -67.55 -40.75 84.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.207 1.403 . . . . 0.0 111.61 169.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.8 m -78.76 -15.23 58.69 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.795 1.638 . . . . 0.0 113.252 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -86.62 -12.56 48.18 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.215 1.406 . . . . 0.0 112.88 162.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 55.17 53.18 10.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.227 1.411 . . . . 0.0 109.34 -177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.08 135.42 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.087 1.755 . . . . 0.0 111.502 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.5 mmtt -83.71 -51.58 7.13 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -165.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 24.1 tp -97.58 -119.62 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.393 1.477 . . . . 0.0 107.551 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.553 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 72.0 t90 -139.18 -50.15 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-O 116.741 -1.6 . . . . 0.0 111.841 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 98.0 Cg_endo -72.74 101.47 1.3 Allowed 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.869 1.712 . . . . 0.0 108.705 168.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.3 m -156.28 141.06 17.07 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 124.914 1.286 . . . . 0.0 108.389 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -139.63 130.87 26.65 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.665 0.745 . . . . 0.0 110.78 178.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -108.4 121.1 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.24 1.816 . . . . 0.0 110.02 -170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -87.65 116.25 25.64 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.566 1.146 . . . . 0.0 109.28 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 mp -103.54 157.24 17.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.747 1.619 . . . . 0.0 110.288 172.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 -163.96 129.36 2.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.222 1.809 . . . . 0.0 108.537 172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 t70 59.85 29.11 18.68 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.347 1.459 . . . . 0.0 112.458 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.26 -10.38 49.44 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.998 1.761 . . . . 0.0 115.064 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -97.12 139.35 33.24 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.982 1.713 . . . . 0.0 110.295 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -63.72 120.04 11.07 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 168.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 m -97.15 -22.68 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.844 1.258 . . . . 0.0 112.524 176.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.07 175.21 3.28 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.612 1.965 . . . . 0.0 110.483 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -154.36 153.63 31.94 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.135 0.974 . . . . 0.0 110.378 161.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -116.17 129.79 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.191 0.996 . . . . 0.0 108.588 176.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 95.5 t -119.31 128.63 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.71 1.604 . . . . 0.0 107.228 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.8 ttt180 57.84 76.44 0.47 Allowed Pre-proline 0 CA--C 1.56 1.355 0 C-N-CA 125.325 1.45 . . . . 0.0 112.127 174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.8 -55.24 1.17 Allowed 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 124.029 3.153 . . . . 0.0 113.48 -171.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.29 -50.14 3.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.656 1.122 . . . . 0.0 113.758 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.9 m -148.41 144.39 27.43 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.157 1.383 . . . . 0.0 111.246 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.31 -27.85 56.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.078 0.951 . . . . 0.0 112.884 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.0 p -56.82 -30.03 63.35 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 172.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.0 t -83.86 -41.69 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.177 0.991 . . . . 0.0 110.567 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -72.71 -49.18 32.89 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -175.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.25 -41.57 79.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.613 1.165 . . . . 0.0 112.411 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.84 -36.44 72.3 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.197 0.999 . . . . 0.0 112.647 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.21 -48.0 25.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.948 -0.47 . . . . 0.0 111.435 172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -54.94 -50.47 68.78 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 121.082 -1.011 . . . . 0.0 111.708 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -34.85 73.36 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 176.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.0 t -68.1 -36.24 79.44 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.647 0.379 . . . . 0.0 111.328 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -92.13 -32.48 15.12 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.708 -0.62 . . . . 0.0 112.634 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.28 -25.46 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.955 0.902 . . . . 0.0 111.474 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.71 -3.39 49.36 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.539 2.019 . . . . 0.0 114.943 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -69.37 -22.17 63.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.721 1.208 . . . . 0.0 112.808 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 C-N-CA 125.696 1.617 . . . . 0.0 113.295 171.392 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 120.6 0.238 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -70.89 0.73 6.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.702 1.601 . . . . 0.0 114.132 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.1 p -71.8 -17.57 62.15 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.45 2.3 . . . . 0.0 113.185 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.11 146.52 32.95 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.052 1.341 . . . . 0.0 112.507 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -93.75 165.95 12.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.1 m -127.32 124.79 39.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.533 1.133 . . . . 0.0 112.714 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.86 -26.92 36.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.471 1.108 . . . . 0.0 111.451 169.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -76.11 37.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.36 2.264 . . . . 0.0 112.912 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.7 155.88 88.11 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.27 1.028 . . . . 0.0 111.909 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.53 160.75 46.52 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.846 3.031 . . . . 0.0 112.797 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.28 159.19 34.46 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.915 164.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -36.72 75.19 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 121.514 -0.741 . . . . 0.0 112.385 178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -68.21 -22.71 64.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 174.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -92.22 -28.91 16.73 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.419 1.087 . . . . 0.0 110.901 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -78.44 -27.66 46.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.243 1.817 . . . . 0.0 112.428 173.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.21 -19.41 54.2 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.058 1.343 . . . . 0.0 112.766 171.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -76.23 -9.02 58.31 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.781 1.632 . . . . 0.0 113.427 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.0 mt -55.15 159.15 2.64 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.29 -48.79 0.16 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.71 169.0 54.57 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-O 119.226 -0.764 . . . . 0.0 112.873 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -64.85 112.72 2.08 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.063 2.509 . . . . 0.0 109.152 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 m -133.47 124.59 27.3 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.186 0.994 . . . . 0.0 109.54 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -92.41 127.83 38.04 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.932 0.893 . . . . 0.0 110.095 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.09 113.58 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.274 1.03 . . . . 0.0 109.536 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -109.41 131.2 55.29 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 127.852 2.461 . . . . 0.0 110.805 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.57 130.45 56.02 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.523 1.529 . . . . 0.0 111.524 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.04 -148.48 16.45 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.501 1.048 . . . . 0.0 112.824 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -146.5 171.5 14.96 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 126.436 1.895 . . . . 0.0 109.196 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -80.32 -1.13 39.71 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.153 -0.967 . . . . 0.0 112.722 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -129.05 -17.29 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -166.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.0 t -65.25 143.6 57.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.138 1.79 . . . . 0.0 111.676 176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.76 -20.67 68.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.572 1.082 . . . . 0.0 114.127 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -65.04 -50.81 64.78 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.503 1.651 . . . . 0.0 110.455 164.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 25.1 m -61.86 -37.29 83.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.446 1.099 . . . . 0.0 112.864 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -65.18 -23.74 67.18 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.648 1.113 . . . . 0.0 111.975 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.9 -39.97 15.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.517 1.527 . . . . 0.0 112.527 175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.74 -31.03 32.19 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.5 -54.74 50.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.32 -1.324 . . . . 0.0 113.405 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.23 -21.38 48.19 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.161 1.907 . . . . 0.0 112.102 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.32 -56.88 10.16 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.207 1.003 . . . . 0.0 109.107 176.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.59 -47.07 87.0 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 123.893 0.877 . . . . 0.0 109.108 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.19 -36.74 71.2 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -71.78 -44.43 64.02 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.011 0.524 . . . . 0.0 111.572 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 97' ' ' LEU . 96.9 t -63.1 -51.99 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 118.735 0.698 . . . . 0.0 110.758 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -56.13 -15.56 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.925 1.69 . . . . 0.0 113.124 174.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -66.08 -24.8 66.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.142 0.883 . . . . 0.0 112.413 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -99.66 -10.69 21.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.637 1.175 . . . . 0.0 113.441 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.9 47.22 2.37 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.131 1.372 . . . . 0.0 114.212 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.11 -17.0 58.02 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 113.807 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.69 -16.03 63.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.55 141.27 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.94 156.18 26.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.173 0.892 . . . . 0.0 112.365 174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -135.15 117.99 16.19 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.394 1.097 . . . . 0.0 112.181 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 40.8 tp -107.24 107.09 17.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 109.448 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -89.42 99.72 12.66 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.751 0.82 . . . . 0.0 110.747 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.3 t -88.94 116.78 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.186 1.794 . . . . 0.0 109.943 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -79.39 132.69 36.47 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.62 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -67.17 149.11 50.93 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.271 1.428 . . . . 0.0 112.303 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.01 -117.45 5.77 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -165.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.39 106.8 1.28 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.441 2.094 . . . . 0.0 109.273 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 127.9 -10.4 6.67 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 124.899 1.237 . . . . 0.0 115.351 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -55.1 -30.37 59.58 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -57.71 -35.02 70.08 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.786 0.834 . . . . 0.0 112.669 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.6 tp -66.27 -54.11 28.74 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.734 -0.603 . . . . 0.0 110.076 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.18 -29.73 71.96 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 118.947 0.794 . . . . 0.0 114.218 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 ttt85 -65.26 -47.91 75.09 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.055 1.342 . . . . 0.0 111.558 170.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.9 m -76.02 -11.24 59.91 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -86.61 -12.7 47.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.712 1.205 . . . . 0.0 112.899 162.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 54.21 51.69 13.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.996 1.318 . . . . 0.0 110.164 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 t -59.59 132.04 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.952 1.301 . . . . 0.0 110.721 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -81.55 -49.54 10.44 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -165.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.88 -117.15 0.21 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.147 1.379 . . . . 0.0 107.461 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.507 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 66.9 t90 -142.41 -51.23 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 116.478 -1.725 . . . . 0.0 111.287 167.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 83.2 Cg_endo -72.76 100.53 1.19 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 CA-C-N 121.489 1.567 . . . . 0.0 108.994 167.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.2 m -156.98 138.78 14.25 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -168.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.52 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -138.86 128.07 24.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.078 0.942 . . . . 0.0 110.671 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.29 121.13 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.942 1.697 . . . . 0.0 109.249 -171.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.53 117.86 24.7 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.088 0.955 . . . . 0.0 109.019 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 mp -107.27 152.53 23.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.138 1.375 . . . . 0.0 111.252 174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -163.72 135.69 4.94 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.947 1.699 . . . . 0.0 108.508 174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.1 t70 60.26 25.02 14.43 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.901 1.28 . . . . 0.0 112.629 -168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 76.77 -4.48 52.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.834 1.207 . . . . 0.0 115.325 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -103.15 143.08 33.07 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.679 1.991 . . . . 0.0 109.865 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.68 120.75 12.4 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.302 -0.874 . . . . 0.0 109.484 169.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -96.93 -23.51 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.81 1.244 . . . . 0.0 112.423 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.95 178.07 2.64 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.552 1.941 . . . . 0.0 111.101 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.98 156.76 36.58 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 124.348 1.059 . . . . 0.0 111.438 162.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.0 t -121.04 127.77 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -113.15 127.55 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.472 1.509 . . . . 0.0 108.011 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 56.74 81.33 0.26 Allowed Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 125.905 1.682 . . . . 0.0 112.301 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -62.7 127.71 21.36 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.496 2.797 . . . . 0.0 111.689 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.41 -33.38 11.74 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.879 0.752 . . . . 0.0 113.509 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 t -175.8 162.47 2.67 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.423 2.289 . . . . 0.0 110.049 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.33 -28.9 56.79 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.427 1.091 . . . . 0.0 112.375 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.7 p -61.57 -28.01 69.03 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.669 -1.269 . . . . 0.0 113.819 173.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -93.09 -37.69 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.756 1.623 . . . . 0.0 110.793 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.699 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -71.2 -48.18 53.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.088 0.555 . . . . 0.0 111.481 177.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.407 ' HG3' HG22 ' A' ' 44' ' ' VAL . 54.3 mt-10 -61.8 -35.17 77.4 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.322 -0.861 . . . . 0.0 111.993 176.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -60.06 -33.95 72.75 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.094 1.357 . . . . 0.0 112.301 177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -45.3 27.13 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.425 -0.797 . . . . 0.0 111.008 171.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -56.71 -49.7 74.39 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.951 -1.093 . . . . 0.0 112.679 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -33.45 65.8 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 174.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.3 t -73.84 -31.24 63.1 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.79 -25.33 14.41 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.79 -26.91 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.379 1.072 . . . . 0.0 111.245 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.24 13.21 56.4 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.883 1.23 . . . . 0.0 114.741 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -76.69 -33.69 58.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.029 0.914 . . . . 0.0 111.038 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 C-N-CA 124.901 1.239 . . . . 0.0 114.169 175.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -79.53 166.74 21.62 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.892 1.677 . . . . 0.0 112.774 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.4 p -69.32 162.85 26.38 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.874 1.27 . . . . 0.0 110.967 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -172.86 4.23 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.69 1.596 . . . . 0.0 111.118 -174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.449 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 25.7 m-85 -64.15 149.01 48.65 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 71.8 m -121.67 124.36 44.09 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.399 1.08 . . . . 0.0 112.887 -170.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.12 -34.02 68.26 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -74.7 31.05 0.09 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 126.894 2.077 . . . . 0.0 115.133 -175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 154.87 65.89 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 120.86 -1.15 . . . . 0.0 113.093 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.42 160.47 49.68 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.826 3.017 . . . . 0.0 112.695 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.91 146.8 30.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.572 0.749 . . . . 0.0 110.807 165.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -27.6 64.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.03 0.932 . . . . 0.0 112.84 -175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -68.86 -43.06 76.17 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.184 0.994 . . . . 0.0 113.078 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.16 -34.76 59.39 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.219 0.533 . . . . 0.0 111.518 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 tt -65.88 -14.77 62.1 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.513 1.525 . . . . 0.0 112.625 172.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.82 -22.73 59.69 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 120.13 1.332 . . . . 0.0 112.157 173.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.4 mtm-85 -96.48 -4.75 40.98 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.308 1.443 . . . . 0.0 114.045 -170.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -60.98 168.61 2.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.184 0.994 . . . . 0.0 112.518 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.67 -36.18 0.96 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.78 163.02 52.31 Favored Glycine 0 CA--C 1.539 1.537 0 CA-C-N 119.01 0.823 . . . . 0.0 113.943 -174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -65.53 108.33 1.19 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.207 2.605 . . . . 0.0 109.36 176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.2 m -128.83 117.41 21.02 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.062 1.345 . . . . 0.0 109.443 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.0 tp -86.02 125.11 33.17 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.354 0.662 . . . . 0.0 110.029 171.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -107.78 111.7 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.296 1.038 . . . . 0.0 109.661 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -110.15 127.52 54.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 127.374 2.27 . . . . 0.0 110.925 -170.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -107.44 119.21 38.78 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.049 1.34 . . . . 0.0 110.526 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.61 -162.73 29.58 Favored Glycine 0 N--CA 1.469 0.876 0 C-N-CA 123.697 0.665 . . . . 0.0 113.787 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.5 p -145.0 175.69 10.04 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.229 1.812 . . . . 0.0 109.893 176.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -82.71 -3.59 56.65 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.549 -0.72 . . . . 0.0 112.678 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.2 p-90 -125.83 -16.52 5.65 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -165.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 44.5 t -66.34 143.16 57.34 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 120.855 1.661 . . . . 0.0 112.06 173.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.59 -25.55 74.91 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.96 1.267 . . . . 0.0 114.203 176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -66.78 -45.79 77.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.372 1.586 . . . . 0.0 110.45 165.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 m -60.93 -34.4 74.66 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 123.572 0.749 . . . . 0.0 112.963 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.32 -24.89 67.81 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.934 1.243 . . . . 0.0 112.389 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.67 -37.69 12.88 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.615 1.566 . . . . 0.0 112.853 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.62 -29.9 29.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.779 0.831 . . . . 0.0 113.061 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -58.51 -54.24 58.01 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.593 -1.194 . . . . 0.0 113.178 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.77 -18.29 41.91 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.653 1.568 . . . . 0.0 112.009 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -57.97 5.28 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.3 mm? -58.29 -42.08 85.81 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.194 0.998 . . . . 0.0 109.715 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.72 -39.48 77.36 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.983 0.913 . . . . 0.0 112.886 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.38 -46.28 56.04 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.019 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.65 -50.56 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 118.97 0.804 . . . . 0.0 112.186 176.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -57.0 -25.22 58.09 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.9 m -62.97 -19.5 64.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -100.81 -7.39 23.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.504 1.122 . . . . 0.0 113.379 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -128.97 49.91 5.23 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.127 1.371 . . . . 0.0 114.258 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.01 -15.13 47.44 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.788 2.992 . . . . 0.0 114.337 -173.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -74.18 -14.33 60.93 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -82.97 139.67 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.19 153.56 22.33 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.345 0.974 . . . . 0.0 112.009 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.18 135.57 50.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.135 0.967 . . . . 0.0 110.968 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.35 99.0 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.775 170.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 31.6 mtmt -76.09 87.66 2.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.883 1.273 . . . . 0.0 110.446 171.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.2 t -72.8 119.24 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 C-N-CA 124.412 1.085 . . . . 0.0 108.849 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -70.22 100.71 1.73 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.667 167.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -100.87 -172.96 2.27 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.771 2.028 . . . . 0.0 111.137 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.1 171.37 27.03 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 120.897 -1.127 . . . . 0.0 114.72 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.4 -30.36 29.93 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.062 3.175 . . . . 0.0 113.751 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.01 1.27 88.98 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.265 0.936 . . . . 0.0 114.048 171.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 72.76 125.13 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 129.347 3.059 . . . . 0.0 112.474 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -94.14 -111.07 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.816 1.646 . . . . 0.0 108.978 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.7 tp -64.37 -30.95 71.98 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.481 1.491 . . . . 0.0 111.63 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.15 -24.43 58.64 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 119.344 0.975 . . . . 0.0 114.374 172.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 ttt85 -64.49 -46.22 83.96 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.311 1.056 . . . . 0.0 111.16 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -70.83 -28.19 64.42 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.283 1.033 . . . . 0.0 111.773 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -79.66 -4.24 50.84 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.081 1.753 . . . . 0.0 113.685 171.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.44 34.5 8.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.371 1.869 . . . . 0.0 111.374 177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.51 126.13 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.385 1.074 . . . . 0.0 110.75 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -43.83 43.99 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.746 1.218 . . . . 0.0 113.174 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.9 tp -91.52 -129.46 0.1 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.974 1.31 . . . . 0.0 108.518 176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.531 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 35.8 t90 -150.03 -49.2 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 116.59 -1.672 . . . . 0.0 113.306 167.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 97.4 Cg_endo -72.1 96.84 0.8 Allowed 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.873 1.715 . . . . 0.0 108.457 172.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -159.87 136.54 9.14 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.019 1.327 . . . . 0.0 107.594 -165.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -132.96 127.02 33.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.776 -178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.8 t -106.26 121.21 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.986 1.715 . . . . 0.0 109.015 -171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -84.36 114.72 22.08 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.75 151.91 23.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.377 1.471 . . . . 0.0 110.487 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -167.44 136.89 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.404 1.882 . . . . 0.0 108.673 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.59 23.77 14.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.234 1.413 . . . . 0.0 112.801 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.6 -9.79 57.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.896 1.712 . . . . 0.0 114.863 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 -101.6 152.05 21.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.985 1.714 . . . . 0.0 110.164 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -65.75 126.58 28.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 164.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.2 m -100.46 -24.22 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.235 1.014 . . . . 0.0 112.485 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.2 179.73 2.93 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.251 1.82 . . . . 0.0 110.913 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.84 156.14 35.66 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.227 1.011 . . . . 0.0 110.844 161.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.2 t -120.19 129.83 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.5 t -112.65 129.96 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 108.602 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 50.8 78.35 0.41 Allowed Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 126.338 1.855 . . . . 0.0 113.292 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.59 127.33 22.36 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.29 2.66 . . . . 0.0 111.595 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.05 -29.49 20.13 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.86 0.743 . . . . 0.0 113.805 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.6 p -174.07 159.07 3.2 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.675 1.59 . . . . 0.0 110.629 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.9 Favored 'General case' 0 C--O 1.22 -0.465 0 O-C-N 121.369 -0.832 . . . . 0.0 111.601 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.4 p -64.17 -21.85 66.72 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.013 -1.054 . . . . 0.0 113.634 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 53.3 t -89.19 -41.17 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.552 1.141 . . . . 0.0 111.396 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.18 -50.37 40.94 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.679 -0.638 . . . . 0.0 111.912 -178.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.39 -38.2 71.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.887 1.275 . . . . 0.0 112.956 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.12 -34.65 75.31 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.334 1.053 . . . . 0.0 112.707 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.15 -44.55 29.91 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.703 -0.623 . . . . 0.0 111.373 171.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -56.56 -49.27 75.34 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.27 0.941 . . . . 0.0 112.577 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -34.53 72.36 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.3 m -73.7 -25.78 60.39 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.544 -0.722 . . . . 0.0 112.688 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -103.25 -23.53 13.6 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.67 -25.11 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 124.06 0.944 . . . . 0.0 111.297 168.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.4 -5.72 48.97 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.524 2.011 . . . . 0.0 114.981 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -62.61 -40.11 95.9 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 118.578 1.189 . . . . 0.0 111.682 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.263 0 C-N-CA 124.491 1.043 . . . . 0.0 114.224 176.634 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.6 mtm . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -61.74 -26.57 68.15 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.047 1.339 . . . . 0.0 114.054 -172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 41.5 p -75.78 -26.96 57.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.08 1.752 . . . . 0.0 113.639 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -70.67 148.82 47.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.265 1.026 . . . . 0.0 113.566 -166.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -77.5 172.3 13.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.672 1.989 . . . . 0.0 115.954 -172.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -132.96 131.54 40.91 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 172.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.08 -23.42 35.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.344 1.058 . . . . 0.0 113.766 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.65 40.9 0.99 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.477 1.511 . . . . 0.0 112.621 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.77 155.05 78.69 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.217 1.007 . . . . 0.0 113.096 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.03 161.42 45.89 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 124.324 3.35 . . . . 0.0 112.849 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.15 153.82 35.92 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.345 0.658 . . . . 0.0 110.604 163.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -63.51 -28.28 69.84 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.143 -0.973 . . . . 0.0 113.109 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.94 -29.17 66.26 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.949 -1.094 . . . . 0.0 112.854 172.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -78.72 -26.38 44.74 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.082 -1.011 . . . . 0.0 111.181 173.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.96 -33.35 61.9 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 111.354 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.63 -19.0 23.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.454 1.902 . . . . 0.0 113.853 171.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.3 mmt-85 -71.86 -11.84 60.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.145 0.978 . . . . 0.0 112.897 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.95 169.45 1.95 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.82 -45.32 0.31 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.088 1.355 . . . . 0.0 113.936 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.79 171.55 53.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-O 119.092 -0.838 . . . . 0.0 113.832 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.31 117.84 4.93 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 109.685 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.7 m -129.61 154.14 47.39 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.11 1.364 . . . . 0.0 110.003 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.8 tp -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.18 1.392 . . . . 0.0 109.432 170.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.1 t -107.14 114.15 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.392 1.077 . . . . 0.0 108.738 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -106.23 126.29 52.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.998 1.719 . . . . 0.0 111.684 -175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -102.75 122.99 45.6 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.947 1.299 . . . . 0.0 109.827 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.81 -163.21 29.15 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 123.757 0.694 . . . . 0.0 113.607 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 72.9 p -148.64 171.79 15.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.797 2.039 . . . . 0.0 109.59 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.69 -6.24 53.25 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.253 -0.904 . . . . 0.0 112.414 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -125.79 -17.64 5.37 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 47.2 t -67.01 140.54 57.7 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.699 1.59 . . . . 0.0 111.433 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.08 -22.96 74.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.615 1.103 . . . . 0.0 113.365 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -67.44 -45.77 75.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.215 1.507 . . . . 0.0 110.412 166.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.8 m -60.78 -37.85 83.28 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -64.06 -23.13 67.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.673 0.669 . . . . 0.0 112.478 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.3 -39.23 12.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.581 1.552 . . . . 0.0 112.274 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.6 -31.44 28.91 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.558 0.743 . . . . 0.0 112.874 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -59.69 -52.46 73.73 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 117.805 -1.093 . . . . 0.0 113.633 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.76 -17.41 42.27 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.81 1.673 . . . . 0.0 112.234 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.39 -56.57 9.13 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.014 0.825 . . . . 0.0 109.556 172.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.1 mm? -54.0 -48.04 70.82 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.076 0.95 . . . . 0.0 108.799 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.33 -30.84 63.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -76.99 -45.88 25.85 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.986 0.812 . . . . 0.0 112.123 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 97' ' ' LEU . 2.4 p -66.52 -47.5 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-N 118.61 0.641 . . . . 0.0 112.64 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -24.83 67.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.499 1.519 . . . . 0.0 113.846 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.3 m -59.81 -20.81 59.13 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -96.09 -10.68 27.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.189 0.996 . . . . 0.0 113.094 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -129.75 42.55 0.92 Allowed Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 126.031 1.732 . . . . 0.0 115.129 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.98 -16.66 51.23 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.442 2.761 . . . . 0.0 113.81 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -69.01 -15.35 63.45 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.1 t -75.86 139.72 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.509 1.05 . . . . 0.0 108.858 172.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.6 132.06 10.97 Favored Glycine 0 N--CA 1.474 1.194 0 CA-C-O 118.579 -1.123 . . . . 0.0 111.144 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -108.12 124.62 50.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 119.832 1.816 . . . . 0.0 110.881 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 99.39 8.91 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.885 1.274 . . . . 0.0 108.859 176.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 29.7 mtmt -81.2 101.22 9.55 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.736 0.814 . . . . 0.0 111.851 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t -88.34 120.68 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.906 0.882 . . . . 0.0 110.328 174.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -76.26 71.43 2.97 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 122.603 1.192 . . . . 0.0 110.869 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.43 10.81 1.47 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.044 2.137 . . . . 0.0 113.695 -165.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.73 -86.03 1.47 Allowed Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.014 1.293 . . . . 0.0 110.527 167.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.85 -13.28 9.4 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.268 3.312 . . . . 0.0 114.587 -172.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.2 -167.78 34.23 Favored Glycine 0 N--CA 1.472 1.076 0 CA-C-N 119.512 1.051 . . . . 0.0 113.85 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 63.4 mtm-85 -62.49 -23.76 67.1 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 69.47 159.28 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.222 2.609 . . . . 0.0 112.046 -176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.0 tp -151.15 -28.11 0.2 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.739 1.216 . . . . 0.0 112.287 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.16 -23.78 66.51 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-N 120.222 1.374 . . . . 0.0 113.544 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -49.98 -54.47 19.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.776 2.031 . . . . 0.0 111.537 162.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 m -86.24 -7.03 58.83 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.454 1.502 . . . . 0.0 113.639 -172.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -90.84 -6.02 54.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.223 1.409 . . . . 0.0 112.734 160.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 56.64 46.89 19.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.564 1.545 . . . . 0.0 110.499 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.6 t -61.8 143.18 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.122 1.769 . . . . 0.0 112.179 -177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -96.19 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.948 1.299 . . . . 0.0 110.627 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tp -75.14 141.22 43.74 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.2 t90 -61.38 -41.06 77.48 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -170.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.83 87.55 1.51 Allowed 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.57 2.18 . . . . 0.0 109.975 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.0 m -141.73 149.9 41.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 125.816 1.646 . . . . 0.0 109.218 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.6 OUTLIER -139.54 129.79 25.32 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.416 174.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -104.85 124.67 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.998 1.719 . . . . 0.0 109.346 -174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.429 ' CG ' HD13 ' A' ' 23' ' ' LEU . 48.7 m-85 -87.38 123.47 32.37 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.129 0.972 . . . . 0.0 109.247 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.05 156.5 21.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.968 2.107 . . . . 0.0 110.13 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -167.97 136.64 2.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.699 2.0 . . . . 0.0 108.523 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.7 t70 62.34 28.2 16.78 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.382 1.073 . . . . 0.0 112.069 -172.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.64 6.67 59.51 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-O 118.904 -0.942 . . . . 0.0 115.02 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -124.83 151.28 45.44 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.86 1.664 . . . . 0.0 110.986 -175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -70.24 123.94 22.91 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.833 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.9 m -99.25 -24.31 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.98 1.312 . . . . 0.0 112.485 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.18 179.29 2.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.238 1.815 . . . . 0.0 111.047 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -155.69 155.79 33.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.038 0.935 . . . . 0.0 111.208 162.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.6 t -117.7 120.3 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.5 t -107.22 128.07 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.569 1.548 . . . . 0.0 107.542 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 55.91 81.6 0.26 Allowed Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.53 1.532 . . . . 0.0 112.852 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.51 127.65 20.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.124 2.549 . . . . 0.0 111.153 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.7 -33.19 9.34 Favored Glycine 0 N--CA 1.477 1.396 0 C-N-CA 123.547 0.594 . . . . 0.0 113.879 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 t -173.43 163.25 4.43 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.804 2.041 . . . . 0.0 109.98 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.39 61.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.764 0.826 . . . . 0.0 111.892 177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -60.82 -22.2 63.93 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.3 t -91.2 -41.75 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.461 1.504 . . . . 0.0 110.36 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.569 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.4 -50.17 48.43 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.022 -0.424 . . . . 0.0 111.864 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -56.34 -41.04 75.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.728 1.211 . . . . 0.0 112.574 174.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -58.21 -37.19 74.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.566 1.146 . . . . 0.0 112.373 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.97 -44.92 37.51 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.89 -0.506 . . . . 0.0 110.789 173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.32 -51.69 65.91 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.194 0.906 . . . . 0.0 111.94 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -32.68 72.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.9 t -70.31 -31.39 68.7 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.54 -0.725 . . . . 0.0 112.34 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.48 -25.32 14.48 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.16 -23.7 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 0.0 111.596 168.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.66 -7.4 57.73 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.742 1.639 . . . . 0.0 114.938 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -64.43 -32.53 74.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.708 1.254 . . . . 0.0 111.821 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.443 0 C-N-CA 125.343 1.449 . . . . 0.0 114.225 175.025 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 121.285 0.564 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -77.3 138.72 39.54 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.87 0.868 . . . . 0.0 110.456 168.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.9 p -86.2 151.73 23.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.228 1.011 . . . . 0.0 112.574 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -84.48 -25.24 29.02 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.436 1.494 . . . . 0.0 112.924 174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.13 161.25 31.43 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.107 1.763 . . . . 0.0 113.208 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 m -134.6 124.8 26.0 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.348 1.059 . . . . 0.0 112.762 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.57 -25.01 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.268 -0.895 . . . . 0.0 112.735 174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.46 39.47 0.4 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.277 1.431 . . . . 0.0 112.457 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 156.33 86.58 Favored Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 120.845 -1.159 . . . . 0.0 111.835 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.84 156.08 66.58 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.403 2.735 . . . . 0.0 112.731 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.87 160.84 28.03 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.607 0.763 . . . . 0.0 110.444 159.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -54.38 -35.55 62.95 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.233 -0.917 . . . . 0.0 112.893 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.37 -30.17 65.83 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -79.66 -37.59 35.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.894 1.278 . . . . 0.0 110.313 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.02 -32.48 72.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.419 2.288 . . . . 0.0 112.388 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.38 -21.17 59.48 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.691 1.197 . . . . 0.0 113.026 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -75.98 -15.5 60.14 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.104 0.962 . . . . 0.0 113.17 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -69.1 162.69 26.44 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.465 1.029 . . . . 0.0 112.226 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.26 -34.64 0.64 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.48 169.81 54.53 Favored Glycine 0 CA--C 1.536 1.373 0 CA-C-N 119.027 0.831 . . . . 0.0 113.019 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 110.86 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.188 2.592 . . . . 0.0 109.39 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.7 m -130.76 118.26 20.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.551 1.14 . . . . 0.0 109.776 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -86.71 128.46 35.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 169.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.15 113.33 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.035 0.934 . . . . 0.0 109.129 177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -107.85 127.18 53.5 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.797 2.039 . . . . 0.0 111.286 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -99.81 133.68 43.81 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 0.0 109.598 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.69 -158.17 31.0 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 123.825 0.726 . . . . 0.0 112.405 -177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -143.27 179.13 7.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.156 1.782 . . . . 0.0 109.006 167.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -87.65 1.28 54.12 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.306 -0.872 . . . . 0.0 112.524 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 -130.11 -13.81 3.96 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.7 t -68.91 143.45 54.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.449 1.477 . . . . 0.0 111.287 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.08 70.62 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.814 1.197 . . . . 0.0 113.695 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.14 -48.59 75.45 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.322 1.561 . . . . 0.0 110.689 165.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.7 m -63.75 -36.61 84.45 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.832 0.853 . . . . 0.0 112.821 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -63.17 -24.44 67.89 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.461 1.028 . . . . 0.0 112.717 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.0 -37.69 14.14 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.67 1.588 . . . . 0.0 112.99 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.94 -29.27 23.72 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -58.27 -53.24 68.0 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 117.14 -1.41 . . . . 0.0 113.164 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.52 -20.55 47.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.991 1.794 . . . . 0.0 111.913 175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -65.98 -57.0 8.8 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.849 0.86 . . . . 0.0 109.672 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.32 -45.55 93.01 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.029 0.932 . . . . 0.0 109.184 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.51 -37.07 74.82 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -71.01 -44.18 66.4 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.013 0.525 . . . . 0.0 111.674 174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.672 HG21 ' HB3' ' A' ' 97' ' ' LEU . 98.5 t -63.75 -50.12 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.638 -0.663 . . . . 0.0 110.96 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.45 -15.46 6.9 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.957 1.703 . . . . 0.0 113.146 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.0 t -63.7 -27.52 69.27 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.796 0.725 . . . . 0.0 112.364 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.3 -13.47 24.78 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.935 1.694 . . . . 0.0 113.437 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -130.11 47.02 2.53 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.014 1.326 . . . . 0.0 114.175 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -62.92 -17.14 58.36 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 123.005 2.47 . . . . 0.0 114.02 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.87 -15.48 63.51 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.99 141.15 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.986 1.314 . . . . 0.0 108.618 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 154.06 23.38 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.369 0.985 . . . . 0.0 112.293 174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -128.56 116.67 20.01 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.37 1.085 . . . . 0.0 111.268 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.87 107.95 20.09 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.188 0.995 . . . . 0.0 109.124 176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -88.01 94.74 9.88 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.612 0.765 . . . . 0.0 110.495 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.0 t -80.08 117.7 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.146 0.978 . . . . 0.0 109.552 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -76.95 75.9 3.53 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.612 1.196 . . . . 0.0 110.082 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -80.93 29.59 0.33 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 127.823 2.449 . . . . 0.0 112.775 -162.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.89 -74.26 0.71 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.915 1.721 . . . . 0.0 111.472 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -60.08 -38.05 80.13 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.555 2.837 . . . . 0.0 115.846 -170.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.51 169.84 39.08 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-N 118.503 0.592 . . . . 0.0 114.403 -175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 51.68 46.79 25.97 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.443 1.497 . . . . 0.0 111.668 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -71.78 78.24 0.86 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.913 2.085 . . . . 0.0 112.125 -170.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.0 -29.01 64.94 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.4 1.88 . . . . 0.0 113.388 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.2 -23.04 67.73 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.476 1.034 . . . . 0.0 114.439 178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -63.98 -42.33 97.27 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.857 0.829 . . . . 0.0 111.129 168.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.1 m -82.44 -5.74 58.86 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.315 1.446 . . . . 0.0 113.783 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -95.61 -4.04 45.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.808 1.243 . . . . 0.0 113.019 160.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 57.67 43.49 22.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.689 1.596 . . . . 0.0 110.788 178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 t -55.76 141.6 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 127.232 2.213 . . . . 0.0 113.823 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.21 -63.33 1.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.003 1.321 . . . . 0.0 112.465 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.7 tp -122.92 140.09 53.36 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.743 1.617 . . . . 0.0 107.901 173.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -49.85 -42.23 67.69 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -168.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.87 75.0 5.26 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 123.19 2.593 . . . . 0.0 110.398 173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.3 m -119.1 149.95 40.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.205 1.802 . . . . 0.0 108.348 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -135.71 125.86 26.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.38 1.072 . . . . 0.0 109.936 172.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.08 121.69 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.982 1.713 . . . . 0.0 108.484 -173.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.417 ' CD2' HD13 ' A' ' 23' ' ' LEU . 49.9 m-85 -82.89 117.98 23.13 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.853 0.861 . . . . 0.0 109.254 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.85 152.52 23.78 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.197 1.399 . . . . 0.0 110.507 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -164.69 136.62 4.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.878 1.671 . . . . 0.0 108.827 173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.9 t70 64.9 19.32 11.82 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.413 1.485 . . . . 0.0 112.956 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.66 -7.57 80.56 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.37 1.462 . . . . 0.0 114.583 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -106.9 155.16 20.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.434 1.894 . . . . 0.0 110.349 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -63.47 128.06 34.14 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.664 0.786 . . . . 0.0 110.016 164.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.0 m -102.28 -22.0 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.794 1.238 . . . . 0.0 112.236 171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.06 177.91 2.24 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.681 1.992 . . . . 0.0 110.997 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -154.82 157.0 37.24 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.059 0.944 . . . . 0.0 111.191 164.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 73.8 t -126.08 141.0 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.008 1.323 . . . . 0.0 107.702 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.07 139.33 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.476 1.51 . . . . 0.0 109.694 -176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 54.71 63.95 6.54 Favored Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.066 1.347 . . . . 0.0 110.991 176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.93 126.6 22.18 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 124.334 3.356 . . . . 0.0 111.074 -172.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.86 -34.79 12.38 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.863 0.744 . . . . 0.0 113.382 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 97.3 p -171.12 161.16 6.66 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.186 1.794 . . . . 0.0 110.374 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.82 -30.86 64.16 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -62.89 -24.06 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.613 -1.304 . . . . 0.0 113.81 174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 77.1 t -91.98 -41.02 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.029 1.332 . . . . 0.0 111.154 173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.672 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -70.95 -48.04 55.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.277 0.631 . . . . 0.0 111.633 -178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.03 -36.15 80.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.088 0.955 . . . . 0.0 111.849 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -60.74 -35.56 76.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.115 1.366 . . . . 0.0 112.274 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.06 -45.11 43.7 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.385 -0.822 . . . . 0.0 111.105 170.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -55.9 -50.62 70.18 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.245 -0.91 . . . . 0.0 112.377 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -32.55 70.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 176.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.6 t -68.96 -33.57 73.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.765 -0.584 . . . . 0.0 112.331 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.09 -24.57 16.25 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.79 -28.69 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.89 0.876 . . . . 0.0 111.471 171.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.53 -5.72 44.53 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.251 1.881 . . . . 0.0 114.729 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.34 -24.06 67.16 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.676 1.238 . . . . 0.0 113.116 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.26 0 C-N-CA 125.301 1.429 . . . . 0.0 115.161 174.6 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 mtt . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 110.845 -0.058 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -76.4 -0.15 21.74 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.0 p -64.29 163.83 12.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.581 1.552 . . . . 0.0 112.828 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.16 149.11 50.48 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -172.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -65.52 161.75 19.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.994 1.718 . . . . 0.0 114.659 171.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 t -132.61 137.64 47.11 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.82 -15.73 58.85 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.627 1.171 . . . . 0.0 113.187 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -86.37 38.79 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.087 1.355 . . . . 0.0 112.635 -170.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.6 155.42 93.55 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.187 0.995 . . . . 0.0 113.212 177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -71.17 164.1 36.89 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 124.112 3.208 . . . . 0.0 112.021 175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.87 151.44 37.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.974 161.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -28.72 69.77 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.343 -0.848 . . . . 0.0 112.86 -174.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.65 -38.82 70.67 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.978 0.911 . . . . 0.0 112.494 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -72.6 -33.87 67.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.258 1.023 . . . . 0.0 111.827 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -60.16 -40.18 89.01 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.728 1.611 . . . . 0.0 110.606 171.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.1 -13.32 34.97 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.752 1.221 . . . . 0.0 113.308 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -78.12 -18.11 56.06 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.01 0.924 . . . . 0.0 113.028 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.7 164.86 22.54 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.935 1.243 . . . . 0.0 112.147 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.02 -26.57 1.71 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.6 54.82 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 119.102 0.865 . . . . 0.0 113.964 -174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.07 111.27 2.83 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.11 2.54 . . . . 0.0 108.739 173.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 m -134.1 123.12 23.92 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.278 1.031 . . . . 0.0 110.445 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.9 tp -88.23 124.39 33.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.089 0.956 . . . . 0.0 110.437 171.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -107.1 112.88 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.501 1.12 . . . . 0.0 109.28 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -106.64 125.17 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.549 2.34 . . . . 0.0 110.656 -170.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -105.52 123.84 48.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.107 1.363 . . . . 0.0 111.173 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.67 -154.59 20.23 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 123.723 0.677 . . . . 0.0 112.888 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -148.21 174.17 12.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.334 1.854 . . . . 0.0 108.889 170.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -83.84 0.04 49.18 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.006 -1.059 . . . . 0.0 112.451 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -127.56 -15.99 4.91 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -167.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 46.3 t -68.37 142.88 55.32 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 120.711 1.596 . . . . 0.0 111.396 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -22.62 71.4 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.902 1.239 . . . . 0.0 114.104 176.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -65.2 -46.68 79.73 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.365 1.582 . . . . 0.0 110.434 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.2 m -65.17 -33.92 77.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 113.126 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.0 -24.74 67.6 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.681 0.673 . . . . 0.0 111.998 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.25 -38.11 17.91 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.341 1.457 . . . . 0.0 112.438 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.14 -29.68 38.87 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -53.56 -56.12 28.05 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.3 -18.27 26.74 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.888 2.392 . . . . 0.0 112.472 176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -56.6 9.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.9 mm? -56.96 -44.99 83.13 Favored 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.1 0.875 . . . . 0.0 109.011 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.71 69.54 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -71.54 -46.85 58.36 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.433 0.56 . . . . 0.0 111.555 176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG11 HD22 ' A' ' 97' ' ' LEU . 3.1 p -67.04 -48.5 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.592 0.633 . . . . 0.0 112.33 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -20.25 62.47 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.052 1.341 . . . . 0.0 113.905 -175.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.8 t -60.27 -21.98 62.55 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -101.95 -11.2 19.14 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.045 1.338 . . . . 0.0 114.25 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -129.68 40.39 0.6 Allowed Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 125.478 1.511 . . . . 0.0 114.637 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -62.71 -16.07 50.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 123.437 2.758 . . . . 0.0 114.091 -171.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.75 -16.05 62.73 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -76.04 145.54 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.347 0.976 . . . . 0.0 109.542 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.66 149.12 28.25 Favored Glycine 0 N--CA 1.472 1.088 0 O-C-N 121.101 -0.999 . . . . 0.0 111.031 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -132.91 129.47 38.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.734 1.267 . . . . 0.0 110.896 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.6 tt -126.25 97.5 5.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.658 1.183 . . . . 0.0 108.902 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -82.3 100.3 9.85 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.872 0.869 . . . . 0.0 111.575 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.9 t -84.88 113.21 23.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.679 1.992 . . . . 0.0 109.486 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.29 112.22 8.17 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.162 171.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -102.48 -125.0 0.19 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.235 1.814 . . . . 0.0 109.754 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.91 -147.51 17.88 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.103 1.335 . . . . 0.0 111.767 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -30.24 22.81 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.709 2.272 . . . . 0.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.59 97.81 2.35 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 165.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -64.66 142.48 58.41 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.777 0.831 . . . . 0.0 112.209 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -153.67 119.35 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.802 1.241 . . . . 0.0 112.014 -173.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 tp 67.12 -45.21 0.46 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 129.565 3.146 . . . . 0.0 114.752 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.09 -21.31 65.78 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 120.253 1.388 . . . . 0.0 113.827 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -56.72 -50.36 72.42 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.159 1.784 . . . . 0.0 111.393 165.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.1 m -80.12 -9.5 59.71 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.498 1.519 . . . . 0.0 113.071 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -89.55 -8.55 52.48 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.96 1.304 . . . . 0.0 113.014 161.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 57.93 45.11 18.75 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.517 1.527 . . . . 0.0 110.391 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.72 132.58 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.653 1.181 . . . . 0.0 111.684 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -80.3 -50.56 10.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 0.0 113.698 -166.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -96.51 -123.22 0.12 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.326 1.85 . . . . 0.0 107.491 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.544 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 54.2 t90 -141.95 -49.48 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 116.689 -1.624 . . . . 0.0 112.875 162.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 92.2 Cg_endo -71.63 99.79 0.98 Allowed 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.619 1.546 . . . . 0.0 108.72 169.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.4 m -156.13 137.1 13.56 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.235 1.414 . . . . 0.0 108.006 -170.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.558 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -134.73 126.1 28.34 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.118 0.967 . . . . 0.0 109.467 -179.1 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.53 122.76 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 126.05 1.74 . . . . 0.0 108.777 -173.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -84.19 117.44 23.5 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.287 1.035 . . . . 0.0 108.655 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.61 155.91 18.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.621 1.568 . . . . 0.0 109.273 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -168.14 134.74 2.03 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.521 1.928 . . . . 0.0 109.181 173.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 64.39 21.11 12.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.094 1.358 . . . . 0.0 112.165 -168.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.91 -1.83 88.63 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 125.619 1.581 . . . . 0.0 115.57 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -130.92 157.85 41.82 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.396 1.478 . . . . 0.0 111.774 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.01 123.4 20.12 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.06 0.944 . . . . 0.0 110.643 -171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 m -97.53 -24.4 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.66 1.184 . . . . 0.0 112.078 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.83 178.85 2.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.042 1.737 . . . . 0.0 110.825 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -153.27 156.45 38.47 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.208 1.003 . . . . 0.0 111.245 160.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 75.3 t -122.27 139.83 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 p -139.97 134.59 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.319 1.448 . . . . 0.0 108.995 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 56.12 70.45 1.49 Allowed Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 125.661 1.584 . . . . 0.0 111.742 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.15 -43.44 35.63 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.603 2.868 . . . . 0.0 114.604 -165.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 -49.38 3.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.604 1.097 . . . . 0.0 114.187 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -161.2 155.37 22.71 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.072 1.349 . . . . 0.0 111.88 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.52 -33.94 47.46 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 125.631 1.573 . . . . 0.0 112.817 -177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -57.89 -28.55 64.29 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.8 -41.31 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.947 0.899 . . . . 0.0 110.937 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.13 -50.65 38.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.853 0.861 . . . . 0.0 111.626 -178.329 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -54.32 -45.64 72.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.77 1.228 . . . . 0.0 112.502 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -55.5 -39.5 70.54 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.507 1.123 . . . . 0.0 112.586 177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.39 60.96 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.38 -0.825 . . . . 0.0 111.892 174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.83 -50.38 72.53 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.723 -1.235 . . . . 0.0 110.656 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.16 -37.79 81.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.3 m -65.51 -25.81 67.63 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.61 -24.69 12.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.216 1.006 . . . . 0.0 113.583 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.75 -28.0 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.497 0.719 . . . . 0.0 110.884 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.37 15.31 19.72 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.801 1.667 . . . . 0.0 114.565 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -97.68 -6.95 31.95 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.027 1.731 . . . . 0.0 113.535 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 124.886 1.231 . . . . 0.0 113.69 -176.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.151 0.796 . . . . 0.0 113.151 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -69.84 145.16 52.28 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.517 0.727 . . . . 0.0 112.068 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 p -82.94 156.89 23.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.614 1.566 . . . . 0.0 111.568 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -80.41 -29.41 37.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.464 1.506 . . . . 0.0 113.668 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -86.44 161.4 18.65 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.608 1.963 . . . . 0.0 114.271 178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -127.13 127.01 43.92 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.34 25.86 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.323 1.049 . . . . 0.0 112.779 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.09 42.39 0.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.354 1.462 . . . . 0.0 111.516 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.11 153.59 95.88 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 124.449 1.1 . . . . 0.0 113.016 -178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.78 162.92 39.3 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 124.193 3.262 . . . . 0.0 112.231 175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.42 161.19 15.1 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 0.0 112.208 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -27.95 68.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.219 1.008 . . . . 0.0 113.105 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.98 -25.29 65.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 113.653 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -84.14 -28.57 27.35 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.589 1.156 . . . . 0.0 110.748 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -73.06 -23.76 60.61 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.281 -0.887 . . . . 0.0 112.63 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -60.6 -22.0 63.27 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.188 0.904 . . . . 0.0 112.133 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -80.48 -12.57 59.53 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.471 1.509 . . . . 0.0 113.208 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.1 169.65 8.15 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 112.854 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.9 -45.95 0.18 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.89 171.75 54.59 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 119.386 -0.675 . . . . 0.0 112.981 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.07 115.34 3.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.064 2.509 . . . . 0.0 109.206 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 m -133.45 116.19 15.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.673 1.189 . . . . 0.0 109.67 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.3 tp -87.02 130.51 34.43 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.044 0.938 . . . . 0.0 109.662 173.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.4 115.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.358 1.063 . . . . 0.0 108.515 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -109.34 130.63 55.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.134 1.774 . . . . 0.0 112.237 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -106.15 125.47 51.04 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.233 1.413 . . . . 0.0 109.313 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.27 -164.98 35.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.669 0.652 . . . . 0.0 113.356 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -143.39 176.19 9.35 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.464 1.506 . . . . 0.0 110.308 168.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.31 -18.46 60.7 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.439 0.696 . . . . 0.0 111.4 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -123.94 -18.99 5.81 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -159.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 49.1 t -69.86 142.58 53.03 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 120.581 1.537 . . . . 0.0 111.681 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -26.1 70.25 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.2 1.381 . . . . 0.0 113.765 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -61.44 -46.85 88.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.73 1.265 . . . . 0.0 111.187 165.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 m -68.22 -34.42 76.22 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -65.21 -23.22 67.02 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 120.139 1.336 . . . . 0.0 111.795 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.91 16.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.505 1.522 . . . . 0.0 112.775 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.97 -28.49 35.61 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -55.96 -56.66 28.13 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.151 1.381 . . . . 0.0 112.462 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.79 -18.35 36.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.347 2.031 . . . . 0.0 112.492 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.42 6.82 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.782 0.833 . . . . 0.0 109.209 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.6 mm? -57.1 -46.69 82.38 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.058 0.943 . . . . 0.0 108.767 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.76 -38.0 63.99 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -72.52 -47.25 49.94 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.156 0.582 . . . . 0.0 111.965 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -66.58 -50.24 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.014 0.825 . . . . 0.0 112.177 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -22.52 65.58 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.578 1.551 . . . . 0.0 113.495 -173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -60.68 -20.0 59.89 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.57 -9.21 25.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.096 0.958 . . . . 0.0 113.557 173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -128.95 43.73 1.18 Allowed Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -61.07 -16.97 49.19 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.488 2.792 . . . . 0.0 113.967 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.84 -16.57 64.16 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 173.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.14 146.31 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.353 1.061 . . . . 0.0 109.07 174.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.45 151.22 23.19 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.837 -1.164 . . . . 0.0 111.682 172.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -133.22 112.14 11.46 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.361 1.58 . . . . 0.0 112.021 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.79 114.08 25.77 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -93.2 101.52 13.8 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.632 0.773 . . . . 0.0 110.48 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.3 t -90.07 121.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.048 0.939 . . . . 0.0 109.272 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -76.68 75.17 3.35 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 124.757 1.286 . . . . 0.0 110.576 177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.78 28.49 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.34 2.256 . . . . 0.0 112.593 -168.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -79.06 -61.1 2.43 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.34 -1.811 . . . . 0.0 113.543 -171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.79 71.06 7.24 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.769 2.98 . . . . 0.0 110.681 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.16 168.6 32.98 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.603 1.097 . . . . 0.0 112.657 -167.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.3 mmp_? -71.14 118.3 13.75 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.682 0.393 . . . . 0.0 110.319 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -90.83 -120.1 0.07 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.018 1.727 . . . . 0.0 108.554 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.13 -30.37 64.35 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.854 1.206 . . . . 0.0 112.166 174.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.47 -19.22 59.83 Favored Glycine 0 N--CA 1.477 1.372 0 CA-C-N 119.315 0.961 . . . . 0.0 114.803 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -62.4 -46.42 88.7 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.526 1.131 . . . . 0.0 111.017 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -71.38 -27.34 63.26 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.643 1.177 . . . . 0.0 112.12 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -82.56 -8.64 59.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.597 1.559 . . . . 0.0 113.867 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 57.61 48.93 13.38 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.733 1.213 . . . . 0.0 110.526 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.86 134.5 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.288 1.435 . . . . 0.0 111.896 -177.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -82.13 -52.54 6.89 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -165.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.7 tp -101.86 -112.34 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.734 1.613 . . . . 0.0 107.255 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.514 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 37.6 t90 -151.11 -46.59 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.526 -1.702 . . . . 0.0 113.994 166.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 60.9 Cg_endo -71.46 94.54 0.68 Allowed 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.895 1.73 . . . . 0.0 107.93 169.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.0 m -152.64 142.47 22.06 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 125.318 1.447 . . . . 0.0 108.172 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.577 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -145.09 127.89 16.31 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.745 0.818 . . . . 0.0 110.507 179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.72 122.55 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.79 1.636 . . . . 0.0 109.527 -173.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.9 m-85 -85.73 114.1 22.43 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 mt -99.38 159.24 15.15 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.218 1.007 . . . . 0.0 110.573 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -165.24 131.43 2.75 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.703 2.401 . . . . 0.0 107.443 170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.36 26.89 12.02 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.412 1.085 . . . . 0.0 112.058 -162.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.93 56.93 Favored Glycine 0 N--CA 1.479 1.512 0 C-N-CA 124.619 1.104 . . . . 0.0 115.499 -169.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -132.49 139.32 47.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.454 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.99 116.42 5.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.201 0.524 . . . . 0.0 111.831 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.8 -23.96 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.235 1.414 . . . . 0.0 111.918 170.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.58 177.63 2.49 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 126.406 1.882 . . . . 0.0 110.903 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -152.23 155.5 37.88 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 110.852 160.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 69.1 t -121.84 139.45 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 p -137.34 137.97 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.39 1.476 . . . . 0.0 109.153 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 56.86 64.75 4.34 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 125.211 1.404 . . . . 0.0 111.264 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -61.35 120.17 7.7 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.7 2.933 . . . . 0.0 110.423 -174.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.87 -28.53 41.8 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.326 0.489 . . . . 0.0 113.876 -173.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -174.46 162.68 3.54 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.138 2.175 . . . . 0.0 109.12 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.54 57.38 Favored 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.471 1.108 . . . . 0.0 112.208 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p -54.93 -38.02 67.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.548 1.067 . . . . 0.0 113.356 173.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.69 -40.49 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.207 1.403 . . . . 0.0 110.904 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.34 -48.93 54.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.978 0.511 . . . . 0.0 111.477 178.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -56.77 -41.81 78.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.099 1.36 . . . . 0.0 112.522 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -58.05 -34.21 69.85 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.637 1.175 . . . . 0.0 113.088 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.74 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.859 -0.526 . . . . 0.0 111.215 171.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.13 -50.43 64.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.105 0.866 . . . . 0.0 111.958 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -34.33 68.91 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 t -74.91 -32.69 61.87 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.153 0.581 . . . . 0.0 112.178 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.95 -28.66 15.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.443 0.697 . . . . 0.0 112.748 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 -31.55 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.941 0.896 . . . . 0.0 111.096 170.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.48 22.9 17.68 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.772 1.654 . . . . 0.0 114.609 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.53 -24.65 19.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 C-N-CA 124.796 1.188 . . . . 0.0 115.844 175.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -73.91 -39.93 63.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.666 1.186 . . . . 0.0 112.369 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.26 173.0 10.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.558 1.943 . . . . 0.0 110.774 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.09 153.02 33.1 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.088 1.755 . . . . 0.0 111.6 174.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -109.32 166.84 10.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.0 1.32 . . . . 0.0 113.871 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.9 t -136.99 134.78 37.01 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.63 -9.95 59.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.389 1.076 . . . . 0.0 113.025 170.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -91.37 23.45 3.39 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.598 1.559 . . . . 0.0 112.794 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.64 155.89 80.11 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.677 1.191 . . . . 0.0 113.126 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.09 162.8 40.25 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.941 3.094 . . . . 0.0 112.748 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.63 30.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.434 0.694 . . . . 0.0 111.377 164.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.63 -36.04 73.45 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.522 -0.736 . . . . 0.0 111.938 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.55 -38.85 70.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.758 0.823 . . . . 0.0 113.053 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -67.72 -32.59 73.32 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.52 0.728 . . . . 0.0 111.465 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.17 -32.97 63.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.471 2.308 . . . . 0.0 111.437 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.37 -20.25 53.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.451 1.5 . . . . 0.0 113.215 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -72.62 -15.6 61.73 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.864 1.266 . . . . 0.0 113.002 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.36 160.75 24.01 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.73 1.15 . . . . 0.0 112.668 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.69 -28.85 0.81 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 166.51 50.58 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-N 119.511 1.05 . . . . 0.0 112.886 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.96 114.63 2.05 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.182 2.588 . . . . 0.0 109.579 172.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.9 m -137.26 121.9 18.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.014 0.925 . . . . 0.0 109.543 -175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 76' ' ' PHE . 32.4 tp -90.46 123.24 34.0 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.351 1.061 . . . . 0.0 110.079 173.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 t -103.29 110.48 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.416 1.087 . . . . 0.0 109.404 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -108.09 128.16 54.44 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.159 2.184 . . . . 0.0 110.697 -169.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -112.4 126.31 55.15 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 111.363 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.81 -150.4 18.38 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.973 0.797 . . . . 0.0 112.708 -176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 64.9 p -146.0 174.06 11.61 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.256 1.823 . . . . 0.0 109.24 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -79.98 -5.42 55.67 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.199 -0.938 . . . . 0.0 112.662 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 41.1 p-90 -125.58 -15.73 5.99 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.3 t -68.58 145.81 53.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.877 1.671 . . . . 0.0 111.677 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.07 70.61 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.031 1.301 . . . . 0.0 113.826 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -59.39 -49.86 76.18 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.833 1.316 . . . . 0.0 110.888 166.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 m -66.26 -32.77 74.38 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.116 0.966 . . . . 0.0 113.24 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -66.08 -22.83 66.43 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.027 1.285 . . . . 0.0 112.037 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.26 12.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.723 1.609 . . . . 0.0 113.165 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.49 -29.62 25.87 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.743 0.702 . . . . 0.0 112.823 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -60.83 -50.91 82.98 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 117.168 -1.396 . . . . 0.0 113.867 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.57 -17.86 38.2 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.902 1.734 . . . . 0.0 111.441 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.74 -56.8 8.91 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.475 0.71 . . . . 0.0 109.304 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -55.14 -49.3 72.14 Favored 'General case' 0 C--O 1.215 -0.712 0 C-N-CA 124.327 1.051 . . . . 0.0 108.275 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.71 58.08 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -71.67 -47.37 54.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.439 0.695 . . . . 0.0 112.364 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.47 -49.23 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.026 0.83 . . . . 0.0 112.179 177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -21.36 64.3 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.144 1.778 . . . . 0.0 113.565 -174.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.0 m -61.95 -18.12 59.24 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -100.69 -9.74 21.56 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.852 1.261 . . . . 0.0 113.805 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -130.21 41.63 0.77 Allowed Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 125.58 1.552 . . . . 0.0 114.699 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.92 -16.65 50.94 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.4 2.733 . . . . 0.0 114.394 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -69.69 -16.61 63.38 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.31 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 119.671 1.123 . . . . 0.0 109.192 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.22 150.66 27.6 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 121.199 -0.938 . . . . 0.0 111.537 174.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -137.29 113.06 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.847 1.323 . . . . 0.0 111.48 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.56 105.36 14.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.523 1.129 . . . . 0.0 109.331 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -89.52 100.11 12.97 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.902 0.881 . . . . 0.0 110.432 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -87.36 114.87 27.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.536 1.534 . . . . 0.0 109.599 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -75.18 111.56 10.55 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.631 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -89.12 -18.31 27.47 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.06 1.344 . . . . 0.0 113.445 -174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -38.53 95.29 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.069 1.795 . . . . 0.0 114.051 -177.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -62.2 -8.94 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.986 3.124 . . . . 0.0 115.794 170.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.41 20.35 32.6 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.693 1.139 . . . . 0.0 114.246 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -56.29 140.39 45.13 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.708 1.203 . . . . 0.0 113.21 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -92.6 1.69 57.12 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.102 1.361 . . . . 0.0 114.494 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.7 tp -60.52 -49.87 75.8 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.971 1.259 . . . . 0.0 110.701 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.53 84.46 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 119.555 1.071 . . . . 0.0 113.511 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -65.27 -41.84 93.82 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.075 0.95 . . . . 0.0 111.497 170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -69.83 -30.22 67.68 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.284 1.034 . . . . 0.0 111.769 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -78.41 -10.55 59.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.046 1.738 . . . . 0.0 113.327 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.0 44.01 13.88 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.37 1.868 . . . . 0.0 110.971 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 t -52.01 125.74 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.269 1.428 . . . . 0.0 111.214 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.67 -56.88 3.21 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 -161.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.2 tp -109.79 152.5 25.63 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 157.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.3 t90 -53.71 -46.76 98.21 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-O 116.985 -1.483 . . . . 0.0 113.96 -172.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.32 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.956 1.771 . . . . 0.0 110.438 169.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.1 m -130.29 146.04 51.84 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.995 1.318 . . . . 0.0 108.708 174.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -133.76 126.96 31.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.22 172.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.66 120.01 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 125.826 1.65 . . . . 0.0 109.178 -171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' CG ' HD13 ' A' ' 23' ' ' LEU . 46.9 m-85 -83.88 116.47 22.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.19 0.996 . . . . 0.0 108.591 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.58 154.74 20.98 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.34 1.456 . . . . 0.0 110.103 175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.07 134.21 2.4 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.439 1.896 . . . . 0.0 108.156 176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 63.04 18.97 11.35 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.693 1.597 . . . . 0.0 113.181 -171.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 88.95 -11.09 70.28 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.169 1.842 . . . . 0.0 114.613 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 53.5 mtm-85 -103.65 154.93 18.97 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.435 1.494 . . . . 0.0 111.056 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -67.03 126.24 28.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.96 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.598 1.159 . . . . 0.0 112.389 172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 178.69 2.22 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.243 1.817 . . . . 0.0 110.889 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -152.98 158.55 42.21 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.212 1.005 . . . . 0.0 111.185 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 54.5 t -120.67 123.16 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -110.04 122.84 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 126.043 1.737 . . . . 0.0 107.853 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 53.4 85.32 0.19 Allowed Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 126.162 1.785 . . . . 0.0 112.908 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.34 121.76 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.676 2.25 . . . . 0.0 110.638 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.61 -30.27 36.78 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 123.286 0.469 . . . . 0.0 113.594 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.4 t -174.42 165.24 3.92 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.275 2.23 . . . . 0.0 109.537 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.55 -32.05 62.64 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.022 0.929 . . . . 0.0 112.292 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 p -58.84 -28.08 65.72 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 120.987 -1.07 . . . . 0.0 113.757 173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -85.65 -42.75 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.207 1.403 . . . . 0.0 110.434 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.38 -49.06 58.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.017 -0.427 . . . . 0.0 111.806 -178.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.36 -41.39 84.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.44 1.096 . . . . 0.0 112.664 175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -57.01 -36.06 69.98 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.609 1.163 . . . . 0.0 112.256 177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.12 -47.98 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.52 -50.32 68.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.301 0.955 . . . . 0.0 112.04 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -33.73 71.3 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.766 0.826 . . . . 0.0 113.024 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.2 t -73.06 -31.58 64.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.63 -25.66 15.04 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.389 -0.819 . . . . 0.0 113.056 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.51 -27.13 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.204 1.002 . . . . 0.0 110.942 171.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.64 18.78 31.53 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.556 1.551 . . . . 0.0 114.633 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -86.97 -20.02 27.89 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.739 1.269 . . . . 0.0 113.46 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 CA-C-N 118.545 0.611 . . . . 0.0 113.004 176.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 137.53 57.16 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.738 1.615 . . . . 0.0 113.804 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.6 m -79.83 136.87 36.81 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.811 1.645 . . . . 0.0 111.375 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.8 143.08 30.19 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.258 1.023 . . . . 0.0 112.874 -171.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -82.24 169.32 16.69 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.314 2.246 . . . . 0.0 115.395 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.7 m -122.91 134.1 54.37 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.841 1.256 . . . . 0.0 112.59 174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.15 -22.77 17.64 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.632 1.173 . . . . 0.0 113.169 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.1 27.27 0.41 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.33 2.252 . . . . 0.0 113.571 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.31 67.93 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.017 1.327 . . . . 0.0 113.977 -176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -72.84 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 124.56 3.507 . . . . 0.0 111.739 175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.19 161.04 20.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.401 1.081 . . . . 0.0 113.074 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -31.51 68.64 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 121.043 -1.036 . . . . 0.0 112.781 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -75.26 -18.92 59.97 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.708 1.203 . . . . 0.0 113.835 174.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -88.99 -30.02 19.07 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.204 1.402 . . . . 0.0 111.82 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.76 -32.66 71.96 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.0 0.92 . . . . 0.0 111.592 169.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.64 -20.29 55.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.045 1.338 . . . . 0.0 112.995 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -81.84 -13.5 57.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.246 1.419 . . . . 0.0 113.916 176.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.5 167.36 18.54 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 119.304 0.956 . . . . 0.0 112.828 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.04 -45.25 0.64 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.46 168.19 54.71 Favored Glycine 0 CA--C 1.54 1.631 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.49 -176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -64.25 109.25 1.12 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.145 2.563 . . . . 0.0 109.71 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.4 m -129.61 115.15 16.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.447 1.099 . . . . 0.0 109.797 -175.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.0 tp -83.86 128.54 34.61 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 121.648 -0.658 . . . . 0.0 109.44 170.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -110.59 114.05 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.392 1.077 . . . . 0.0 109.348 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -108.71 130.41 55.36 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.59 1.556 . . . . 0.0 111.685 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -103.1 127.86 50.22 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.195 1.398 . . . . 0.0 109.822 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.54 -160.51 29.91 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.661 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.4 p -146.74 174.42 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.406 2.282 . . . . 0.0 109.214 169.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.84 -6.16 56.83 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.393 -0.817 . . . . 0.0 112.557 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -125.4 -17.14 5.68 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -165.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.68 142.08 58.15 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.928 1.695 . . . . 0.0 111.967 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.54 -24.39 72.43 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 118.664 -1.075 . . . . 0.0 113.802 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -64.83 -47.75 76.85 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.381 1.59 . . . . 0.0 110.536 165.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -61.83 -38.68 89.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.045 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -61.8 -23.98 66.56 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.227 0.922 . . . . 0.0 112.288 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.56 -40.54 12.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.893 1.677 . . . . 0.0 112.475 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.46 -31.35 33.06 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.828 0.851 . . . . 0.0 112.892 -176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -58.73 -54.8 52.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.367 -1.301 . . . . 0.0 112.341 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 -17.5 42.47 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.212 1.941 . . . . 0.0 112.524 174.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -57.22 7.02 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.351 0.661 . . . . 0.0 109.233 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.6 -42.83 89.02 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.796 0.838 . . . . 0.0 109.216 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.8 -35.67 71.16 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.1 -47.81 33.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.433 0.693 . . . . 0.0 111.655 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG11 HD22 ' A' ' 97' ' ' LEU . 2.8 p -64.21 -48.12 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.123 0.874 . . . . 0.0 112.38 178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.08 -26.25 60.08 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.75 1.22 . . . . 0.0 114.056 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.4 m -63.01 -19.83 64.74 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.7 -9.05 29.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.817 0.847 . . . . 0.0 113.13 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.61 46.98 2.47 Favored Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.813 1.645 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.94 -17.21 58.8 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.356 2.704 . . . . 0.0 113.752 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -70.19 -13.95 62.41 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -82.72 140.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 171.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.52 152.71 22.15 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.41 1.005 . . . . 0.0 112.056 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -125.24 127.62 47.02 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.222 1.011 . . . . 0.0 111.23 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.2 tp -111.18 101.74 10.23 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.011 1.324 . . . . 0.0 109.48 173.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 55' ' ' LYS . 19.3 mtmt -81.53 98.45 8.3 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.647 1.179 . . . . 0.0 111.041 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -95.22 121.07 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.895 0.77 . . . . 0.0 111.339 178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -70.96 94.91 1.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.025 1.33 . . . . 0.0 109.64 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -105.29 10.31 33.62 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 113.022 -163.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -83.6 -42.86 7.59 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.89 1.709 . . . . 0.0 114.018 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -61.0 178.21 0.56 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 124.424 3.416 . . . . 0.0 113.84 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.69 -28.84 73.97 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.14 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -75.93 122.13 23.71 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.342 1.057 . . . . 0.0 109.591 167.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -143.09 155.33 44.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.647 1.579 . . . . 0.0 111.865 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.0 tp -114.48 -33.52 5.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.119 1.367 . . . . 0.0 111.309 168.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.27 -20.25 60.58 Favored Glycine 0 N--CA 1.48 1.57 0 CA-C-N 119.72 1.145 . . . . 0.0 114.441 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -56.73 -48.73 77.11 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.14 1.376 . . . . 0.0 111.693 165.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -83.81 -7.84 59.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.58 1.152 . . . . 0.0 113.703 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.91 -5.04 56.03 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.589 1.156 . . . . 0.0 112.416 162.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 56.3 44.8 24.13 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 125.29 1.436 . . . . 0.0 110.883 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 t -59.39 140.28 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.673 1.589 . . . . 0.0 113.582 -171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -75.09 -51.49 13.36 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.137 1.375 . . . . 0.0 113.327 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.9 tp -132.78 139.66 47.65 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.814 1.646 . . . . 0.0 108.238 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 57.5 t90 -55.37 -40.58 85.43 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -166.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -79.93 80.24 3.11 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.499 2.133 . . . . 0.0 109.623 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.9 m -132.34 148.48 52.43 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.803 1.641 . . . . 0.0 109.067 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.551 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.4 OUTLIER -136.11 129.31 31.64 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.495 174.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.5 t -106.25 121.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 126.172 1.789 . . . . 0.0 108.889 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.3 m-85 -83.09 117.27 22.75 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -106.77 152.63 23.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.714 1.206 . . . . 0.0 110.477 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -166.09 138.6 3.97 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.925 1.69 . . . . 0.0 109.098 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.8 t70 62.11 24.43 14.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.236 1.414 . . . . 0.0 112.807 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 83.47 -5.85 75.76 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.251 1.405 . . . . 0.0 114.755 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -108.36 154.7 21.47 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.669 1.587 . . . . 0.0 110.534 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -67.87 124.35 23.08 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.99 -23.98 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.59 1.156 . . . . 0.0 112.58 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.39 178.58 2.75 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.56 1.944 . . . . 0.0 110.397 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -153.9 157.12 38.77 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.067 0.947 . . . . 0.0 111.04 162.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 56.0 t -119.73 124.48 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.7 t -108.72 128.69 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.246 1.818 . . . . 0.0 108.344 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.1 ttt-85 55.44 77.39 0.43 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 125.516 1.526 . . . . 0.0 112.824 174.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -61.59 128.3 24.26 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.021 2.481 . . . . 0.0 111.142 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -92.0 -31.83 8.91 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.086 0.851 . . . . 0.0 114.181 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.2 m -176.22 155.76 1.55 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.622 2.369 . . . . 0.0 109.799 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.88 -34.73 56.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.89 0.876 . . . . 0.0 112.834 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 9.9 m -57.73 -25.19 60.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.6 -38.95 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.744 1.218 . . . . 0.0 110.603 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.68 -49.82 49.78 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.935 -0.478 . . . . 0.0 111.248 178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -56.61 -39.34 73.44 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.202 1.401 . . . . 0.0 112.743 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -60.16 -34.04 73.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.397 1.079 . . . . 0.0 112.314 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.85 -44.74 22.29 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.525 -0.734 . . . . 0.0 111.622 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -55.29 -50.71 68.84 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.562 -0.711 . . . . 0.0 111.988 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -59.69 -33.34 71.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -75.83 -25.42 56.27 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.93 -25.1 13.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.546 0.738 . . . . 0.0 112.9 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -30.23 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.732 0.813 . . . . 0.0 111.041 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.54 26.84 19.26 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.487 1.518 . . . . 0.0 113.878 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.47 -32.41 48.35 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 118.534 1.167 . . . . 0.0 113.153 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.899 0 C-N-CA 123.546 0.593 . . . . 0.0 113.637 170.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -68.94 -23.19 64.13 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -167.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.3 p -77.33 -49.28 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 111.839 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -91.49 -159.62 0.66 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.882 2.073 . . . . 0.0 111.087 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -70.05 147.13 50.41 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.8 -1.188 . . . . 0.0 112.532 168.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 t -133.48 134.17 43.18 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.53 -7.77 59.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.361 1.064 . . . . 0.0 113.442 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -91.34 23.3 3.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.661 1.584 . . . . 0.0 112.887 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.32 153.12 77.2 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.045 0.938 . . . . 0.0 112.901 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.65 159.44 51.02 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.706 2.938 . . . . 0.0 113.11 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 159.23 31.78 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.274 160.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.26 -27.82 67.56 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.207 -0.933 . . . . 0.0 113.294 -176.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -69.82 -32.08 70.31 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.534 1.134 . . . . 0.0 113.507 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -82.19 -32.47 29.87 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.429 1.092 . . . . 0.0 111.125 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.2 tp -65.27 -34.81 79.23 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.904 1.682 . . . . 0.0 111.317 171.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -59.28 -23.32 62.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.958 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -77.91 -15.09 59.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.571 1.549 . . . . 0.0 112.427 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.84 160.17 31.09 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.985 0.812 . . . . 0.0 111.65 175.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.41 -35.72 0.54 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.05 169.22 54.95 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 119.001 0.819 . . . . 0.0 112.865 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.0 110.14 1.44 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.249 2.633 . . . . 0.0 109.627 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.2 m -128.38 117.98 22.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.288 1.035 . . . . 0.0 109.553 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.527 HD11 ' HB2' ' A' ' 76' ' ' PHE . 25.7 tp -86.08 127.95 34.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.259 0.624 . . . . 0.0 109.504 172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.14 114.23 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.308 1.043 . . . . 0.0 109.441 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -107.48 129.55 54.94 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.741 2.016 . . . . 0.0 111.596 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -106.66 132.04 53.11 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.411 1.484 . . . . 0.0 109.976 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 161.47 -151.46 21.7 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.235 0.921 . . . . 0.0 112.501 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.4 p -144.85 176.99 9.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.957 1.703 . . . . 0.0 110.044 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -78.93 -9.18 59.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.664 0.785 . . . . 0.0 112.246 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -129.02 -12.61 4.65 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -162.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.8 t -68.29 142.77 55.45 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 120.76 1.618 . . . . 0.0 111.552 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.9 68.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.93 1.252 . . . . 0.0 113.705 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -64.4 -48.72 74.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.367 1.583 . . . . 0.0 110.821 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.4 m -61.99 -36.42 81.44 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.647 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.9 -22.64 66.52 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.615 1.098 . . . . 0.0 112.237 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.99 14.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.288 1.435 . . . . 0.0 112.783 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.66 -28.49 26.38 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -61.61 -52.2 71.17 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-O 117.173 -1.394 . . . . 0.0 113.186 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.13 -17.03 50.4 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.256 1.971 . . . . 0.0 111.87 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.99 -58.52 4.0 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -56.59 -42.56 78.91 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.247 1.019 . . . . 0.0 109.838 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.16 73.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.97 0.908 . . . . 0.0 112.864 177.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.87 -45.55 60.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.119 0.568 . . . . 0.0 111.648 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.445 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -67.85 -49.47 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 118.72 0.691 . . . . 0.0 112.045 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -57.26 -25.66 59.56 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.785 1.234 . . . . 0.0 113.204 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.2 m -62.87 -18.62 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -99.25 -9.89 23.08 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.131 0.878 . . . . 0.0 113.254 172.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -129.74 47.32 2.77 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.793 1.637 . . . . 0.0 113.941 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.09 -17.82 58.4 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.254 2.636 . . . . 0.0 113.894 -175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.17 -14.6 63.1 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.84 138.67 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.766 1.226 . . . . 0.0 108.546 173.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.53 155.84 25.27 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.492 1.044 . . . . 0.0 112.74 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -128.8 116.06 18.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.477 1.138 . . . . 0.0 112.159 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.8 tp -99.32 112.77 24.88 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.738 1.215 . . . . 0.0 109.456 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -93.53 100.52 12.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.588 0.755 . . . . 0.0 110.964 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.9 t -89.38 114.96 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.192 1.397 . . . . 0.0 110.015 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -76.78 110.64 11.54 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.501 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -89.35 132.62 34.87 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.284 1.034 . . . . 0.0 110.908 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.95 -142.56 3.44 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.288 -1.284 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.27 -31.82 34.6 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.842 2.361 . . . . 0.0 112.016 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.09 107.16 3.4 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.717 1.151 . . . . 0.0 110.454 167.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -86.44 59.94 5.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.634 1.174 . . . . 0.0 110.56 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.5 ptm85 -61.8 -23.46 66.24 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -160.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.2 tp -137.42 -38.53 0.6 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.697 0.799 . . . . 0.0 112.982 -175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.06 -25.14 69.26 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 120.113 1.324 . . . . 0.0 114.171 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -59.54 -47.88 83.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.277 1.431 . . . . 0.0 111.307 166.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -69.44 -25.94 64.35 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 111.919 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -84.08 -9.79 58.33 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.7 44.76 23.12 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 109.969 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.6 t -52.44 127.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 124.77 1.228 . . . . 0.0 111.29 -172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.09 -97.06 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.06 1.744 . . . . 0.0 112.145 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.8 tp -75.75 151.81 37.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -61.1 -45.52 96.04 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 116.871 -1.537 . . . . 0.0 114.638 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -79.7 93.76 1.06 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.295 1.997 . . . . 0.0 109.674 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.0 m -141.58 147.55 37.86 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.089 1.356 . . . . 0.0 108.944 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -137.73 128.68 27.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.997 0.919 . . . . 0.0 110.71 174.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -107.49 121.72 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.203 1.801 . . . . 0.0 109.118 -173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.8 m-85 -83.98 120.18 25.81 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.612 1.165 . . . . 0.0 109.159 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.07 155.92 21.23 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.513 1.125 . . . . 0.0 111.054 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -163.64 139.31 6.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.795 2.038 . . . . 0.0 108.93 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 63.32 21.21 12.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.757 1.223 . . . . 0.0 113.284 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.3 85.96 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.411 1.482 . . . . 0.0 114.714 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -112.42 157.24 21.3 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.471 1.908 . . . . 0.0 110.615 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -66.72 131.51 46.11 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.687 0.795 . . . . 0.0 110.263 165.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.59 -22.5 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 124.677 1.191 . . . . 0.0 112.518 171.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -174.4 177.65 2.16 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.726 2.01 . . . . 0.0 110.737 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -154.67 157.52 38.26 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.181 0.993 . . . . 0.0 111.62 164.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 53.3 t -121.49 125.96 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 171.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -112.31 128.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.986 1.715 . . . . 0.0 107.666 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 55.02 80.58 0.29 Allowed Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 125.274 1.429 . . . . 0.0 112.986 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.61 124.87 14.42 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.188 2.592 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -89.6 -23.29 34.05 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 123.929 0.776 . . . . 0.0 114.109 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.4 p -172.13 161.72 5.56 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.961 1.704 . . . . 0.0 111.105 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.41 -34.13 73.5 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 118.491 -0.766 . . . . 0.0 111.155 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.7 p -63.8 -34.1 77.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.754 1.616 . . . . 0.0 112.745 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.87 -43.54 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.182 0.993 . . . . 0.0 112.016 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.522 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -68.5 -49.1 62.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.834 0.743 . . . . 0.0 111.696 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -57.13 -41.1 78.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.759 1.224 . . . . 0.0 112.716 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.75 -36.92 72.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.583 1.153 . . . . 0.0 112.478 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.93 -46.06 46.6 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.461 -0.774 . . . . 0.0 111.315 172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -56.34 -50.78 70.5 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.01 -1.056 . . . . 0.0 111.828 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -32.7 71.57 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.0 t -68.11 -34.65 76.77 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.665 -0.647 . . . . 0.0 112.62 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -93.25 -25.82 17.62 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.37 -25.13 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.05 0.94 . . . . 0.0 112.087 172.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.34 58.05 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.121 1.819 . . . . 0.0 115.387 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -77.48 -2.64 36.44 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.766 1.626 . . . . 0.0 113.617 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 C-N-CA 126.236 1.874 . . . . 0.0 116.068 -179.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -93.74 -11.45 31.39 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.003 1.321 . . . . 0.0 113.384 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.4 p -89.9 -27.32 19.95 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -168.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -124.61 152.18 43.91 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.061 1.345 . . . . 0.0 112.968 -166.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 55' ' ' LYS . 82.3 m-85 -102.08 162.97 12.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -163.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.5 m -128.35 134.35 48.84 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.339 1.056 . . . . 0.0 112.142 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.47 -22.48 35.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.195 0.998 . . . . 0.0 112.557 173.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.23 30.63 0.18 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.146 2.578 . . . . 0.0 113.554 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.2 159.12 51.07 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 124.904 1.282 . . . . 0.0 112.58 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.91 170.09 20.55 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.672 2.914 . . . . 0.0 111.642 171.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.45 150.36 36.7 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.806 0.443 . . . . 0.0 110.349 162.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -16.16 63.78 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.212 -0.93 . . . . 0.0 113.423 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -85.9 -20.75 28.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.006 1.323 . . . . 0.0 113.264 171.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -91.29 -28.51 17.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.973 1.309 . . . . 0.0 111.633 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -58.04 -38.19 75.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.39 1.876 . . . . 0.0 111.228 167.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.3 -17.7 44.48 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.307 1.843 . . . . 0.0 112.761 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -77.25 -16.37 59.05 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.62 1.168 . . . . 0.0 112.42 176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.24 166.45 18.38 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 119.576 1.08 . . . . 0.0 112.668 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.03 -21.36 1.65 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.9 167.07 43.55 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.643 1.111 . . . . 0.0 113.889 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.84 105.05 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.384 2.723 . . . . 0.0 108.966 173.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.7 m -131.39 113.89 14.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.384 1.073 . . . . 0.0 109.15 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 76' ' ' PHE . 22.9 tp -81.38 129.04 34.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 168.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.1 t -113.58 113.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.272 1.029 . . . . 0.0 109.362 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -108.57 134.93 50.65 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.738 1.615 . . . . 0.0 112.064 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -108.03 129.83 55.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.117 1.367 . . . . 0.0 109.929 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.82 -165.22 38.0 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.785 0.707 . . . . 0.0 113.712 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.6 p -145.71 167.98 21.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.983 1.713 . . . . 0.0 109.708 171.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.72 -2.16 41.75 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.732 0.813 . . . . 0.0 112.8 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.4 p-90 -125.02 -16.06 6.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -167.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.7 t -75.24 136.95 40.94 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.355 1.434 . . . . 0.0 111.295 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.93 -29.87 75.58 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.794 1.188 . . . . 0.0 113.832 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -32.88 69.9 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.033 0.933 . . . . 0.0 110.884 174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.5 m -73.02 -37.04 67.07 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.575 1.15 . . . . 0.0 113.497 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -60.96 -23.95 65.72 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.521 1.055 . . . . 0.0 112.335 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.906 1.682 . . . . 0.0 112.077 176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.53 -31.03 21.48 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.482 1.113 . . . . 0.0 113.562 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -56.13 -53.74 60.23 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 117.512 -1.233 . . . . 0.0 113.782 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.08 -16.92 25.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.84 2.36 . . . . 0.0 111.78 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -55.96 11.52 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.637 0.775 . . . . 0.0 109.342 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.56 -43.04 93.67 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.877 0.871 . . . . 0.0 109.693 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.51 -36.36 71.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.811 0.844 . . . . 0.0 113.239 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -71.62 -49.84 36.39 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.611 0.764 . . . . 0.0 112.214 175.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.467 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.71 -48.94 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.008 0.822 . . . . 0.0 112.76 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -56.7 -25.17 53.52 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.771 1.228 . . . . 0.0 113.785 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.1 m -62.56 -18.95 63.13 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -100.06 -7.44 24.97 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.602 1.161 . . . . 0.0 113.451 173.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -129.16 52.47 9.33 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.213 1.405 . . . . 0.0 114.353 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.75 -15.63 50.02 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 123.605 2.87 . . . . 0.0 114.117 -173.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 -14.08 60.51 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -83.01 139.65 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.91 0.884 . . . . 0.0 108.691 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.59 152.1 20.66 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.441 1.02 . . . . 0.0 112.207 172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -124.36 114.43 19.52 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.888 1.344 . . . . 0.0 112.101 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 44.8 tp -92.42 108.0 19.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.983 0.913 . . . . 0.0 109.162 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . 2.1 mppt? -92.21 104.94 17.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.255 0.622 . . . . 0.0 109.703 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.0 t -90.68 121.96 41.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.6 0.76 . . . . 0.0 109.561 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -73.63 71.04 1.38 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 109.453 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.94 -15.95 61.11 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.51 1.524 . . . . 0.0 113.986 -155.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.5 -73.74 0.95 Allowed Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.107 -1.385 . . . . 0.0 110.656 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -87.13 -17.34 3.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.709 2.939 . . . . 0.0 114.622 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.24 -159.58 29.8 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.508 1.051 . . . . 0.0 114.165 -177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.2 ttm-85 -57.53 -35.9 70.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.695 0.798 . . . . 0.0 112.806 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 77.71 133.06 0.05 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.335 2.654 . . . . 0.0 110.436 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -135.13 -30.02 1.07 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.095 1.358 . . . . 0.0 111.969 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.27 -24.27 63.22 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 119.63 1.105 . . . . 0.0 113.871 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.4 ttp180 -52.42 -56.15 16.99 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.58 1.952 . . . . 0.0 111.33 165.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -85.74 -5.07 59.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.781 1.632 . . . . 0.0 113.396 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -92.46 -4.61 53.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.901 1.68 . . . . 0.0 113.178 159.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 55.83 45.78 23.55 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.339 1.455 . . . . 0.0 110.878 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.58 138.96 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.081 1.752 . . . . 0.0 112.024 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -85.97 -44.97 11.91 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -170.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -97.36 -117.22 0.13 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.306 1.842 . . . . 0.0 108.261 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -156.73 -50.7 0.01 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 116.833 -1.556 . . . . 0.0 113.725 167.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.5 96.71 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 121.59 1.604 . . . . 0.0 107.978 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.0 m -154.61 144.54 21.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.729 1.611 . . . . 0.0 107.514 -163.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.518 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -142.85 125.24 15.6 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.723 0.773 . . . . 0.0 110.614 -177.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.0 t -103.77 120.28 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.191 1.796 . . . . 0.0 109.268 -173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' CG ' HD13 ' A' ' 23' ' ' LEU . 32.6 m-85 -81.38 113.93 19.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 mt -99.03 158.42 15.67 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.181 0.991 . . . . 0.0 110.741 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -163.49 134.27 4.57 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.221 2.208 . . . . 0.0 107.803 168.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 65.69 19.62 11.44 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.176 1.39 . . . . 0.0 112.12 -167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.56 80.47 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 124.839 1.209 . . . . 0.0 114.051 -174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -132.95 139.26 47.22 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.017 1.727 . . . . 0.0 109.395 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -56.79 121.3 9.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.341 0.591 . . . . 0.0 111.686 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.4 m -98.39 -23.6 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.73 1.612 . . . . 0.0 111.917 168.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.78 177.63 2.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.898 2.079 . . . . 0.0 111.033 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -153.25 155.02 35.81 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.131 0.972 . . . . 0.0 110.75 163.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.5 t -124.48 144.32 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.177 1.391 . . . . 0.0 108.513 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.2 p -144.49 135.31 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.515 1.526 . . . . 0.0 109.927 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 55.33 67.6 3.0 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 125.986 1.715 . . . . 0.0 111.879 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -59.93 -41.5 52.99 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 124.057 3.171 . . . . 0.0 115.167 -161.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.53 -48.87 3.52 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.36 0.981 . . . . 0.0 114.032 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.7 t -160.47 156.21 25.62 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.902 1.281 . . . . 0.0 112.208 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.56 62.06 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.04 1.336 . . . . 0.0 112.975 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.1 p -55.56 -34.85 65.12 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.97 -39.19 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 111.079 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -71.87 -50.21 31.43 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.19 0.596 . . . . 0.0 111.645 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -56.43 -40.78 75.32 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.568 1.147 . . . . 0.0 112.836 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -57.61 -34.78 69.64 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.645 1.178 . . . . 0.0 112.906 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.67 -45.05 22.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.61 -0.681 . . . . 0.0 111.364 172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -56.6 -49.99 73.3 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.558 1.072 . . . . 0.0 111.501 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -35.47 70.42 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 175.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.2 t -71.13 -31.07 67.28 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.95 -24.61 14.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -29.37 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.364 1.066 . . . . 0.0 111.166 170.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 8.92 53.47 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.256 1.408 . . . . 0.0 114.948 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -81.52 -26.06 35.42 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.327 1.051 . . . . 0.0 112.26 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 C-N-CA 125.227 1.394 . . . . 0.0 113.473 -177.159 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -76.84 -39.88 49.73 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.398 1.079 . . . . 0.0 112.974 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.7 m -81.64 146.65 29.96 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.22 1.408 . . . . 0.0 111.721 -173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.01 152.95 31.96 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.768 1.627 . . . . 0.0 111.561 168.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.52 158.46 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.547 1.539 . . . . 0.0 113.428 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.0 m -100.01 117.62 34.67 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.01 -27.62 60.18 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.423 0.689 . . . . 0.0 111.402 159.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.5 pm0 -73.78 22.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.789 2.836 . . . . 0.0 114.17 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.72 154.79 87.93 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.19 0.996 . . . . 0.0 112.497 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.21 164.12 36.15 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.33 3.354 . . . . 0.0 112.614 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.03 155.31 37.42 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.961 160.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 tpt85 -63.43 -30.61 71.71 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.167 -0.958 . . . . 0.0 113.021 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -72.03 -33.88 68.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.229 1.012 . . . . 0.0 112.5 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -73.96 -35.29 64.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.963 0.905 . . . . 0.0 111.248 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.83 -34.66 78.3 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 126.248 1.819 . . . . 0.0 111.479 172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -58.09 -23.65 55.57 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.16 1.384 . . . . 0.0 113.895 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 57.8 mtt85 -76.61 -12.74 60.06 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.859 1.664 . . . . 0.0 112.865 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.64 157.11 30.84 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.673 1.124 . . . . 0.0 112.362 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.87 70.09 0.81 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.959 0.904 . . . . 0.0 112.819 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.13 41.56 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.216 -1.325 . . . . 0.0 113.107 172.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.46 110.56 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.68 2.92 . . . . 0.0 111.058 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.2 m -140.18 116.49 10.61 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.833 1.253 . . . . 0.0 109.476 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 76' ' ' PHE . 37.4 tp -85.4 126.93 34.17 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.184 0.594 . . . . 0.0 109.662 168.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.53 111.37 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.165 0.986 . . . . 0.0 108.985 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -105.26 129.52 53.6 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.496 1.918 . . . . 0.0 111.827 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -109.25 137.61 46.86 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.418 1.487 . . . . 0.0 111.22 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 156.35 -148.7 19.04 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.842 1.211 . . . . 0.0 112.184 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 79.0 p -143.02 175.81 9.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.172 1.789 . . . . 0.0 109.953 170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -79.07 -7.43 58.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.139 -0.975 . . . . 0.0 112.877 176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -125.49 -17.11 5.65 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 -163.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 42.9 t -67.68 145.9 54.33 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 120.48 1.491 . . . . 0.0 111.963 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.2 -29.6 75.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.444 1.497 . . . . 0.0 113.326 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -63.39 -46.2 87.54 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.478 1.139 . . . . 0.0 110.736 168.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -62.79 -37.21 85.77 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -65.69 -21.35 66.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.819 1.19 . . . . 0.0 112.431 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.12 -40.09 14.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.343 1.457 . . . . 0.0 112.538 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.82 -29.68 35.91 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -57.06 -56.15 36.55 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.745 177.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.59 -18.84 42.83 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.287 1.991 . . . . 0.0 112.248 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -57.68 7.67 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.75 0.82 . . . . 0.0 108.995 172.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.8 mm? -56.72 -46.41 81.31 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 124.652 1.181 . . . . 0.0 109.13 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.18 67.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -71.93 -45.7 60.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.456 0.702 . . . . 0.0 111.96 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -66.6 -48.92 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 118.785 0.721 . . . . 0.0 112.091 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -23.45 65.22 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.959 1.304 . . . . 0.0 114.009 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.4 m -60.81 -18.15 53.78 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -103.8 -8.18 19.98 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.889 1.276 . . . . 0.0 113.987 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -129.63 45.09 1.58 Allowed Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 125.711 1.604 . . . . 0.0 115.218 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.78 -14.48 43.22 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.845 3.03 . . . . 0.0 114.775 -172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.83 -14.24 60.66 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.94 145.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.177 0.898 . . . . 0.0 108.781 172.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.13 154.0 25.02 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.989 -1.069 . . . . 0.0 112.287 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -136.15 124.78 23.71 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 118.842 1.321 . . . . 0.0 112.173 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.27 111.73 22.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.088 1.355 . . . . 0.0 108.986 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -84.36 102.7 12.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.353 0.661 . . . . 0.0 110.611 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.03 116.74 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.837 1.655 . . . . 0.0 110.2 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -71.76 128.93 37.35 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.809 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -119.97 144.72 47.34 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.273 1.429 . . . . 0.0 111.483 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -144.38 -166.26 11.4 Favored Glycine 0 CA--C 1.54 1.649 0 C-N-CA 125.156 1.36 . . . . 0.0 113.834 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.9 -25.9 22.79 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.276 2.651 . . . . 0.0 112.237 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.53 143.25 19.95 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.438 1.018 . . . . 0.0 111.447 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.53 148.61 41.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.058 0.943 . . . . 0.0 113.321 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -161.65 -176.34 5.24 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.821 2.048 . . . . 0.0 108.35 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.5 tp -38.26 -40.21 0.5 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.884 2.873 . . . . 0.0 116.112 -173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.91 -27.09 66.35 Favored Glycine 0 N--CA 1.483 1.814 0 CA-C-N 120.451 1.478 . . . . 0.0 114.793 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -70.89 -39.07 73.03 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.603 0.761 . . . . 0.0 111.161 171.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -74.68 -19.82 60.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.88 1.272 . . . . 0.0 112.458 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.24 -14.53 55.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.717 1.207 . . . . 0.0 113.017 166.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.18 44.68 12.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.928 1.691 . . . . 0.0 111.35 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.0 t -51.77 135.79 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.469 1.508 . . . . 0.0 112.528 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -74.46 -102.95 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.796 1.638 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tp -70.91 148.72 47.46 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 164.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 49.3 t90 -59.33 -45.37 99.07 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-O 116.772 -1.585 . . . . 0.0 114.667 -171.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -79.26 92.6 1.12 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.236 1.957 . . . . 0.0 109.725 171.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 m -139.92 150.53 44.66 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.641 1.576 . . . . 0.0 108.664 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.569 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.7 OUTLIER -138.64 130.13 27.46 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.941 0.896 . . . . 0.0 110.227 175.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.99 121.03 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.779 1.631 . . . . 0.0 109.294 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.415 ' CG ' HD13 ' A' ' 23' ' ' LEU . 37.2 m-85 -86.09 116.09 24.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.856 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.39 154.68 20.96 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.39 1.476 . . . . 0.0 110.715 176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -159.91 130.21 5.55 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.113 1.765 . . . . 0.0 108.585 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.6 t70 60.22 23.22 12.59 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 125.149 1.379 . . . . 0.0 112.689 -171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.49 -5.15 74.95 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.364 1.459 . . . . 0.0 114.91 -176.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.9 ttm-85 -102.52 141.86 34.65 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 109.975 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.02 122.17 15.89 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.515 0.726 . . . . 0.0 109.904 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -96.53 -22.72 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.511 1.124 . . . . 0.0 112.396 172.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.66 177.94 2.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.677 1.991 . . . . 0.0 111.291 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -153.92 155.21 35.25 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.343 1.057 . . . . 0.0 110.693 163.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 58.5 t -121.12 125.5 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.04 137.25 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.943 1.697 . . . . 0.0 107.75 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.4 tpt85 40.81 80.67 0.27 Allowed Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 126.651 1.98 . . . . 0.0 114.892 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.9 129.37 28.69 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.738 2.959 . . . . 0.0 111.052 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.83 -32.85 13.75 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 123.912 0.768 . . . . 0.0 113.813 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.3 t -173.7 164.33 4.37 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.526 2.331 . . . . 0.0 109.494 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.13 -34.43 63.73 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.442 1.097 . . . . 0.0 112.149 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.9 p -54.92 -36.38 65.17 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.99 -41.22 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.237 1.415 . . . . 0.0 110.886 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.552 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.88 -49.29 53.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.816 0.447 . . . . 0.0 111.833 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.58 -42.19 78.25 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.703 1.201 . . . . 0.0 113.175 173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -57.04 -36.0 69.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.669 1.188 . . . . 0.0 112.531 176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.13 -47.34 29.03 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.179 -0.951 . . . . 0.0 111.414 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.64 -50.7 67.51 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.956 0.798 . . . . 0.0 111.626 -177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -33.04 73.1 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 t -67.59 -33.24 74.6 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.684 -0.635 . . . . 0.0 112.607 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -94.12 -25.9 16.95 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.89 -28.75 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.04 0.936 . . . . 0.0 111.803 173.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.56 -13.04 39.3 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.512 2.006 . . . . 0.0 114.688 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -55.92 -29.11 59.55 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.224 1.409 . . . . 0.0 113.063 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.064 0.84 . . . . 0.0 114.807 176.669 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -72.83 -24.27 60.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.643 0.777 . . . . 0.0 111.924 166.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.5 m -71.73 141.6 49.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.658 1.983 . . . . 0.0 110.064 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.83 168.05 12.29 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.126 1.371 . . . . 0.0 113.431 -174.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -59.28 163.0 4.14 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.007 1.323 . . . . 0.0 113.017 164.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -137.88 139.86 40.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.45 -8.9 59.61 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.04 1.336 . . . . 0.0 113.235 171.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -85.43 19.29 2.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.173 1.389 . . . . 0.0 113.047 -172.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 154.52 90.25 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.595 1.158 . . . . 0.0 113.203 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.66 165.75 31.57 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 124.535 3.49 . . . . 0.0 112.84 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.08 154.57 33.2 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.233 162.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -60.8 -37.87 83.44 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.501 -0.75 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.07 -20.05 65.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.298 1.439 . . . . 0.0 114.284 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.28 -37.9 12.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.55 1.14 . . . . 0.0 110.986 172.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.39 -30.49 71.53 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.808 1.643 . . . . 0.0 112.136 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -53.6 -25.33 16.96 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.647 1.979 . . . . 0.0 113.318 172.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -79.39 -11.41 59.92 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.207 1.003 . . . . 0.0 113.06 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.31 168.14 5.96 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.201 0.909 . . . . 0.0 113.416 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.76 143.42 29.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.978 0.911 . . . . 0.0 111.25 167.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.15 162.02 22.74 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.322 1.915 . . . . 0.0 112.156 -175.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.5 122.33 8.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.903 2.402 . . . . 0.0 110.654 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -141.47 127.4 19.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.424 1.09 . . . . 0.0 109.289 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 76' ' ' PHE . 29.7 tp -94.68 130.96 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.468 0.707 . . . . 0.0 109.858 171.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.7 113.27 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.473 1.109 . . . . 0.0 109.136 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -110.28 127.87 55.23 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.85 1.66 . . . . 0.0 111.714 -172.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -101.77 139.47 37.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.147 1.379 . . . . 0.0 110.95 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.38 -153.05 24.34 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.704 1.145 . . . . 0.0 112.122 -177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -142.85 178.62 7.54 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.805 1.642 . . . . 0.0 109.239 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -84.77 -3.21 58.5 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.532 -1.355 . . . . 0.0 112.403 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -125.66 -13.0 6.56 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -165.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.82 143.42 52.9 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.37 1.441 . . . . 0.0 111.276 173.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.16 70.67 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.015 1.293 . . . . 0.0 113.98 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -65.76 -48.0 73.33 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.974 1.387 . . . . 0.0 110.737 166.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.6 m -61.44 -37.24 82.84 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -62.39 -24.82 67.6 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.771 0.714 . . . . 0.0 112.433 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.71 -37.84 14.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.394 1.478 . . . . 0.0 112.733 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.69 36.83 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -52.66 -56.45 22.87 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 117.894 -1.051 . . . . 0.0 113.327 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.9 -21.49 37.57 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.4 2.066 . . . . 0.0 112.378 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -64.97 -56.56 12.47 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.258 1.023 . . . . 0.0 109.391 176.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.57 -43.26 99.18 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.169 0.988 . . . . 0.0 109.217 178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.58 76.79 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.69 -41.96 71.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.222 0.609 . . . . 0.0 111.405 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' A' ' 97' ' ' LEU . 93.1 t -68.19 -50.74 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.792 . . . . 0.0 110.971 -178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -57.39 -16.19 8.51 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.947 1.699 . . . . 0.0 112.771 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.4 t -63.56 -27.05 68.99 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 118.331 0.514 . . . . 0.0 112.111 175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -98.74 -12.07 21.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.534 1.134 . . . . 0.0 113.559 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -126.29 48.85 3.28 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 125.183 1.393 . . . . 0.0 114.1 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -62.59 -18.13 62.05 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.128 2.552 . . . . 0.0 113.825 -175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.39 -15.97 63.98 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.73 140.43 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.824 1.25 . . . . 0.0 108.802 174.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.51 156.87 25.17 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.218 0.913 . . . . 0.0 112.842 174.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -129.37 129.71 45.11 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.392 1.096 . . . . 0.0 111.917 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 109.75 19.47 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.183 1.393 . . . . 0.0 108.939 178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -89.35 96.53 10.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.806 0.842 . . . . 0.0 111.23 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.9 t -88.95 116.49 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.542 1.137 . . . . 0.0 110.492 -173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -64.78 105.95 1.1 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.756 0.789 . . . . 0.0 110.418 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -105.23 -163.1 0.92 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.409 1.884 . . . . 0.0 109.481 169.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 -166.15 38.52 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 119.754 -1.841 . . . . 0.0 115.047 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.52 -41.74 74.85 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 124.23 3.287 . . . . 0.0 112.172 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.74 109.26 3.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -67.59 146.48 53.84 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.731 0.812 . . . . 0.0 112.346 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.8 mtm-85 -119.56 -122.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.709 1.604 . . . . 0.0 109.604 173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.6 tp -53.56 -37.45 62.9 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.392 1.477 . . . . 0.0 113.352 -169.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.24 -22.85 63.57 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.487 1.04 . . . . 0.0 114.553 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -70.92 -37.54 72.93 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.482 1.141 . . . . 0.0 111.751 170.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -77.6 -16.34 58.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.598 1.159 . . . . 0.0 112.705 178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -87.26 -9.01 56.13 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.71 1.204 . . . . 0.0 113.085 161.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 59.23 48.07 10.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.437 1.895 . . . . 0.0 111.045 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.1 t -65.63 137.09 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.621 1.568 . . . . 0.0 111.25 177.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -83.49 -45.61 13.41 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.8 tp -92.83 -124.79 0.09 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.743 1.217 . . . . 0.0 108.83 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.483 ' H ' ' HD2' ' A' ' 74' ' ' PRO . 30.3 t90 -150.23 -49.51 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 116.712 -1.613 . . . . 0.0 113.062 169.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 73' ' ' TRP . 88.5 Cg_endo -72.49 94.0 0.76 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.266 1.978 . . . . 0.0 108.829 168.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 78.3 m -150.53 143.34 24.63 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.504 1.522 . . . . 0.0 107.898 -168.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -138.29 125.41 21.48 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.774 0.797 . . . . 0.0 110.476 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.39 123.1 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.916 1.686 . . . . 0.0 109.052 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 23' ' ' LEU . 47.0 m-85 -84.54 117.32 23.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.189 0.995 . . . . 0.0 109.035 177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.03 155.91 18.04 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.226 1.41 . . . . 0.0 109.655 174.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -161.92 131.82 4.72 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.195 1.798 . . . . 0.0 109.485 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.7 t70 60.63 25.85 15.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.277 1.431 . . . . 0.0 112.874 -173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.21 5.37 87.32 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.012 1.292 . . . . 0.0 114.864 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttt-85 -113.47 143.16 44.97 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 126.42 1.888 . . . . 0.0 109.443 -178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -62.04 128.13 34.66 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.638 -0.664 . . . . 0.0 109.309 168.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.6 m -103.43 -24.1 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.52 1.128 . . . . 0.0 111.995 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.21 -179.73 2.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -157.04 155.47 31.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.617 1.167 . . . . 0.0 111.512 163.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 70.9 t -127.35 145.18 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.323 1.449 . . . . 0.0 109.23 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 p -140.31 143.97 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.633 1.573 . . . . 0.0 109.513 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 45.19 68.87 2.92 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 127.196 2.198 . . . . 0.0 113.522 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.65 -43.77 15.93 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 124.434 3.423 . . . . 0.0 115.199 -161.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.26 -55.79 4.02 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.23 0.919 . . . . 0.0 114.541 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.2 m -148.71 142.28 25.42 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.595 1.158 . . . . 0.0 111.601 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.62 -34.79 27.5 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.889 1.276 . . . . 0.0 112.128 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.7 m -56.32 -30.99 63.29 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 81.6 t -87.46 -37.45 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.174 0.989 . . . . 0.0 111.098 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -72.07 -47.19 53.31 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.877 0.871 . . . . 0.0 111.451 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.6 mt-10 -61.14 -38.32 85.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.21 1.004 . . . . 0.0 111.731 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.43 -36.96 74.44 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.853 1.261 . . . . 0.0 112.122 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.31 -44.79 51.15 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.515 -0.741 . . . . 0.0 111.278 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -57.02 -49.91 74.35 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 120.885 -1.135 . . . . 0.0 112.119 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.05 -32.45 70.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.6 t -69.41 -30.39 68.34 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -99.06 -24.65 14.82 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.22 -28.04 34.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.034 0.933 . . . . 0.0 110.971 170.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 105.33 -7.98 44.0 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.802 1.667 . . . . 0.0 114.75 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -67.4 -23.22 65.54 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.53 1.132 . . . . 0.0 112.932 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.312 0 C-N-CA 125.312 1.434 . . . . 0.0 115.322 174.661 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -68.22 -9.58 48.17 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 116.584 2.068 . . . . 0.0 116.584 -171.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.4 p -69.32 162.74 26.62 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.027 1.731 . . . . 0.0 112.574 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.62 161.83 16.84 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.42 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 40.9 m-85 -67.0 164.68 17.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.79 1.636 . . . . 0.0 114.843 175.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.8 t -129.01 132.57 47.53 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 172.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.83 -15.89 58.73 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.101 0.96 . . . . 0.0 113.17 171.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.87 40.13 1.01 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 111.816 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.52 156.67 76.5 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 124.456 1.102 . . . . 0.0 112.226 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.85 160.76 45.26 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.688 2.925 . . . . 0.0 112.054 175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.12 153.91 40.57 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 167.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.2 ttt-85 -63.51 -26.86 68.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -68.06 -31.14 70.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.341 1.457 . . . . 0.0 113.729 171.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -81.05 -36.95 29.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.0 0.92 . . . . 0.0 111.0 174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.44 -33.37 74.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.559 1.943 . . . . 0.0 111.248 174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -61.61 -19.17 61.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.333 1.453 . . . . 0.0 112.717 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -82.35 -12.49 57.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.363 1.465 . . . . 0.0 113.087 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.11 165.36 13.7 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.225 0.92 . . . . 0.0 112.567 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -135.14 -45.57 0.71 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.94 168.37 54.79 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.247 -0.751 . . . . 0.0 113.226 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.83 112.16 1.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.132 2.555 . . . . 0.0 109.666 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.1 m -129.34 118.07 21.65 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.248 1.019 . . . . 0.0 109.652 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 76' ' ' PHE . 26.6 tp -86.74 133.4 33.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.369 0.668 . . . . 0.0 110.059 171.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 111.99 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.039 1.336 . . . . 0.0 108.793 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.18 129.75 55.49 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 112.049 -171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -104.94 128.69 53.29 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.969 1.308 . . . . 0.0 110.293 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.68 -160.18 30.24 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.009 0.814 . . . . 0.0 113.853 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 71.4 p -148.5 168.24 23.25 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.036 2.134 . . . . 0.0 109.019 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.02 0.98 33.29 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.419 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -130.14 -15.91 3.67 Favored 'General case' 0 CA--C 1.552 1.019 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -166.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -71.28 142.61 50.51 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 120.405 1.457 . . . . 0.0 111.667 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.12 -26.28 71.41 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.353 1.454 . . . . 0.0 113.381 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.01 -48.29 80.95 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.987 1.393 . . . . 0.0 110.759 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.2 m -65.03 -35.55 81.53 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.955 0.902 . . . . 0.0 112.799 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -63.56 -23.65 67.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.903 0.774 . . . . 0.0 111.731 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.85 -40.3 13.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.296 1.438 . . . . 0.0 112.412 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.95 -29.99 28.65 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.215 0.916 . . . . 0.0 113.248 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -58.44 -53.8 62.48 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.615 -1.183 . . . . 0.0 112.995 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.59 -18.25 37.9 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.906 1.737 . . . . 0.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -57.27 7.47 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.83 0.852 . . . . 0.0 109.38 174.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -58.93 -42.64 90.25 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 123.853 0.861 . . . . 0.0 109.582 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.56 -38.88 75.51 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.616 0.766 . . . . 0.0 112.695 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.44 -46.11 60.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.318 0.647 . . . . 0.0 111.967 177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 HD22 ' A' ' 97' ' ' LEU . 2.5 p -65.88 -49.74 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.558 1.072 . . . . 0.0 112.08 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -56.52 -25.35 51.38 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.752 1.221 . . . . 0.0 113.416 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.9 m -63.43 -20.15 65.31 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -99.34 -10.92 21.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.638 1.175 . . . . 0.0 113.177 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -127.97 48.11 3.2 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.633 1.573 . . . . 0.0 114.052 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.53 -16.83 57.02 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.049 2.499 . . . . 0.0 114.085 -174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.4 -14.48 62.93 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.312 1.226 . . . . 0.0 114.312 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.64 140.27 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.351 1.06 . . . . 0.0 108.857 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.05 155.12 24.24 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 124.571 1.082 . . . . 0.0 112.328 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -128.16 134.76 49.12 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 118.544 1.172 . . . . 0.0 111.683 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.17 108.4 16.11 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.764 1.226 . . . . 0.0 108.665 172.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 33.3 mtmt -83.97 96.99 9.02 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.076 0.95 . . . . 0.0 111.914 175.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 t -86.65 113.15 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.192 1.397 . . . . 0.0 109.763 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -72.38 111.21 7.37 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.574 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -94.0 141.78 28.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.334 1.053 . . . . 0.0 112.197 -175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.93 -172.19 43.17 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.107 1.336 . . . . 0.0 113.472 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.99 138.28 61.73 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.277 2.651 . . . . 0.0 110.125 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.69 1.4 90.54 Favored Glycine 0 CA--C 1.536 1.349 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.625 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -115.46 129.38 56.54 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.633 1.573 . . . . 0.0 110.14 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.12 -16.69 12.98 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -166.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.36 -48.4 80.71 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.678 1.126 . . . . 0.0 112.297 -168.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.45 -26.74 72.8 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-N 119.123 0.874 . . . . 0.0 114.089 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -71.09 -39.87 71.86 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.777 0.788 . . . . 0.0 111.228 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -76.26 -12.57 60.1 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.362 1.065 . . . . 0.0 113.686 174.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -87.7 -11.15 49.14 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.363 1.065 . . . . 0.0 113.456 161.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 56.2 48.25 17.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.932 1.293 . . . . 0.0 109.965 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -55.65 135.92 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.507 1.523 . . . . 0.0 110.939 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.54 -97.59 0.05 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.208 1.403 . . . . 0.0 110.767 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tp -73.45 143.13 46.79 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 165.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -54.07 -42.55 94.04 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -171.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.95 85.33 1.87 Allowed 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.386 2.057 . . . . 0.0 110.428 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.0 m -127.32 148.34 50.24 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.724 1.61 . . . . 0.0 108.805 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.546 ' HB2' HD11 ' A' ' 23' ' ' LEU . 0.5 OUTLIER -136.65 126.74 26.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.493 1.117 . . . . 0.0 109.546 171.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.8 t -102.79 123.59 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.855 1.662 . . . . 0.0 109.154 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -86.02 116.33 24.17 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.253 1.021 . . . . 0.0 108.808 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -103.69 155.56 18.48 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.147 1.379 . . . . 0.0 109.587 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -167.98 138.84 2.79 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 126.6 1.96 . . . . 0.0 108.478 172.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 t70 63.14 26.68 15.42 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.786 1.235 . . . . 0.0 112.517 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.56 8.22 87.91 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.061 1.315 . . . . 0.0 114.628 -175.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -135.86 144.44 45.62 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.477 1.511 . . . . 0.0 111.131 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -66.46 119.7 12.1 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.9 m -94.46 -23.97 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.239 1.015 . . . . 0.0 112.067 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -173.27 178.97 2.29 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 126.385 1.874 . . . . 0.0 110.875 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -153.0 156.97 39.85 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.094 0.958 . . . . 0.0 110.627 160.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 71.6 t -124.33 140.4 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.588 1.155 . . . . 0.0 108.091 173.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 p -137.08 137.02 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 125.473 1.509 . . . . 0.0 109.575 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 52.24 69.38 2.46 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 125.974 1.71 . . . . 0.0 112.204 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.61 122.23 10.74 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.591 2.861 . . . . 0.0 110.878 -173.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.53 -29.36 33.02 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.57 0.605 . . . . 0.0 114.07 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.5 t -172.86 162.27 4.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.856 2.062 . . . . 0.0 109.752 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.06 63.61 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.671 1.188 . . . . 0.0 112.247 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 p -52.92 -42.52 65.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.321 0.964 . . . . 0.0 112.907 173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 56.1 t -74.95 -38.75 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.776 1.231 . . . . 0.0 111.253 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -70.15 -49.8 46.87 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.915 0.486 . . . . 0.0 111.188 177.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.4 -41.69 73.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.22 1.408 . . . . 0.0 112.96 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -57.7 -34.42 69.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.37 1.068 . . . . 0.0 113.139 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.05 -44.26 26.92 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.747 -0.596 . . . . 0.0 110.975 172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -57.58 -48.97 77.9 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.028 -1.045 . . . . 0.0 111.869 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.82 69.12 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.8 t -74.01 -30.46 62.47 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.576 -0.703 . . . . 0.0 112.305 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -101.8 -23.82 14.14 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.99 -27.0 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.416 1.086 . . . . 0.0 111.125 168.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.02 21.46 25.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.005 1.288 . . . . 0.0 113.609 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.45 -29.55 57.01 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.117 0.959 . . . . 0.0 111.171 170.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.128 0 C-N-CA 124.018 0.818 . . . . 0.0 111.668 164.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 CA--C 1.541 0.609 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.75 -12.9 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.018 1.327 . . . . 0.0 114.569 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.9 p -71.64 -68.1 0.48 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.36 1.864 . . . . 0.0 111.973 -176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -176.41 2.35 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.235 1.814 . . . . 0.0 113.118 177.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 55' ' ' LYS . 29.8 m-85 -62.85 159.08 17.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.7 m -121.66 124.36 44.1 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.338 1.055 . . . . 0.0 112.943 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.04 -25.0 47.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.608 0.763 . . . . 0.0 112.763 172.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.81 32.78 0.14 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.502 1.921 . . . . 0.0 113.966 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.02 62.57 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 124.665 1.186 . . . . 0.0 112.768 177.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.84 159.13 54.18 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.82 3.013 . . . . 0.0 112.335 174.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.9 164.84 24.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.936 0.894 . . . . 0.0 111.329 165.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.9 -40.57 69.95 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 0.0 112.34 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.15 -29.6 61.87 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.242 1.017 . . . . 0.0 113.281 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -76.62 -35.84 57.82 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.933 0.893 . . . . 0.0 110.94 174.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.8 tt -66.65 -40.13 88.54 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.377 1.471 . . . . 0.0 112.225 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.45 -21.87 62.82 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.461 1.104 . . . . 0.0 113.401 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -83.21 -10.05 58.81 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.597 1.959 . . . . 0.0 113.114 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.12 166.99 10.76 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.613 1.097 . . . . 0.0 112.036 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.09 -34.23 0.66 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.06 170.38 54.61 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-N 118.832 0.742 . . . . 0.0 113.99 -170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.47 107.68 1.26 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.879 3.053 . . . . 0.0 109.811 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.0 m -121.71 153.35 38.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.11 1.364 . . . . 0.0 110.161 -169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 76' ' ' PHE . 40.7 tp -127.76 122.79 33.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.298 1.039 . . . . 0.0 108.62 164.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.3 113.7 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.924 0.89 . . . . 0.0 108.947 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.68 129.86 54.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.501 1.521 . . . . 0.0 111.352 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -103.81 134.15 47.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.768 1.227 . . . . 0.0 110.124 174.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 169.34 -163.4 37.04 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 114.173 0.429 . . . . 0.0 114.173 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.0 p -141.74 174.28 10.72 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.143 1.777 . . . . 0.0 109.445 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -84.8 -0.65 54.57 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.162 -0.961 . . . . 0.0 112.284 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -128.88 -17.86 3.9 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -165.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 52.6 t -68.87 142.24 54.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.273 1.397 . . . . 0.0 111.506 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -26.5 70.75 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.156 1.36 . . . . 0.0 113.933 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -63.82 -47.69 79.81 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.552 1.176 . . . . 0.0 111.342 167.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.4 m -63.65 -35.43 80.49 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.761 0.824 . . . . 0.0 113.012 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -63.05 -23.01 67.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.045 0.838 . . . . 0.0 112.123 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.79 -38.87 13.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.536 1.534 . . . . 0.0 113.081 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.87 -29.41 23.71 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -58.72 -53.68 63.88 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 118.176 -0.916 . . . . 0.0 112.715 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.54 -17.21 38.7 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.88 1.72 . . . . 0.0 112.224 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -55.63 10.93 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.203 0.601 . . . . 0.0 109.514 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -56.37 -46.16 80.19 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 123.858 0.863 . . . . 0.0 108.774 176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.5 65.58 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -74.99 -49.02 21.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.369 0.668 . . . . 0.0 111.748 175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 97' ' ' LEU . 2.7 p -64.18 -47.66 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.177 0.899 . . . . 0.0 112.117 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -21.76 64.97 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.842 1.257 . . . . 0.0 113.882 -173.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.4 t -58.04 -21.63 46.24 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -101.89 -10.42 19.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 175.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -128.87 42.42 0.89 Allowed Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -60.73 -16.49 44.05 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.446 2.764 . . . . 0.0 114.429 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.58 -17.15 64.07 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 172.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 77.9 t -76.5 140.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.404 1.002 . . . . 0.0 109.478 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 110.55 3.83 Favored Glycine 0 N--CA 1.475 1.25 0 O-C-N 121.048 -1.032 . . . . 0.0 111.691 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -89.67 131.26 35.74 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.134 1.467 . . . . 0.0 111.465 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.3 tp -115.37 104.81 12.15 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.341 1.457 . . . . 0.0 110.126 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 5' ' ' TYR . 35.1 mtmt -82.69 94.23 7.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.436 1.094 . . . . 0.0 111.533 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.3 117.38 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.97 0.908 . . . . 0.0 110.547 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -76.21 118.59 19.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.024 177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -100.12 171.16 7.99 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.021 1.329 . . . . 0.0 112.022 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -164.23 -169.96 28.5 Favored Glycine 0 CA--C 1.536 1.403 0 O-C-N 120.908 -1.12 . . . . 0.0 113.682 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -54.26 -40.86 80.59 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 124.282 3.321 . . . . 0.0 113.165 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.85 4.62 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 161.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -77.3 134.76 38.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 117.335 0.567 . . . . 0.0 112.257 -167.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -79.8 -85.46 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.466 1.506 . . . . 0.0 112.196 -169.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.0 tp -106.42 -33.95 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.099 0.96 . . . . 0.0 113.523 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.52 -22.0 63.2 Favored Glycine 0 N--CA 1.481 1.652 0 CA-C-N 119.591 1.087 . . . . 0.0 113.395 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -52.53 -50.02 63.68 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.177 1.791 . . . . 0.0 111.857 163.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.4 m -87.09 -3.84 59.1 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.986 1.714 . . . . 0.0 113.377 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -94.64 -2.63 50.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.779 1.231 . . . . 0.0 112.624 159.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 56.48 44.39 24.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.384 1.473 . . . . 0.0 110.346 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.92 136.28 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 111.956 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -81.17 -86.51 0.09 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.778 1.231 . . . . 0.0 110.788 177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.5 tp -80.74 138.44 36.31 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.028 0.831 . . . . 0.0 109.711 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -57.78 -44.94 99.8 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.47 90.89 0.89 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.503 2.136 . . . . 0.0 110.253 175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.8 m -141.44 145.66 35.56 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.66 1.584 . . . . 0.0 109.614 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CE2' HD21 ' A' ' 97' ' ' LEU . 0.3 OUTLIER -139.13 129.5 25.59 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.659 1.183 . . . . 0.0 109.136 175.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.3 t -105.62 120.4 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.856 1.662 . . . . 0.0 109.233 -172.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.428 ' CG ' HD13 ' A' ' 23' ' ' LEU . 42.3 m-85 -82.71 121.85 27.4 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.924 0.889 . . . . 0.0 108.769 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.7 mp -113.95 155.8 25.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.914 1.686 . . . . 0.0 111.219 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.4 ttp180 -165.68 138.62 4.28 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.594 1.957 . . . . 0.0 109.285 173.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 22.0 t70 62.63 20.89 12.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.873 1.269 . . . . 0.0 112.842 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.88 -5.28 85.36 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.716 1.15 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -115.13 156.5 25.14 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.87 1.668 . . . . 0.0 110.289 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -66.04 130.26 42.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.755 0.822 . . . . 0.0 110.837 170.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.5 m -102.37 -23.63 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 169.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -171.86 178.87 2.9 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.412 1.885 . . . . 0.0 110.765 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -153.31 158.3 41.38 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.718 0.807 . . . . 0.0 111.133 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' CE2' ' A' ' 76' ' ' PHE . 55.4 t -117.47 121.54 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 91.7 t -109.79 126.46 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.67 1.588 . . . . 0.0 107.306 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 55.12 80.0 0.31 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 125.286 1.435 . . . . 0.0 112.8 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.19 120.26 7.54 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.81 2.34 . . . . 0.0 110.083 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.3 -24.19 52.14 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 114.287 0.475 . . . . 0.0 114.287 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.8 t -176.93 162.47 2.08 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.177 2.191 . . . . 0.0 109.453 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.1 -34.88 58.62 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.979 0.912 . . . . 0.0 111.301 173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.7 m -60.94 -23.1 65.03 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 175.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.9 -43.85 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.258 1.423 . . . . 0.0 110.108 174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.543 HD21 ' CE2' ' A' ' 76' ' ' PHE . 0.5 OUTLIER -69.45 -50.45 45.45 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.191 0.596 . . . . 0.0 112.134 -177.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -55.1 -44.41 74.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.36 1.064 . . . . 0.0 112.447 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -56.22 -39.3 72.29 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.659 1.184 . . . . 0.0 112.55 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.56 62.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.501 -0.75 . . . . 0.0 111.956 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -61.38 -51.73 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.893 -1.129 . . . . 0.0 110.76 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -34.85 74.75 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 176.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -69.37 -27.32 65.23 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.77 -24.69 13.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.489 1.116 . . . . 0.0 113.153 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -22.13 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.911 0.884 . . . . 0.0 111.609 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.89 10.91 54.68 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.491 1.519 . . . . 0.0 114.932 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -90.0 -16.71 29.28 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.186 1.394 . . . . 0.0 112.965 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 C-N-CA 125.964 1.745 . . . . 0.0 113.916 -177.728 . . . . . . . . 0 0 . 1 stop_ save_